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SUMMARY
 
The goal of this study is to try to understand multi-strain diseases with the pres­
ence of cross-immunity by using mathematical models and other mathematical tools. 
Cross-immunity occurs when a host who is exposed to one disease, or one strain of a 
disease, develops resistance or partial resistance to related diseases or strains. It is an 
important factor in the epidemiology of diseases prone to mutation. This work includes 
modelling inﬂuenza in both presence and absence of controls. It also includes modelling 
malaria when cross-species immunity is present. In addition, vector-bias of mosquitoes 
to infected humans is also studied in the single-strain malaria model. 
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Chapter 1 
Introduction 
Public health has been challenged by the reemergence of infectious diseases for decades. 
The pathogens mutate to evade host immunity which is acquired from previous infec­
tion, vaccination or in response to antiviral drugs. Pathogen mutations are found 
commonly in many reemerging infectious diseases such as: 1) measles (Cattaneo et al., 
1988), 2) hepatitis B (Carman et al., 1990; Sato et al., 1995; Chen and Oon, 2000), 3) 
HIV (Eron et al., 1998), 4) West Nile virus (Ebel et al., 2001), 5) pertussis (Cassiday 
et al., 2000; Weber et al., 2001), 6) malaria (Gupta, Trenholme, Anderson and Day, 
1994), and 7) inﬂuenza (Palese and Young, 1982; Webster, 1998). 
A determinant of epidemic behaviour relates to time scale of infection dynamics and 
replenishment of susceptible hosts so that the epidemiological distinction is between 
fast infections and persistent infections (Gog and Grenfell, 2002). Conversely, phylo­
genic patterns are aﬀected by natural selection arising from cross-immunity and neutral 
epidemiology processes such as spatial population separation. Pathogen strains and 
phylogenic lineages are produced by mutation, and their survival depends upon the 
epidemiological and immunological forces (Grenfell et al., 2004). Consequently, RNA 
viruses are categorized as follows: 1) short infections with strong cross-immunity (e.g. 
measles), 2) short infections with partial cross-immunity (e.g.inﬂuenza A), 3) infections 
with immune enhancement (e.g. dengue), and 4) persistent infections (e.g. HIV, HCV). 
There are three types of inﬂuenza viruses A, B, and C. Inﬂuenza A is additionally 
classiﬁed by subtype on the basis of the two main surface glycoproteins haemagglutinin 
(HA) and neuraminidase (NA). Subtypes currently circulating in the human population 
include H1N1, H2N2, and H3N2 viruses. Subtypes are further classiﬁed by strains. 
Antigenic variation in inﬂuenza A is driven by two important mechanisms called anti­
genic shift and drift. Antigenic shift generates a new subtype; antigenic binding sites 
are very diﬀerent in diﬀerent subtypes, so that immunity gained to strains of one sub­
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type is virtually useless against strains of another (Webster et al., 1992). The major 
shift is frequently contributed by genetic reassortment or the mixing between genetic 
material between diﬀerent strains (Holmes et al., 2005; Nelson and Holmes, 2007; Car-
rat and Flahault, 2007). The new viral subtype is normally associated with pandemics. 
The pandemic inﬂuenza viruses of 1957 (H2N2) and 1968 (H3N2) arose through reas­
sortment between human and avian viruses, while the Spanish ﬂu virus of 1918 (H1N1) 
appears to be entirely derived from an avian source (Belshe, 2005). The pandemic ﬂu 
virus of 2009 (H1N1) contains genes from diverse strains of inﬂuenza originating in 
humans, birds, and pigs (Smith et al., 2009). On the other hand, we shall concern with 
antigenic drift, which generates a new strain by gradually changing the composition of 
the antigenic sites by point mutations. The new virus is normally responsible for an 
annual epidemic. Gupta et al. (1996, 1998) give the concept of a cluster of strains as a 
collection of independently transmitted strains with nonoverlapping repertoires of dom­
inant polymorphic determinants that organize themselves. Although a point mutation 
always produces a new strain that has the same distance away in genotype space, the 
distance in antigenic space is variable (Smith et al., 2004; Koelle et al., 2006). More­
over, there is higher rate of antigenic evolution between clusters than within clusters. 
Antigenic evolution is punctuated while genetic evolution is more continuous. Because 
the new strain from antigenic drift process is not very diﬀerent from the ancestor, host 
immune system might recognize it via the mechanism called cross-immunity. Some 
evidences show that cross-immunity plays an important roles between getting infected 
with the diﬀerent strain from previous infection(s) (Larson et al., 1978; Davies et al., 
1984). However, cross-immunity between subtypes has no clear pattern and is low 
(Frank et al., 1983; Sonoguchi et al., 1985). 
Cross-immunity occurs when a host who is exposed to one disease, or one strain of a 
disease, develops resistance or partial resistance to related diseases or strains. It is an 
important factor in the epidemiology of diseases prone to mutation (Larson et al., 1978; 
Davies et al., 1984). It can act in many ways such as: 1) reducing susceptibility when 
hosts get infected with one strain and become less susceptible to other similar strains, 
2) reducing infectivity during subsequent infections with similar strains from previous 
infection, and 3) polarizing immunity when only some individuals acquire complete 
immunity to certain strains from previous infection while others gain no immunity. 
Cross-immunity is high between diﬀerent strains in the same subtype while it is very 
low if they are from diﬀerent subtypes (Frank et al., 1983; Sonoguchi et al., 1985). In 
inﬂuenza A, cross-immunity between diﬀerent strains can be estimated by the distance 
between them on the antigenic space. 
Mathematical epidemiological models have often been used to study the dynamics of 
microparasites in a host population (Kermack and McKendrick, 1927; Becker, 1978; 
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Anderson and May, 1991; Herbert, 2000; Grenfell et al., 2001). It is now known that 
in some infectious diseases modelling a single pathogen strain that reduces lifelong 
immunity is not enough to explain their epidemics. Hence, several types of models 
have been developed to account for multi-strain diseases: for instance, models under 
a competitive exclusion where the strain with a maximum basic reproductive ratio 
outcompete others and survive in the host population (Bremermann and Thieme, 1989), 
models for superinfection in which one strain of a pathogen displaces another in an 
infected host (Nowak and May, 1994), models for coinfection which coexistence of 
diﬀerent strains in the same host is possible (May and Nowak, 1995) , and cross-
immunity models in which getting infected with one strain may protect the host from 
certain related strains (Castillo-Chavez et al., 1989; Gupta et al., 1996; Andreasen 
et al., 1997; Feng and Velasco-Hernandez, 1997; Gupta et al., 1998; Lin et al., 1999; 
Gog and Swinton, 2002; Gog and Grenfell, 2002; Kamo and Sasaki, 2002; Lin et al., 
2003; Restif and Grenfell, 2006a; Adams and Sasaki, 2007). In this work, we are 
particularly interested in modelling multi-strain diseases with cross-immunity. Models 
of cross-immunity can be separated into at least two types: 1) history-based models in 
which hosts are categorized by their immune memory (Gupta, Trenholme, Anderson 
and Day, 1994; Andreasen et al., 1997; Gupta et al., 1998), and 2) status-based models 
in which hosts are categorized by their current immune status (Gog and Swinton, 2002; 
Gog and Grenfell, 2002). Many models in this work are based on the latter. 
Controlling diseases is important for public health, to reduce the loss from infections 
and try to stop the the spread of the diseases. Several methods are used in controlling 
infectious diseases, such as vaccination, isolation, applying drugs and treatment. In 
this work, we concentrate on only the ﬁrst two strategies and the combination between 
them. Vaccination is one of the most eﬃcient ways to control infectious diseases. The 
most successful example is smallpox which has been completely eradicated in all coun­
tries. The aim of vaccination is to reduce the prevalence of the diseases and decrease 
susceptibility of a population. However, vaccines against highly mutable viruses such 
as inﬂuenza have to be reformulated annually to control the disease. Some examples of 
modelling multi-strain diseases with vaccination are as follows: Gupta et al. (1998); Res­
tif and Grenfell (2006b); Raimundo et al. (2007); Gandon and Day (2007); Martcheva 
et al. (2008); Billings et al. (2008). Isolation is used to prevent infected individuals 
from further contacts and subsequent transmissions to other individuals. It is normally 
primarily used to control the disease when it suddenly emerges or reemerges. However, 
the disadvantages of isolation are the diﬃculty of detecting infected individuals and 
the cost of isolation and treatment. Although multi-strain models have been developed 
frequently, models including isolation are still scant (Nuno et al., 2005, 2007). 
According to the characteristics of the diseases, we separate the studies of modelling 
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multi-strain diseases into two diﬀerent chapters (2&3), modelling directly transmitted 
multi-strain diseases and modelling vector-borne diseases. Other types of multi-strain 
diseases such as sexually transmitted diseases will be roughly mentioned in the litera­
ture review part, which is mainly divided into two parts, modelling multi-strain diseases 
with and without controls. The studies of control strategies in multi-strains models can 
be found in Chapter 4. Lastly, we summarize all this work in Chapter 5. 
1.1 Literature review 
1.1.1 Modelling multi-strain diseases 
Modelling cross-immunity 
In this part, we introduce several models of cross-immunity from previous authors. Our 
work is developed from some models we mention here. 
Gupta et al. (1996) created a model for genetic exchange of a sexually reproducing 
pathogen population, Neisseria meningitidis, in the human hosts. It is assumed that a 
locus encodes a set of dominant immunogens. A strain is deﬁned by its alleles at a small 
number of loci instead of by its entire genotype. Each locus consists of alleles and each 
combination of alleles generates a particular antigenic type. The model is more general 
than this, but let us assume that there are two dominant loci each with two alleles, four 
possible types of strains are ay, ax, bx, by, ranged as strain 1-4, where a and b are alleles 
of the ﬁrst locus, and x and y are alleles of the second locus and a set of nonoverlapping 
variants such as {ax, by} is called a discordant set. Immunity is rendered not only to a 
given strain but also partially to other strains sharing any of the relevant determinants. 
Hence, infection with strain ax will limit the transmission of strains ay and bx, but 
will not aﬀect the transmission of by. Transmission of these strains is reduced by a 
factor γ for individuals who have been exposed to strains sharing alleles with i but 
not i itself. Strains that do not share alleles are assumed not to interfere with each 
other’s transmission. Hence, cross-immunity acts through reduced transmission. For 
simplicity, in the model the authors assume that an individual enters the immune and 
infectious classes simultaneously upon infection and the immunity is lifelong, so that 
losses from the immune categories occur at the same rate as mortality. The model is 
described by the following equations 
z˙i(t) = λi(1 − zi) − µzi, 
y˙i(t) = λi(1 − zi)(1 − γ(1 − φi)) − σyi 
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for i ∈ {1, 2, 3, 4} and where zi and yi denote the proportion of the hosts who are 
immune to strain i and are infectious with strain i respectively. Note that class yi is 
a subset of class zi and classes yi and yj , zi and zj may overlap. Parameters 1/µ and 
1/σ denote, respectively, the life expectancy and the average duration of infectiousness 
of the host. The per capita force of infection for strain i is denoted by λi and can 
be explicitly formulated as a linear combination of the probability of a set of strains 
coinfecting a host multiplied by the fraction of the reluctant progeny that is likely to be 
of genotype i. The factor γ represents the degree of cross-protection which reduces the 
transmission of strains. Note that φi = 
�
j∼i(1 − zj ) with j denoting any strain that 
shares alleles with i. This is an SIR model with the S class omitted. It is a history-based 
model in which the partial protection aﬀects all individuals with a given history equally. 
However, it can be adjusted to a status-based approach by assuming the set of epitopes 
that the host immune system can recognize. If γ = 1, one set of discordant strains 
will dominate against other strains. By assuming that four strains are circulating and 
have the same reproductive number, an asymmetric equilibrium is obtained. On the 
other hand, when cross-protection is absent, a symmetric equilibrium arises. A critical 
value of γ where the symmetric equilibrium becomes unstable when γ exceeds it is 
found in terms of the basic reproductive ratio (βi/σ). Also, their result demonstrate 
that antigens that elicit the strongest immune response (so having a strongest impact 
on transmission success) are organized by immune selection acting within the host 
population into sets of nonoverlapping variants. 
In a later paper, Gupta et al. (1998) adjusted their model in order to show that 
pathogens with antigens that do not elicit an immune response that is strong enough to 
induce a discrete stable strain structure may exist as a set of strains exhibiting cyclical 
or chaotic ﬂuctuations in frequency over time. A new compartment wi which is the 
proportion of individuals immune to any strain j that shares alleles with strain i is in­
troduced. Previously, their model compartments are individually separated according 
to the strain from the combination of alleles between loci. In this work, all the strains 
that share alleles with strain i are grouped together. Cross-immunity only reduces 
transmission to the nondiscordant strain j. The model is with respect to strain i from 
a set of pathogen strains deﬁned by n loci, each of which consists of m alleles, and it 
is as follows 
z˙i(t) = (1 − zi)λi − µzi,
 
w˙i(t) = (1 − wi) 
�
j∼i λi − µwi,
 
y˙i(t) = [(1 − wi) + (1 − γ)(wi − zi)]λi − σyi
 
Again, j ∼ i means that j shares alleles with i, i.e. j and i are non-discordant. 
In the model, immunity to a strain i reduces the probability of transmission of a 
nondiscordant strain j by a factor (1 − γ). The system with diﬀerent value of γ gives 
three types of dynamical behaviours; 1) all strains coexist in the host population with 
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stable abundance when γ is low 2) one discordant set of strains dominates the other 
when γ is high and 3) cyclical or chaotic strain structure arises for an intermediate 
value of γ. 
In both models, an assumption that the concordance is independent of the number of 
loci that have identical alleles is made. Consequently, genotypes sharing only one vari­
ant are assumed to compete to the same extent as genotypes sharing several variants. 
Recker and Gupta (2005) construct a model that captures the chances of a pathogen 
achieving transmission depending on the number of variants that the host has already 
encountered. Cross-immunity is now dependent on the extent to which strains share 
alleles or epitope regions with each other. From the study, it results that immune 
selection cause pathogen populations to self-organize into sets with a minimum degree 
of overlap between their members. 
According to the pattern of inﬂuenza epidemics and many experiments in vitro and 
vivo supporting the idea of partial immunity, Andreasen et al. (1997) created a model 
that describes the eﬀect of a change in the prevalence of the strains and the selective 
forces. The model includes the immunological history by dividing the population into 
classes, so this is the history-based model. It is an SIR-model of n interacting strains. 
Let K = {1, 2, 3, . . . , n} be the set of all possible strains and let SL denote the number 
of individuals that are currently uninfected but have previously been infected by the 
strains in the set L ⊆ K. Similarly, Ii represents the number of individuals currently L 
infected by strain i who have previously recovered from infection with a strain in L. 
The force of infection of virus type i is modelled by 
Λi = βi 
� 
Ii L, 
L⊆K\i 
where βi is the transmission rate of viral type i. Cross-immunity acts to reduce sus­
ceptibility in the model. Also it is assumed that infection by strain i confers perfect 
and permanent immunity to strain i itself. Susceptibility to strain i of individuals 
with immune history L is reduced by a cross-immunity factor σi which depends on the L 
distance between i and the set L, to be deﬁned later. For the class S∅, 
S˙ ∅ = b − µS∅ − 
� 
Λj S∅, 
j∈K 
and for SL where L �= ∅ 
jS˙L = 
� 
νI − 
� 
σL
i ΛiSL − µSL.L\j 
j∈L i �∈L 
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Similarly, for the class IL
i , L ⊂ K, i �∈ L 
I˙i = σL
i ΛiSL − (µ + ν)ILi .L 
Note that b is the overall birth rate, µ is the per capita death rate, and ν is the recovery 
rate. Since the simultaneous infection with more than one strain is rare in inﬂuenza, 
coinfection is not allowed to occur in the model. 
The system may have many boundary equilibria. Only the disease-free equilibrium is 
easy enough to study by linearisation. It is found that the disease-free equilibrium 
changes its stability when the largest ri, where ri = βiN/(µ + ν), is equal to 1. A 
threshold above which a new strain i can invade other prevalent strains is 
† ri 
� 
σL
i SL > 1 
L⊆K\i 
† †where (SL, I ) is an equilibrium with the strain i being absent. The authors assume L
that the viral strains can be ordered around the circle so as to indicate their degree of 
relatedness. For simplicity, it is assumed that σi = 0 if i ∈ J , σi = σ if i + 1 ∈ L L L 
or i − 1 ∈ L and σi = 1 elsewhere. In addition, strain 1 and strain n are assumed to L 
be neighbours so that the relatedness of strain i and j can be deﬁned by the distance 
|i−j|modn. To do bifurcation analysis additional assumptions are made by focusing on 
a symmetric cross-protection and a symmetric transmission rate. For example, in the 
latter case, when n = 4, it is assumed that strain 1 and 3 have the same transmission 
rate and the transmission rate of strain 2 and 4 are the same. The result is that 
sustained oscillations can occur when n ≥ 4. 
Since the model generally represents the population based on immune history, it may be 
adjusted to model the eﬀect of cross-immunity in other ways. Firstly, if cross-immunity 
only induces cross-protection to related strains for some people while others acquire 
nothing from the infections (polarised immunity), denote C(L, J , i) to be a probability 
distribution that gives the probability that an individual who has immune history L 
and recovers from infection with strain i will acquire complete immunity to the strains 
in J . Then, the ﬂow out of the class Ii is distributed among SJ and is determined by L � 
C(L, J , i)Ii L 
j∈L,i/∈L 
where σi = 1 for all i and L. Secondly, when cross-immunity reduces infectivity during L 
subsequent infections with related strains, the force of infection can be determined by 
Λi = 
� 
βL
i IL
i , 
L⊆K\i 
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where βi is the infectivity of individuals who are infected with strain i and have immune L 
history L. 
Following Andreasen’s work, Lin et al. (1999) suggested that a Hopf bifurcation is even 
possible with only three strains in a linear chain conﬁguration. They assume that there 
is no reciprocal cross-immunity between the strain 1 and 3, and both of them confer the 
same immunity to strain 2. Besides, they assume that there is no additional protection 
from having been infected by both strains. It is assumed that getting infected with 
strain 2 gives full protection against strains 1 and 3. Although the system is similar 
to the previous work, the analysis is done in a diﬀerent way. It is done by folding 
subclasses into plus-minus variables and reducing variables by making the assumption 
of the complete immunity to strains 1 and 3 of individuals previously infected with 
strain 2 (σ1 = σ3 = 0). {2} {2} 
Gog and Swinton (2002) introduced a status-based model with polarized immunity 
which susceptible individuals are categorized by their immune status to explain the 
dynamics of the host population. In their model, SJ represents the proportion of hosts 
that are completely immune to the strains in the set J , whether they are infected 
or susceptible to all other strains. Multiple infections are allowed. The birth rate 
and death rate are deﬁned by µ. A parameter C(L, J , i) is introduced to represent 
the proportion of hosts that recover to a state J , having started in state L and been 
infected by strain i. Also in the model, Ii is the proportion of individuals infected with 
strain i; βi is a transmission rate for strain i; and νi is a recovery rate from infection 
with strain i. The model is shown below 
I˙i = βiIi 
�
J :i/∈J SJ − νiIi − µIi, 
SJ˙ = 
�
i,L C(L, J , i)βiIiSL − 
�
i/∈J βiIiSJ − µSJ + µδJ, ∅, 
where i = 1, 2, 3, . . . , n, J ⊂ {1, 2, . . . , n} and the function δJ, ∅ is 1 if J = ∅ and 
zero otherwise. The model shows contrasting results from Andreasen’s model. Hopf 
bifurcation and oscillations cannot occur in this model. Dawes and Gog (2002) had 
shown why the status-based model does not contain oscillatory dynamics and concluded 
that polarized immunity and implicit assumptions may be an important cause. 
When the number of strains is increased, the number of dynamic variables grows 
rapidly. That situation is the main obstacle to study the dynamics of diseases. Hence, 
Gog and Grenfell (2002) developed a simple model based on the status-based formu­
lation. The model is more tractable than previous one when the number of antigenic 
types is large. Rather than considering complex immune history, they consider the 
current immune status of the host. By integrating the assumption that cross-immunity 
is conferred by exposure even if immunity prevents the full disease from developing 
and the status-based formation with polarized immunity, only one variable is needed 
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to explain the host with respect to each strain. The model is described by the following 
equations for i = 1, 2, 3, . . . , n 
I˙i = βiSiIi − νiIi − µIi, 
S˙i = µ − 
�
j βj SiσijIj − µSi, 
where µ denotes birth and death rate; βi is the transmission rate; νi is the rate of 
recovery; and lastly σij denotes the chance an infection by strain j will give immunity 
to strain i. A single strain is considered as being located at each point in a strain 
space. Full details of how to derive this model from the Gog & Swinton model can 
be found in the next chapter. The authors considered two types of strain spaces, a 
linear strain space and a two-dimensional strain space in rectangular shape. It is found 
that the relative length of host lifetime and the host immunity can aﬀect the patterns 
of coexistence. In the linear strain space, two patterns of infections are observed: a 
prolonged infection in which clusters are built up and distributed across the strain 
space; and a short infection which is seen as a series of jumps, hopping along the space. 
In two-dimensional strain space, the dominant strain move along the axis as a jumping 
series though it is not clearly seen like the linear strain space. 
Kamo and Sasaki (2002) introduced the eﬀect of seasonal forcing and the eﬀect of 
cross immunity to an SIR model with two strains of pathogens. In particular, they 
investigated the pattern of period-doubling in the host density in echovirus disease. In 
the model, seasonality is introduced in terms of transmission rate: 
βi = β0(1 + δ sin 2πt), i = 1, 2i 
where β0 is the base transmission rate of strain i, and δ (0 ≤ δ ≤ 1) is the degree i 
of seasonality. When the seasonality is small enough, the population shows an annual 
cycle. If it exceeds a certain threshold, 2-year, 4-year, etc. cycles will emerge. If the 
seasonality is suﬃciently strong, the population shows chaotic behaviour. Moreover, 
the authors also found that in the two-strain model, the bifurcation diagrams shift 
more rapidly to chaos than in the single strain model if they increase the degree of 
seasonality. 
Since a system of multiple strains with cross-immunity has a tendency to self-organise 
into groups or clusters, Calvez et al. (2005) investigated formation of clusters in or­
dered multi-strain systems. A three-compartment model is modiﬁed from Gupta et al. 
(1998) by considering several levels of cross-protection. Clusters can behave mainly in 
three diﬀerent ways. First, the system may remain in homogeneous equilibrium if no 
structure is observed. Second, one cluster may dominate the others. Third, oscillation 
may arise when the clusters alternate recurrently in succession. Basically, the forma­
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tion of clusters of discordant strains is expected. In an eight-strain system of three loci 
with two alleles, they found that it is possible to have at least two diﬀerent clusters of 
nonoverlapping strains. Furthermore, they also found that the same cluster can arise in 
other models. For instance, both the Gog & Grenfell model (Gog and Grenfell, 2002) 
and the more complex Gog and Swinton model (Gog and Swinton, 2002) generate the 
same cluster formation which is in the same pattern as one of those in the Gupta model 
(Gupta et al., 1998). 
Life-history variation and cross-immunity appear to be two important factors of pathogen 
evolution. Restif and Grenfell (2006a) integrated both factors together to study the 
dynamics of pertussis. If an endemic strain is already present, how those two factors 
aﬀect the ability of a novel strain to invade and persist was studied. They found that if 
an invading strain has a much higher basic reproductive ratio than the prevalent one, 
competitive exclusion occurs. Otherwise, the system converges to a stable coexistence 
equilibrium. 
Adams and Sasaki (2007) examine invasion of the third strain when ﬁrst two strains 
are identical and coexist in the host population and how the emergence of the new 
strain is inﬂuenced by partial cross-immunity. Antigenic structure in cross-immunity 
function (linear, concave, convex) in term of antigenic distance on a one dimensional 
continuous antigenic space is investigated. A discontinuous cross-immunity function is 
further investigated in Adams and Sasaki (2009). 
The other frameworks in modelling cross-immunity are a moving frame in immunity 
space (Pease, 1987; Casagrandi et al., 2006) in which immunity is waning with time 
according to the change of a new strain, the season-to-season drift (Andreasen, 2003; 
Boni et al., 2004), and the SIR with a one-dimensional drift model and mutation as a 
diﬀusion process (Lin et al., 2003). 
Modelling multi-strain pathogens in vector-borne and sexually transmitted 
diseases 
Vector-borne diseases are caused by viruses, bacteria, or protozoa and transmitted by 
biological agents or vectors. Mosquitoes are one of the most important vectors and 
carry infectious diseases such as malaria, dengue, yellow fever, and West Nile Fever. 
Other vectors include assassin bugs carrying Chagas disease and ticks carrying Lyme 
disease. 
Modelling vector-borne diseases began with Ross (1911, 1916), followed by Macdon­
ald (1952, 1957). In the Ross-Macdonald model, a host is assumed to be immune to 
further infection during the infection period only (SIS). Following it, models includ­
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ing acquired immunity in hosts (SIR) were proposed by Dietz et al. (1974); Bailey 
(1975); Aron (1988). Some evidence shows that vector-borne diseases like malaria are 
antigenically diverse (Gupta, Trenholme, Anderson and Day, 1994). Gupta, Swinton 
and Anderson (1994) proposed a model encapsulating cross-immunity for two strains 
of malaria pathogens. Hosts are structured into four states: 1) x0, immune to neither 
strain, 2) x1, immune to strain 1, 3) x2, immune to strain 2, and 4) x3, immune to both 
strains. The symbols xI1 and xI2 represent infectious proportions to strains 1 and 2, 
respectively. Infectious states are nested within the immune compartments. Hence, xI1 
and xI2 are subsets of x1 and x2, respectively. It is assumed that infected mosquitoes 
cannot be reinfected with a diﬀerent strain of virus and do not recover, so mosquitoes 
are structured into three states: 1) y0, susceptible to both strains, 2) y1, infectious to 
strain 1, and 3) y2, infectious to strain 2. With constant populations in both humans 
and mosquitoes, the model is described as follows 
dx1 = λ1(1 − x1 − x3) − (cλ2 + µ)x1,dt 
dx2 = λ2(1 − x2 − x3) − (cλ1 + µ)x2,dt 
dx3 = c(λ1x2 + λ2x1) − µx3,dt 
dxI1 = λ1(1 − Σixi + cx2) − sxI1,dt 
dxI2 = λ2(1 − Σixi + cx1) − sxI2,dt 
dy1 = axI1(1 − Σiyi) − µM y1,dt 
dy2 = axI2(1 − Σiyi) − µM y2dt 
where λi = mabiyi, and x0 and y0 may be found from x0 = 1 − x1 − x2 − x3, and 
y0 = 1 − y1 − y2. In the model, µ is the natural death rate of the host population, 
m is the number of female mosquitoes per human host, a is the biting rate, b is the 
proportion of infected bites on the host that produces an infection, s is the rate of 
losing the capacity to produce infective gametocytes, and µM is the death rate of the 
vectors. The proportion c is the degree of cross-protection aﬀorded by immunity to 
one strain; when c is unity, there is no cross-immunity; when c is zero, there is full 
cross-protection. As c decreases, the behaviour of independent strain transmission and 
coexistence increasingly changes to coupled behaviours. The strain with a lower trans­
missibility is taken over by the strain with a higher one. Oscillation is increased if 
cross-immunity between strains is strong and it is reduced by large diﬀerences in the 
transmission probabilities. From the result, the absence of cross-immunity tends to 
support a variety of strains which corresponds to the strain-speciﬁc immunity that an 
individual acquires to malaria parasites and malaria strains that have evolved mecha­
nisms that act to reduce the degree of cross-immunity to avoid interactions with other 
strains that may lead to their elimination. 
In the malaria models, cross-immunity may act to reduce the probability of the host 
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being infected by the related strains. However, for dengue virus, some evidences show 
that cross-reactive antibodies may act to enhance the severity of a subsequent infection 
by another strain and so lead to dengue shock syndrome and dengue hemorrhagic 
fever. Modelling antibody-dependent enhancement in dengue can be found in Feng and 
Velasco-Hernandez (1997); Ferguson et al. (1999); Esteva and Vargas (2003); Adams 
et al. (2006), for instance. 
Sexually transmitted diseases such as gonorrhoea, chlamydia, genital warts, herpes, 
syphilis, and AIDS are transmitted via sexual contact. It has been suggested that males 
and females should be divided separately in modelling the diseases that are transmitted 
through sexual activity. Castillo-Chavez et al. (1996) introduced a heterosexual model 
to study a human population who get exposed to two diﬀerent strains of gonorrhoea. 
A two-sex SIS model is used. Superscripts m and f denote the male and female 
populations, respectively. There are two groups of infectives: those infected with strain 
1 and those infected with strain 2. The model is described as follows 
Sm˙ = µ˜m − Bm − µmSm + �2 γmIm ,i=1 i i 
Im˙ = Bm − (µm + γm)Im, i = 1, 2,i i i i 
f fS˙f = µ˜f − Bf − µf Sf + �2 γ Ii ,i=1 i 
f˙ f f fI = B − (µf + γ )I , i = 1, 2,i i i i 
where 
Bm f i f i= r m(T m, T f )Smβ
If 
, B = r f (T m, T f )Sf βm 
Im 
,i i i iT f T m 
2 2
rm(T m, T f )Sm rm(T m, T f )Sm f fBm = 
� 
βj Ij , B
f = 
� 
βj
mIj
m . 
T f T f 
j=1 j=1 
In the model, µ˜k, k = m, f represents the birth rate; µk denotes the natural death rate; 
γk is the recovery rate from strain i; βk is the transmission rate of infection to strain i;i i 
and rk as a function of T m and T f is the average rates of partner acquisition per male 
and female. With a behaviourally and genetically homogeneous population, coexistence 
is not possible unless certain assumptions are made. In contrast, in heterosexually 
mixing hosts coexistence is observed in many situations. A question whether a large 
proportion of women who are asymptomatic to gonorrhoea is a suﬃcient condition for 
coexistence was pointed out. Some example of other work in this area can be found in 
Castillo-Chavez et al. (1997, 1999); Li et al. (2003). 
Superinfection and coinfection 
Without considering transmission eﬃciency, hosts favour the lowest virulence strain 
of pathogen. When both virulence and transmission eﬃciency are linked, a trade-oﬀ 
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between host mortality and transmission eﬃciency exists. Consequently, hosts may 
support coexistence of multiple strains. By interaction between strains, there are two 
diﬀerent patterns of coexistence; coinfection when hosts harbour infections of multiple 
strains of pathogen at one time, and superinfection when one strain with more virulence 
takes over a less virulent strain. 
Superinfection is one strain of a pathogen displaces another in an infected host. Nowak 
and May (1994) developed a superinfection model such that a heterogeneous parasite 
population with a range of diﬀerent virulences is considered. Under the assumptions 
that the more virulent strains can drive out less virulent strains and the infection of a 
host is dominated by a single parasite, a more virulent strain takes over a host infected 
by a less virulent strain. The model takes the form 
x˙(t) = b − µx − x �n βiyi,i=1 
y˙i(t) = yi(βix − µ − δi + sβi 
�i
j
−
=1
1 yj − s 
�n
j=i+1 βj yj) 
where i = 1, . . . , n; x represents uninfected hosts; yi denotes infected individuals to 
strain i; b is the birth rate of uninfected hosts; µ is the natural death rate; s is the 
rate at which superinfection occurs; βi is the transmission rate of strain i; and δi is 
the virulence of strain i. They conclude that: 1) superinfection shifts virulence of the 
pathogen to higher levels that are beyond the level that would maximize the basic 
reproductive ratio; and 2) it leads to a polymorphism of strains with several levels of 
virulence. 
Coinfection is a term that indicates a stable coexistence of diﬀerent strains of pathogens 
in the same host. Under the circumstance that there is no competition among diﬀerent 
strains in the same host, host can harbour infection of multiple strains at one time. 
Mosquera and Adler (1998) proposed a coinfection model for two strains of pathogens 
with superinfection and single infection as limits. The coinfection model is described 
by 
S˙(t) = (b − µ)S − c1I1S − c2I2S − �1c1I12S�2c2I12S + γ1I1 + γ2I2, 
I˙1(t) = c1I1S − (k + β1 + γ1)I1 + �1c1I12S − a2c2I1I2 + γ12I12 − �2a2c2I1I12, 
I˙2(t) = c2I2S − (k + β2 + γ2)I2 + �2c2I12S − a1c1I1I2 + γ21I12 − �1a1c1I2I12, 
I12˙ (t) = (a1c1 + a2c2)I1I2 + (�2a2c2I1 + �1a1c1I2)I12 − (γ12 + γ21 + k + β12)I12 
For notations, S represents susceptible individuals; I1, I2, I12 denote infected individu­
als to strain 1, strain 2, and both strains, respectively; b is a birth rate; µ is a natural 
death rate; βi denotes disease-induced mortality rate of strain i; γi denotes a recovery 
rate to strain i; ci denotes transmission rate depending on the parasite’s virulence; �i 
is a proportion to reduce infectiousness of doubly-infected individuals acting as strain 
i; and ai is a proportion to reduce susceptibility to the other strain when infected with 
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strain i. The coinfection function is examined in three diﬀerent shapes, discontinuous, 
piecewise continuous, and diﬀerentiable cases. A single infection model is derived by 
setting a1 = a2 = 0. From the model, to derive the superinfection model, it is assumed 
that the absence of doubly infected individuals is due to the rapid removal through re­
covery class or through enhanced mortality caused by the double infection itself. The 
equations becomes 
S˙(t) = −c1I1S − c2I2S + (r − k)S + γ1I1 + γ2I2, 
I˙1(t) = c1I1S − (k + β1 + γ1)I1 − δI1I2 − σ12I1I2, 
I˙2(t) = c2I2S − (k + β2 + γ2)I2 − δI1I2 − σ21I1I2. 
The new parameters are δ, which is the diﬀerence between the per contact rate of 
transfer from I1 to I2 and the per contact rate of transfer from I2 to I1 and σij , which 
is the mortality rate incurred when Ii individuals are infected with strain j. Conditions 
under which the coinfection and superinfection models allow more than one strain of 
parasites are studied. The authors found that the coinfection model has a propensity 
to favour more virulence and coexistence than the single infection, depending on two 
factors: 1) how close one is to the superinfection limit and 2) the shape of coinfection 
function. Other examples of the study of superinfection and coinfection are Gandon 
et al. (2001, 2002); Saldana et al. (2003); Iannelli et al. (2005); Boldin and Diekmann 
(2008). 
1.1.2 Modelling multi-strain diseases with controls 
Several management strategies have been used to control diseases, depending on the 
epidemiological characteristics of the pathogens. The aim is often to minimize the 
prevalence of the disease and ideally to reduce it to zero. Mathematical models pro­
vide a means to study the eﬀectiveness of diﬀerent strategies so as to understand the 
epidemiology of the disease and perhaps consequently help us to avoid the loss from 
its presence in the population. 
Vaccinating newborns is an eﬀective way to control many harmful diseases. For exam­
ple, a vaccination model for a multi-strain disease is developed by Restif and Grenfell 
(2006b). The model is for studying immune evasion as a dynamic process for two strains 
of pertussis. Initially a single strain is present, controlled at a low endemic level by vac­
cination. A novel mutant strain is then introduced to which the vaccine oﬀers limited 
protection, so as to investigate the circumstances under which the mutant strain can 
invade and persist. Both deterministic and stochastic frameworks were studied and the 
latter is highlighted in their work as it includes the possibility of extinctions of either 
strain. The vaccination programme is paediatric. The vaccine confers full protection 
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against strain 1 but partial protection against strain 2. The model is described as 
follows: 
dS/dt = µ(1 − p − S) − βS(I1 + J1 + I2 + J2 + Iv2) + σ(R1 + R2 + R) + σvV, 
dI1/dt = βS(I1 + J1) − (γ + µ)I1, 
dI2/dt = βS(I2 + J2 + Iv2) − (γ + µ)I2, 
dR1/dt = γI1 − β(1 − θ)R1(I2 + J2 + Iv2) − (µ + σ)R1, 
dR2/dt = γI2 − β(1 − θ)R2(I1 + J1) − (µ + σ)R2, 
dV/dt = µ(p − V ) − β(1 − τ)V (I2 + J2 + Iv2) − σvV, 
γdJ1/dt = β(1 − θ)R2(I1 + J1) − 
� 
+ µ
� 
J1,1−ν 
γdJ2/dt = β(1 − θ)R1(I2 + J2 + Iv2) − 
� 
1−ν + µ
� 
J2, 
γdIv2/dt = β(1 − θ)V (I2 + J2 + Iv2) − 
� 
1−η + µ
� 
Iv2, 
dR/dt = γ 
�
J1+J2 + Iv2 
� 
− (µ + σ)R, 1−ν 1−η 
where S is the proportion of susceptible individuals to both strains, Ii is the proportion 
of primarily infected individuals with strain i, Ri is the proportion of immune individ­
uals to strain i only, Ji is the proportion of secondarily infected individuals with strain 
i, V is the proportion of vaccinated individuals who are still immune to strain 1, Iv2 
is the proportion of vaccinated individuals who are infected by strain 2, and R is the 
proportion of immune individuals to both strains. Other parameters the model are as 
follows: β is the transmission rate, γ the recovery rate, µ the birth and death rate, p 
the vaccine coverage, σ the rate of loss natural immunity, σv the rate of loss vaccine 
immunity, θ the cross-protection conferred by primary infection (reduction in suscep­
tibility), ν the cross-protection conferred by primary infection (reduction in infectious 
period), τ the cross-protection conferred by vaccination (reduction in susceptibility), 
and η the cross-protection conferred by vaccination (reduction in infectious period). 
Two conclusions are made: 1) the probability of persistence of a novel strain can be 
minimized by an intermediate level of cross-protection conferred by vaccination, and 
2) it is lower in case cross-immunity acts to reduce the infectious period instead of 
susceptibility. 
Isolation is one of the most eﬀective ways to control diseases. It is focused only on 
infected individuals, not a large pool of susceptible individuals like vaccination. It can 
be applied instantaneously, while a vaccine against an emerging disease such as inﬂuenza 
may need at least six months to produce. However the disadvantage of isolation is to 
detect infectious individuals when symptoms are ambiguous. Isolation might be made 
more eﬃcient by tracing and quarantining contacts of infected individuals. 
An example of an isolation model of a multi-strain disease is given here is by Nuno 
et al. (2005), who introduced host isolation into a two-strain model of inﬂuenza under 
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various levels of cross-immunity between strains. In the model, individuals are sepa­
rated into classes as follows; susceptible individuals (S); primarily infected individuals 
(Ii); isolated individuals with strain i (Qi); recovered individuals from strain i (Ri); 
secondarily infected individuals (Vi); recovered individuals from both strains (W). The 
model takes the form 
dS (Ii+Vi)= b − �2 βiS − µS, dt i=1 A
 
dIi (Ii+Vi)
= βiS − (µ + γi + δi)Ii,dt A
 
dQi = δiIi − (µ + αi)Qi,
dt 
dRi (Ij +Vj )= γiIi + αiQi − βj σij Ri �− µRi, j = i,dt A 
dVi (Ii+Vi) − (µ + γi)Vi, j = i= βiσij Rj �
dW 
dt A 
= 
�2 γiVi − µWdt i=1 
A = S + W + 
�2 (Ii + Vi + Ri)i=1
where A denotes the non-isolated individuals and σij is the measure of the cross-
immunity of a prior infection with strain i to an exposure with strain j. Other pa­
rameters are described as follows: b is the recruitment rate; βi is the transmission rate 
of strain i; µ is the natural death rate; δi is the per capita isolation rate for strain i; 
γi is the per capita recovery rate from strain i; and αi is the per capita rate at which 
an individual leaves the isolation class resulting from infection with strain i. Nuno 
et al. (2005) conclude that cross-immunity and isolation leads to sustained oscillations 
or periodic epidemic outbreaks. Moreover, the threshold condition for coexistence is 
possible even though the isolation basic reproductive ratio of one of the strains is below 
1, resulting from the backward bifurcation. 
In certain diseases like vector-borne diseases, control strategies can be applied not only 
to the host population but also to the vector population. For example, in malaria and 
dengue, the vectors are mosquitoes which transmit the diseases to hosts, so reducing 
the number of them by destroying their habitats, releasing sterile mosquitoes, using 
larvicide, and using insecticide are possible ways to control the disease. Larvicide is used 
to reduce the number of larvae while insecticide is used to eliminate adult mosquitoes 
(e.g. Yang and Ferreira (2008)). 
16
 
Chapter 2 
Modelling directly transmitted 
multi-strain diseases 
In this chapter, we develop a model with host cross-immunity to a continuum of strains 
of inﬂuenza. The model is based on a status-based framework with polarized immunity 
assumption by Gog and Grenfell (2002). We ﬁrst show how to derive the Gog and 
Grenfell model from the Gog and Swinton model (Gog and Swinton, 2002) to under­
stand the concepts of the model we develop from. The status-based framework where 
hosts are described by their current immune status is applied to both models but, with 
an additional assumption that cross-immunity is conferred by exposure even if immu­
nity prevents the full disease from developing, the number of equations in the Gog and 
Grenfell model is reduced drastically comparing with the Gog and Swinton model, and 
so the system becomes more tractable. To be precise, it is reduced from 2n + n − 1 
to 2n for the system of n co-circulating strains of inﬂuenza. Second we introduce our 
model based on the Gog and Grenfell model, but where a strain is assumed to be a 
point on a real line instead of a point in a discrete space. The dynamics of multi-strain 
inﬂuenza can then be described by two integro-diﬀerential equations. In the presence 
of three diﬀerent types of cross-immunity functions, we study a travelling wave of the 
disease propagation from the infected population to the uninfected population due to 
mutation, calculate the minimum wave speed, and compare the results. 
To study the human disease such as inﬂuenza, the dynamics at a large geographical 
scale should be considered. In section 2.3, we study spatial heterogeneity (diﬀerences 
between populations in diﬀerent locations) by a metapopulation model with a status-
based framework. Metapopulations are one of the simplest spatial models applicable 
to modeling many human diseases (Ruan et al., 2006; Sani and Kroese, 2008). The 
idea is to subdivide the total population into distinct subpopulations, each of which 
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has its own dynamics, together with limited interaction between subgroups (Keeling 
and Rohani, 2008). 
2.1 The derivation of the Gog and Grenfell model 
We consider two-strain models of inﬂuenza for simplicity of exposition. Note however 
that our derivation is still valid for n co-circulating strains. From the Gog and Swinton 
model, we have 
S˙φ = µN − µSφ − C(φ, {1}, 1)Λ1Sφ − C(φ, {1, 2}, 1)Λ1Sφ−
 
C(φ, {2}, 2)Λ2Sφ − C(φ, {1, 2}, 2)Λ2Sφ,
 
˙
S{1} = C(φ, {1}, 1)Λ1Sφ − C({1}, {1, 2}, 2)Λ2S{1}−
 
C({1}, {1, 2}, 1)Λ1S{1} − µS{1},
 
˙
S{2} = C(φ, {2}, 2)Λ2Sφ − C({2}, {1, 2}, 1)Λ1S{2}− (2.1.1)
C({2}, {1, 2}, 2)Λ2S{2} − µS{2},
 
˙
S{1,2} = C(φ, {1, 2}, 1)Λ1Sφ + C(φ, {1, 2}, 2)Λ2Sφ+ 
C({1}, {1, 2}, 2)Λ2S{1} + C({2}, {1, 2}, 1)Λ1S{2} − µS{1,2},
 
I˙1 = Λ1(Sφ + S{2}) − ν1I1 − µI1,
 
I˙2 = Λ2(Sφ + S{1}) − ν2I2 − µI2,
 
where J ⊆ {1, 2}, Λi = βiIi, SJ represents the number of hosts that are completely 
immune to the strains in the set J , Ii the number of infectious individuals to strain i, 
and C(L, J , i) the probability that hosts recover to a state J , having started in state 
L and been infected by strain i. The polarized immunity is assumed which means 
that cross-immunity acts to render some hosts totally immune while other hosts gain 
nothing from infections. Also, the reduced-transmission of cross-immunity is assumed. 
By assuming that cross-immunity is conferred by exposure even if immunity prevents 
the full disease from developing, this allows all hosts to have the same chance of gaining 
immunity to a strain whatever their current immune status is. Besides, S{1,2} does not 
appear in other equations, so it can be omitted from the system. Let S1 = Sφ + S{2}
and S2 = Sφ + S{1}. Hence, by the fact that 
�
J C(K, J , i) = 1: 
S˙1 = µN − µS1 − Λ1S1 − C(φ, {1, 2}, 2)Λ2Sφ − C({2}, {1, 2}, 2)Λ2S{2} 
Deﬁne C(φ, {1, 2}, 2) = C({2}, {1, 2}, 2) = σ12, which is the chance that an infection 
by strain 2 gives immunity to strain 1. The diﬀerential equation of I1 in the Gog and 
Grenfell model is obviously gained from the Gog and Swinton model. The equations 
for S2 and I2 are obtained in the similar way. Therefore, by those assumptions, the 
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system (2.1.1) becomes
 
S˙1 =	 µ − µS1 − β1S1I1 − σ12β2S1I2, 
I˙1 =	 β1S1I1 − (µ + ν1)I1, (2.1.2)
S˙2 =	 µ − µS2 − β2S2I2 − σ21β1S2I1, 
I˙2 =	 β2S2I2 − (µ + ν2)I2, 
in terms of proportion of individuals. Note that these classes are not mutually exclusive, 
and that some individuals do not belong to any of them. For example, an individual 
susceptible to both strains is in both S1 and S2, while an individual who has recovered 
from both is in none of theses classes. 
2.2	 An epidemic model with host cross-immunity to a 
continuum of strains 
For n co-circulating strains in a host population, the Gog and Grenfell model is de­
scribed as follows 
βjS˙i = µN − 
�
j Siσij Ij − µSi,N 
βi 
(2.2.1)
I˙i = SiIi − νiIi − µIi,N 
for i = 1, 2, 3, . . . , n, where Si and Ii are the proportions of susceptible and infectious 
individuals to strain i, respectively. Also in the model, 1/µ is an average lifetime of 
hosts and for the total population size to be constant µ is assumed to be both the 
birth and death rate of hosts. For each strain i, βi is a transmission rate and νi is 
a recovery rate so that 1/νi is the infectious period to strain i. The cross-immunity 
between strains is described by σij , the probability that infected by strain j will give 
immunity to strain i. Note that the system is with frequency-dependent transmission. 
It can be written in terms of proportions of individuals by reusing the previous symbols 
as follows 
S˙i =	 µ − 
�
j βj SiσijIj − µSi, (2.2.2)
I˙i = βiSiIi − νiIi − µIi, 
2.2.1	 Formulation of the model 
First we introduce the mutation term into the system (2.2.2) by assuming that a virus 
in an infectious individual may mutate to a neighbouring strain. Hence, the model 
incorporating mutation is 
S˙i =	 µ − 
�
j βj Siσij Ij − µSi, (2.2.3)
I˙i = βiSiIi − νiIi − µIi + d(Ii+1 − 2Ii + Ii−1), 
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where d is the mutation rate on the antigenic space. Second, we introduce a continuum 
approximation to the system so that strains take values in �. It means that Si and 
Ii can be approximated by S(x, t) and I(x, t); Si±1 and Ii±1 can be approximated by 
S(x ± δx) and I(x ± δx); d can be approximated by Dˆ/δ2; ﬁnally σij can be estimated 
by σ(x, y)δy. The system (2.2.3) becomes 
∂S(x,t) 
∂t 
∂I(x,t) 
∂t 
= 
= 
µ − �y β(y)S(x, t)σ(x, y)I(y, t)δy − µS(x, t), 
β(x)S(x, t)I(x, t) − ν(x)I(x, t) − µI(x, t) + Dˆ (I(x+δx)−2I(x,t)+I(x−δx) δx2 . 
(2.2.4) 
As δx → 0 and δy → 0, we now propose the system with host cross-immune to a 
continuum of strains 
∂S(x,t) = µ − � ∞ β(y)S(x, t)σ(x, y)I(y, t)dy − µS(x, t),∂t −∞ (2.2.5)∂I(x,t) ∂2I(x,t)= β(x)S(x, t)I(x, t) − ν(x)I(x, t) − µI(x, t) + Dˆ .∂t ∂x2 
In the model, x represents a strain positioned as a point on a real line so the other 
position on a line represents the other strain. Consequently, for example, I(x, t) is the 
proportion of infectious individuals to a strain at the position x at time t. Moreover, 
a cross-immunity term in the model can be expressed as the function of the distance 
between two positions and the distance exhibits the antigenic diﬀerence between the 
strains. 
2.2.2 Analysis 
Spatially uniform steady states 
For simplicity, we assume a constant transmission rate and recovery rate for each strain 
in the model (2.2.5). Hence, every strain shares the same general character. Cross-
immunity between two strains σ(x, y) at the position x and y is assumed to be a 
function of the distance between them |x− y|, so σ(x, y) = K(|x − y|) for some function 
K. The function reduces more susceptibility to infections when y approaches x or in 
other words two strains are similar. By these assumptions, we can ﬁnd the spatially 
uniform steady states of the system explicitly as follows: 
1. the disease-free steady state 
(S(x, t), I(x, t)) = (S0, I0) = (1, 0) (2.2.6) 
2. the disease-present steady state � 
1 µ(R0 − 1)
�
(S(x, t), I(x, t)) = (S ∗ , I ∗) = , (2.2.7)
R0 β 
� 
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where R0 = β/(µ + ν) represents the basic reproductive ratio of the inﬂuenza strain 
and Σ = 
� ∞ 
σ(x, y)dy, both of which are independent of x.−∞ 
Spatially uniform linearised perturbation near the steady states 
Let S∗ and I∗ be spatially uniform steady state solutions, and let Sˆ and Iˆ be spatially 
uniform perturbations from them. Then, 
Sˆ(t) = S(t) − S ∗ 
Iˆ(t) = I(t) − I ∗ 
so we have the linearised equations 
∂Sˆ ˆ= −βSˆ(t)I∗ � ∞ σ(x, y)dy − βS∗ � ∞ σ(x, y)Iˆ(t)dy − µS(t),∂t −∞ −∞ (2.2.8)
∂Iˆ ˆ= β(Sˆ(t)I∗ + S∗Iˆ(t)) − νIˆ(t) − µI(t)∂t 
which implies the Jacobian matrix of the system (2.2.5) as follows: � 
−βΣI∗ − µ −βΣS∗ 
� 
J = . (2.2.9)
βI∗ βS∗ − ν − µ 
The Jacobian matrix at the disease-free steady state (S0, I0) = (1, 0) is � 
−µ −βΣ 
� 
J0 = . (2.2.10)
0 (ν + µ)(R0 − 1) 
The eigenvalues of J0 are −µ and (ν + µ)(R0 − 1). Hence, (S0, I0) is stable if and 
only if R0 < 1. We next consider the stability of the disease-present steady state when 
R0 > 1. For the disease-present steady state, we have � 
−µR0 −βΣ/R0 
� 
J ∗ = . (2.2.11) 
µ(R0 − 1)/Σ 0 
Whenever R0 > 1, tr J∗ < 0 and det J∗ > 0. By the Routh-Hurwitz criteria, (S∗, I∗) 
is stable if and only if R0 > 1. 
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Spatially non-uniform linearised perturbation near the steady states
 
We now look at spatially non-uniform perturbations in the form 
ˆ ikx S(x, t) = S(x, t) − S∗ = s(t)e , 
(2.2.12)
ikx Iˆ(x, t) = I(x, t) − I∗ = i(t)e . 
This perturbation includes both positive and negative perturbations from the steady 
state. For example, at the disease-free steady state (I∗ = 0), a small perturbation Iˆ
may take positive and negative values, and hence include biologically infeasible values of 
I(x, t). However, if the steady state is stable to a general sign-indeﬁnite perturbation, 
it is a fortiori stable to a positive perturbation as well. We shall therefore proceed 
to analyse stability to a general perturbation. Note that at k=0 the perturbation 
corresponds to the spatially uniform linearised perturbation in the previous subsection. 
Here, we consider k ≥ 0. 
The linearised equations of (2.2.5) are 
ds = −βI∗Σs − e−ikxK∗(k)βS∗i − µs,dt (2.2.13)
di = βI∗ Dk2i,s + βS∗i − νi − µi − ˆdt 
where � ∞ 
K ∗(k) = K(x − y)eikydy. 
−∞ 
Note that K∗ relates to the cross-immunity function σ(x, y) = K(x−y). By substituting 
z = x − y, we obtain � ∞ 
−ikz ikxdz = e ikx ˜K ∗(k) = K(z)e e K(k) (2.2.14) 
−∞ 
where K˜ is the Fourier transform of K. By the equation (2.2.13), the Jacobian matrix 
of the governed system (2.2.5) is � 
−βΣI∗ − µ −βS∗K˜(k) 
� 
J(k) = (2.2.15)
βI∗ βS∗ − ν − µ − Dˆk2 
At the disease-free steady state, we obtain � 
−µ −βK˜(k) 
� 
J0(k) = (2.2.16)
0 (ν + µ)(R0 − 1) − Dˆk2 
The eigenvalues are −µ and (ν + µ)(R0 − 1) − Dkˆ 2 . Hence, the disease-free steady state 
is stable to spatially non-uniform linearised perturbation if R0 < 1. In conclusion, the 
disease-free steady state is linearly stable to all perturbations whenever R0 < 1. Let us 
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now consider the Jacobian matrix at the disease-present steady state. It is as follows � 
−µR0 −βK˜(k)/R0 
� 
J ∗(k) = (2.2.17) 
µ(R0 − 1)/Σ − Dˆk2 
Whenever R0 > 1, we have tr J∗(k) < 0 and det J∗(k) = Dk2 +(µ(R0 − 1) + µ) ˆ
µβS∗(R0 − 1)K˜(k)/Σ which its sign depends on the value of K˜(k). For example, in 
−( x−y )2one of our case studies which will be mentioned in detail later, K(x − y) = e l , 
we have 
˜ −l2k2/4ΣK(k) = e 
so that 
det J ∗(K) > 0 
for all values of l. The spatially uniform disease-present steady state in this case is 
stable to both uniform and non-uniform linearised perturbations when R0 > 1. 
2.2.3 Numerical Results 
Table 2.1: Lists of parameters for inﬂuenza 
Parameter Description Value References 
µ birth and death rate 1/70 (year−1) estimated 
ν recovery rate 365/7 (year−1) Gog and Grenfell (2002) 
R0 the basic reproductive ratio 3-7 Casagrandi et al. (2006) 
β transmission rate R0(µ + ν) 
We ﬁrst rescale the system (2.2.5) by introducing T = (µ + ν)t. Hence, with the 
constant transmission rate and recover rate of each strain, the system (2.2.5) becomes 
∂S(x,T ) µ β µ= − S(x, T ) � ∞ σ(x, y)I(y, T )dy − S(x, T ),∂T (µ+ν) (µ+ν) −∞ (µ+ν) (2.2.18)∂I(x,T ) β ∂2I(x,T )= S(x, T )I(x, T ) − I(x, T ) + D .∂T (µ+ν)) ∂x2 
To study the propagation of inﬂuenza due to mutation from the infected population 
to the uninfected population, we shall introduce initial conditions as heaviside step 
functions on a one-dimensional antigenic domain [x1, x2] with the equal proportions of 
infectious individuals of I∗ to a strain on the antigenic space [x1, x¯] and the uninfected 
1individuals to the inﬂuenza strain on the antigenic space [x¯, x2], where x¯ = (x1 + x2).2 
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Thus initial conditions are given by 
S(x, 0) S∗ + (1 − S∗)H(x − x¯) x1 ≤ x ≤ x2, 
I(x, 0) I∗ − I∗H(x − x¯) x1 ≤ x ≤ x2, 
S∗ and I∗ correspond to (2.2.7), x¯ = (x1 + x2)/2, and H represents a heaviside 
step function. An example of the initial condition I(x, 0) is shown in Figure 2-1(a). 
The boundary conditions are assumed as zero ﬂuxes: 
∂I 
∂x
(x1, T ) = 0 = 
∂I 
∂x
(x2, T ), T1 ≤ T ≤ T2. 
Note that parameter values can be found in Table 2.1. 
The model (2.2.18) is solved with the initial conditions and the boundary conditions 
relating to types of cross-immunity functions σ(x, y) as follows 
(x, y) Ae−( 
x−y 
l 
)2 where A is a constant, and l is a typical length scale in-
volved in cross-immunity. It is a form that cross-immunity varies smoothly and 
symmetrically about each strain and tails oﬀ with distance. 
(x, y) = δ(x − y), a dirac-delta function. There is no cross-immunity to neigh-
bouring strains; strain x gives target immunity to itself only. 
σ(x, y)I(y, t)dy ≈ σI(x − h, t) + I(x, t) + σI(x + h, t) where σ is a constant and 
< σ < 1. We essentially return to the discrete-strain space with each strain 
giving perfect immunity to itself and partial immunity to the two neighbouring 
strains. 
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Figure 2-1: (a) An initial condition for the I(x, T ) on the domain [0, 200] when σ(x, y) = 
Ae−( 
x−
l
y )2 (A = 1, l = 1, S∗ = 0.2857, I0 = 0, and I∗ = 0.0001) (Note that S0 and S∗ 
are in diﬀerent scale.) (b) For type 1 of σ(x, y), a travelling wave occurs in the infectious 
population and it is driven by mutation on the antigenic space with c1 = 161.7 space 
units per year (A = 1, l = 1, D = 0.25 or d = 1) 
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Figure 2-2: (a) For type 2 of σ(x, y), this graph shows a travelling wave of the disease 
mutation in the infectious population with c2 = 156.5 space units per year (D = 0.25 
or d = 1, S∗ = 0.2857, I∗ = 0.0002) (b) For type 3 of σ(x, y), this graph shows a 
travelling wave of the disease mutation in the infectious population with c3 = 161.7 
space units per year (σ = 0.8, D = 0.25 or d = 1, S∗ = 0.2857, I∗ = 0.0001) 
Figure 2-1(b) and Figure 2-2(a)-(b) show a travelling wave from the infectious popu­
lation to the susceptible population to strains on the antigenic space x. The travelling 
wave represents an antigenic drift process with strains present in the population dy­
ing out and being replaced by new ones at new points in the antigenic space. Each 
peak represents a cluster of inﬂuenza, building up and dying out. Hence, each strain is 
transient. The process repeats over the rest of the strain space. In long term, the pro­
portion of infectious individuals tends to the spatially uniform disease-present steady 
state. By calculating a wave speed from the formula 
x2 − x1 
c = , 
t2 − t1 
where x1 is one position on the antigenic space of a wave at time t1 and x2 is the same 
position on the antigenic space of the wave but at time t2, we ﬁnd that without cross-
immunity to neighbouring strains the wave speed of the infectious population changes 
due to the mutation on the antigenic space (for example, c2 = 88.7 space units per 
year when D = 0.2 or c2 = 156.5 space units per year when D = 1). It is also true 
when cross-immunity is present (c1 = c3 = 156.5 space units per year when D = 1). 
In conclusion, cross-immunity might not alter the wave speed and the speed might be 
inﬂuenced by how fast the virus mutates (mutation rate). We further study the system 
(2.2.18) with type 3 of cross-immunity functions for the relation of cross-immunity, the 
mutation rate, and a wave speed, a minimum wave speed, and spatially non-uniform 
steady states in the next section. 
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2.2.4 Additional analysis 
We study the following system in details 
∂S µ β µ= − S(σI(x − h, T ) + I + σI(x + h, T )) − S, ∂T (µ+ν) (µ+ν) (µ+ν) (2.2.19)
∂I β= SI − I + d(I(x − h, T ) − 2I + I(x + h, T )),∂T (µ+ν) 
where individuals acquire a perfect immunity to a strain they get infected with and a 
partial immunity to two neighbouring strains. The mutation term is approximated by 
a central diﬀerence and d is a function of step size. 
Spatially uniform steady states 
Two spatially uniform steady states are � 
1 µ(R0 − 1)
�
(S, I) = (S0, I0) = (1, 0), and (S, I) = (S ∗ , I ∗) = , . 
R0 β(1 + 2σ) 
Clearly, if inﬂuenza is endemic, the prevalence of it is reduced by the presence of cross-
immunity. 
Spatially non-uniform steady states 
Let Ii−1 = I(x − h), Ii = I(x), and Ii+1 = I(x + h). Given that 
∂Si = µ − µSi − βSi(σIi−1 + Ii + σIi+1),∂t (2.2.20)
∂Ii = βSiIi − νIi − µIi + d(Ii−1 − 2Ii + Ii+1),∂t 
travelling waves in such systems are often blocked, or prevented from occurring, by ho­
moclinic or heteroclinic orbits of the steady state equations. The steady state equations 
of the system (2.2.20) are 
µ − µSi − βSi(σIi−1 + Ii + σIi+1) = 0, (2.2.21)
βSiIi − νIi − µIi + d(Ii−1 − 2Ii + Ii+1) = 0. 
A doubly inﬁnite sequence, 
{(Si, Ii)}i∈Z = . . . , (S−1, I−1), (S0, I0), (S1, I1), . . . , 
is an orbit of (2.2.21) if it satisﬁes (2.2.21) for each i. It is heteroclinic from (S0, I0) to 
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(S∗, I∗) if 
Si → S0, Ii → I0 as i → −∞, and Si → S ∗ , Ii → I ∗ as i →∞. 
It is homoclinic if the sequence tends to the same steady state as i → ±∞. 
We separate values of d and σ into 4 cases: 1) d = σ = 0, 2) d = 0, σ > 0, 3) 
d > 0, σ = 0, and 4) d > 0, σ > 0. 
1. When d = σ = 0, 
for each i, either (Si, Ii) = (1, 0) or (Si, Ii) = (S∗, I∗). Hence there is a heteroclinic 
orbit with a sequence 
. . . , (S−1, I−1), (S0, I0), (S1, I1), . . . := . . . , (1, 0), (S ∗ , I ∗), (S ∗ , I ∗), . . . , (2.2.22) 
for instance. 
2. When d = 0, σ > 0, 
either Ii = 0 or Si = 1/R0. Let Ii = 0 for i ≤ 0, Si = 1 for i ≤ −1, and Si = 1/R0 
for i ≥ 1. Then the second equation of (2.2.21) is satisﬁed for all i, and the ﬁrst 
is satisﬁed for all i ≤ −1. For i ≥ 0 the ﬁrst of (2.2.21) gives 
µ(1 − Si)
σIi−1 + Ii + σIi+1 = . 
βSi 
With i = 0 this gives 
µ(1 − S0)
σI1 = 
βS0 
, (2.2.23) 
or alternatively 
S0 = 
µ 
, (2.2.24) 
µ + σβI1 
and with i > 0 we obtain 
µ(1 − Si)
σIi−1 + Ii + σIi+1 = = (2σ + 1)I ∗ . (2.2.25)
βSi 
We may choose I1 arbitrarily, determining S0 by (2.2.24), and the problem for Ii 
with i ≥ 2 is given by the second-order linear diﬀerence equation (2.2.25) with 
I0 = 0, I1 chosen. The general solution is Ii = I∗ + Aλi + Bλi , where λ1 and λ21 2
are solutions of the auxiliary equation 
σλ2 + λ + σ = 0. 
1For σ < the roots of this quadratic are real, and satisfy λ2 < −1 < λ1 < 0.2 
The solution tending to I∗ as i → ∞ (obtained by choosing I1 = I∗(1 − λ1)) is 
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given by
 
Ii = I ∗(1 − λ1i ).
 
This completes the description of the heteroclinic orbit in this case. For σ > 1 the2 
roots of the quadratic are complex, and lie on the unit circle. In this case Ii does 
not tend to I∗ as i →∞, but the solution circles about (I∗, I∗) in (Ii, Ii+1) space. 
Although this is no longer a heteroclinic orbit, it appears from the numerical 
results of the last section, shown in Figure 2-3(a), that it is nevertheless suﬃcient 
to preclude the existence of a travelling wave with non-zero wave speed. 
3. When d > 0, σ = 0, 
we show that any solution of the system is concave near I = 0 so that neither a 
heteroclinic nor a homoclinic orbit can occur. Deﬁne Mi = Ii+1 − 2Ii + Ii−1. The 
steady state equations are 
µ − µSi − βSiIi = 0, 
βSiIi − νIi − µIi + dMi = 0. 
By eliminating Si between these equations, we have 
µβIi − (µ + ν)Ii + dMi = 0. 
µ + βIi 
Given Ii = I, Mi = M is given by 
µ(β − µ − ν)I − β(µ + ν)I2 
M = − . 
d(µ + βI) 
Hence M = 0 when I = 0 or when I = µ(R0 − 1)/β = I∗, and M < 0 for 
0 < I < I∗ . Any solution is concave near I = 0, so cannot tend to I = 0 
from above, no heteroclinic or homoclinic orbit can exist, and we expect to see a 
travelling wave with positive wave speed. 
4. When d > 0, σ > 0, 
we again use convexity and concavity to show that neither a heteroclinic nor 
a homoclinic orbit can occur. Deﬁne Mi = Ii+1 − 2Ii + Ii−1. Note that for a 
biologically realistic solution, Mi ≥ −2Ii. Then, 
σIi+1 + Ii + σIi−1 = σMi + (1 + 2σ)Ii. 
The steady state equations (2.2.21) become 
µ − µSi − βSiσMi − β(1 + 2σ)SiIi = 0, 
βSiIi − νIi − µIi + dMi = 0. 
28
 
Eliminating Si between these two equations, 
µβIi − (µ + ν)Ii + dMi = 0. 
µ + βσMi + β(1 + 2σ)Ii 
Given Ii = I, we can ﬁnd Mi = M by solving 
Q(M) := βσdM2 + a1(I)M + a2(I) = 0, 
where 
a1(I) = µd + βd(1 + 2σ)I − βσ(µ + ν)I, 
a2(I) = −µ(µ + ν + β)I − β(1 + 2σ)(µ + ν)I2 . 
Note that for ﬁxed I > 0, Q is convex with Q(0) < 0 and 
Q(−2I) = −2µdI − 2βdI2 − µ(µ + ν + β)I − β(µ + ν)I2 < 0. 
Hence, the biologically realistic root Mi (M ≥ −2I) of Q(M) = 0 satisﬁes Mi > 0, 
or Ii+1 − 2Ii + Ii−1 > 0. Consequently the function Ii is convex, and there is no 
heteroclinic orbit or homoclinic orbit, which must have both convex and concave 
regions. Therefore, from Cases 3 & 4, we expect a travelling wave with a positive 
wave speed, as shown numerically in Figure 2-3(a), to exist whenever d > 0. This 
corresponds to sets of strains of inﬂuenza emerging and then dying out, as new 
mutant strains emerge to take their place. 
The study of wave speed 
By varying σ and d between 0 and 1, it can be seen from Figure 2-3(a) that a travelling 
wave is a pulled wave which speed is determined by its leading edge. Thus, the stable 
wave speed should be the minimum wave speed that we get from the linearisation at 
(1,0). We linearise the system (2.2.19) about (S, I) = (1, 0) by deﬁning u = 1 − S and 
neglect terms of higher orders of u and I. We obtain 
∂u µ β 
∂T = − µ+ν u + (σI(x − h, T ) + I + σI(x + h, T )),µ+ν (2.2.26)
∂I β= I − I + d(I(x − h, T ) − 2I + I(x + h, T )).∂T µ+ν 
The second equation of (2.2.26) is a linear equation for I. We look for a solution in the 
form 
I = w(z), 
where z = x + c3T . Thus the equation ∂I/∂T becomes 
c3 
∂w 
= (R0 − 1)w + d(w(z − h) − 2w + w(z + h)). 
∂z 
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Figure 2-3: (a) This graph shows a relation of a diﬀusion rate (d), a cross-immunity 
value (σ), and a wave speed (c) (b) Wave speeds and their lower bound as d varies 
(σ = 0.8) 
Now let us look for a solution of w in the form of an exponential term 
λz w = e . 
We obtain the following characteristic equation 
(R0 − 1) 2d(cosh λh − 1) 
c3 = + 
λ λ 
In order to ﬁnd a minimum of wave speed, we diﬀerentiate through the equation with 
respect to λ to get 
(R0 − 1) 2d(hλ sinh λh − cosh λh + 1) − + = 0 (2.2.27)
λ2 λ2 
Note that obviously the wave speed (c3) does not depend on the parameter σ. Figure 
2-3(b) shows the wave speeds when d varies but σ is ﬁxed at 0.8, and their lower bound. 
2.2.5 Conclusions and discussion 
Under the assumption that a strain is positioned as a point on a real line instead of 
a point in a discrete space, the number of diﬀerential equations in the status-based 
model, with an additional assumption that cross-immunity is conferred by exposure 
even if immunity prevents the full disease from developing, is reduced from 2n to 2, 
where n is the number of co-circulating strains of inﬂuenza. The system becomes more 
tractable although the number of strains increases. Mutation to neighbouring strains in 
an infectious individual is incorporated as a diﬀusion term in the model. Consequently, 
we can study stability of the system for threshold conditions. 
In the model, there are two spatially uniform steady states: the disease-free steady and 
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the disease-present steady state. The model is uniformly perturbed and non-uniformly 
perturbed near each steady state. We ﬁnd that the disease-free steady state is stable 
if R0 < 1 while the disease-present steady state is stable if R0 > 1. 
To study the propagation of inﬂuenza driven by mutation from infectious population 
to susceptible population, we introduce initial conditions as heaviside step functions on 
a one-dimensional antigenic domain and a boundary condition as a zero ﬂux. Three 
types of cross-immunity functions are considered for wave speed calculation; 1) when 
cross-immunity varies smoothly and symmetrically about each strain and tails oﬀ with 
distance, 2) when cross-immunity is absent, and 3) when cross-immunity is only given 
to two neighbouring strains on the discrete space. We ﬁnd that a travelling wave 
occurs from the infectious population to the susceptible population to a new strain 
on the antigenic space. The travelling wave represents an antigenic drift process with 
strains present in the population dying out and being replaced by new ones at new 
points in the antigenic space. Each strain is transient. A cluster of inﬂuenza builds up 
and dies out. This process repeats over the rest of the strain space in the numerical 
results. In long term, the proportion of infectious individuals tends to the spatially 
uniform disease-present steady state ﬁnally and the prevalence of infectious population 
to a strain is reduced when cross-immunity is present. The stronger the cross-immunity, 
the lower prevalence of infectious individuals to strains of inﬂuenza. From the numerical 
results, the presence of cross-immunity may not inﬂuence the uninfected population to 
be infected with a new strain on the antigenic space. So it does not inﬂuence the wave 
speed of travelling waves. This result corresponds to Gog and Grenfell (2002). 
We further study the model with type 3 of cross-immunity functions. We show that 
there are heteroclinic orbits preventing a travelling wave to occur when mutation is 
absent. When cross-immunity is absent, there are no heteroclinic orbits. By inves­
tigating the relation of d (mutation rate), σ (cross-immunity coeﬃcient), and c (the 
wave speed), we ﬁnd that a travelling wave is a pulled wave. Hence, the minimum wave 
speed can be calculated by linearising the system near the spatially uniform disease-
free steady state and it does not depend on cross-immunity coeﬃcient. Note that this 
minimum wave speed is also the minimum wave speed of the system for other types 
of cross-immunity functions, σ(x, y). Therefore, with this type of cross-immunity, we 
not only show that cross-immunity does not inﬂuence the wave speed by comparing 
the numerical results with other type of cross-immunity and considering the minimum 
wave speed formula, but also by analyzing the presence of heteroclinic orbits. The 
latter shows mathematical support with the conclusion so that the conclusion is not 
just from the numerical results. 
All in all, the model with host cross-immunity to a continuum of strains is proposed. 
There are only two integro-diﬀerential equations although the number of strains in­
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creases so that the system is tractable and its mathematical analysis becomes ap­
proachable. By studying the propagation of strains driven by mutation in infected 
individuals, we ﬁnd that a travelling wave represents an antigenic drift process that 
each strain ﬁnally dies out and is replaced by new ones at new points in the antigenic 
space. Also, a cluster of inﬂuenza strains emerges, building up and dying out. 
2.3 A metapopultion model to study inﬂuenza 
We assume that a human population is divided into subpopulations such as cities or 
communities. For simplicity, we assume that there are only 2 subpopulations in our 
model. Each subpopulation is divided into compartments of susceptible to strain i 
(Sj ), infected with strain i (Ij ), for i = 1, 2, and j = 1, 2. The total number of i i 
individuals in each subpopulation is represented by Nj and 
�
j Nj = N . We assume 
that the spread of inﬂuenza is due to migration or permanent movement of individuals 
such that individuals move randomly between subpopulations. Also, for simplicity, we 
assume that a travelling rate between subpopulations is not diﬀerent between infectious 
and susceptible individuals for each strain. Let mlk denote the per capita rate of travel 
from subgroup k to subgroup l with mll = 0, for l = 1, 2 and k = 1, 2. 
The model in this chapter is based on the status-based framework by Gog and Grenfell 
(2002). However, we assume density dependence in the model. Hence we start with 
introducing movements of individuals to the metapopulation model extended from the 
Gog and Swinton model and then reduce it by the additional assumption made in 
the similar way in the Gog and Grenfell model in Section 2.1. The model takes the 
following form: 
1
1dS = µN1 − µS11 − β11I11S11 − σβ21I21S11 + m12S12 − m21S11 ,dt 
1
1dI = 1 S
1 − (µ + ν)I1β11I1 1 1 + m12I12 − m21I11 ,dt 
1
2dS = µN1 − µS21 − β21I21S21 − σβ11I11S21 + m12S22 − m21S21 ,dt 
1
2dI = 2 S
1 − (µ + ν)I1β21I1 2 2 + m12I22 − m21I21 ,dt (2.3.1)
2
1dS = µN2 − µS12 − β12I12S12 − σβ22I22S12 + m21S11 − m12S12 ,dt 
2
1dI = β12I1
2S1
2 − (µ + ν)I12 + m21I11 − m12I12 ,dt 
2
2dS = µN2 − µS2 2 S2 1 S2 2 − β22I2 2 − σβ12I2 2 + m21S21 − m12S22 ,dt 
2
2dI = β22I2
2S2
2 − (µ + ν)I22 + m21I21 − m12I22 ,dt 
for subpopulation 1 and 2, expressed as superscripts, respectively. In the model, we 
assume that the life span of human, and recovery time from strain 1 and 2 are equal 
in both subpopulations. Since we have movements of individuals in infected classes, 
we only have the same type of the steady state in both populations, for example, the 
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disease dies out in both subpopulations and there is no situation that both strains die 
out in subpopulation 1 while only strain 2 persists in subpopulation 2. 
From the system (2.3.1), the disease-free steady state is 
(S1
1, I1
1, S2
1, I2
1, S1
2, I1
2, S2
2, I2) = (S10 , 0, S10 , 0, S20 , 0, S20 , 0),2 1 2 1 2 
where 
S10 
µ(µ + m12)N1 + µm12N2 = S10= ,1 2[(µ + m21)(µ + m12) − m12m21] 
and 
S20 
µ(µ + m21)N2 + µm21N1 = S20= 
[(µ + m21)(µ + m12) − m12m21] .1 2 
Linear stability of the disease-free steady state of the system can be investigated by us­
ing the next-generation matrix (van den Driessche and Watmough, 2002). By ordering 
the infected variables as I1
1, I1
2, I2
1, I2, the matrix of new infections F is given by 2 � 
F1 0 
� 
F = ,
0 F2 
where � 
β11S
10 0 
� � 
β21S2
10 0 
� 
1F1 = , F2 = , and 0 = [0]2×2. 
0 β12S20 0 β22S20 1 2 
The matrix of transfer between classes is � 
V1 0 
� 
V = ,
0 V2 
where � 
(m21 + ν + µ) −m12 
� � 
(m21 + ν + µ) −m12 
� 
V1 = , V2 = , −m21 (m12 + ν + µ) −m21 (m12 + ν + µ) 
Hence, we obtain � 
F1V 
−1 � 
1 0 FV −1 = ,
0 F2V −1 2 
and the basic reproductive ratio is the spectrum of FV −1, thus, 
Spec(FV −1) = max{eigenvalues of F1V −1 , eigenvalues of F2V −1}.1 2 
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Figure 2-4: (a) Both strains die out in both subpopulations when R01 = 0.9 and 
R02 = 0.8 (m12 = 0.2,m21 = 0.16, σ = 0.8, N1 = 100000, N2 = 80000). (b) Only strain 
1 persists in both subpopulations when R01 = 3 and R02 = 0.8 (c) Strain 2 persists 
when R01 = 0.8 and R02 = 3. (d) Both strains coexist when R01 = 3 and R02 = 2. 
or 
R0 = max{R01, R02} √ √ 
tr(F1V −1)+ tr(F1V −1)2−4 det(F1V −1) tr(F2V −1)+ tr(F2V −1)2−4 det(F2V −1) , 1 1 1 2 2 2= max{ , }2 2 
where R01 and R02 represent the basic reproductive ration of strain 1 and 2, respectively. 
We show that; 1) both strains die out when R01 < 1 and R02 < 1, 2) stain 1 persists 
in both subpopulations when R01 > 1 and R02 < 1, 3) strain 2 persists in both 
subpopulations when R01 < 1 and R02 > 1, and 4) both strains coexist when R01 > 1 
and R02 > 1 (see Figure 2-4). 
2.4 Conclusions and discussion 
In this chapter, we propose a mathematical model of continuum strains of inﬂuenza. 
The goal of this study is to use a real line to represent a strain space so that the 
number of equations from the Gog and Grenfell models from 2n is reduced to 2 and 
to study what can be derived from this approachable system. The system of equations 
becomes tractable although the number of strains increases. Consequently, we can 
study stability of the system for threshold conditions. We study three types of cross-
immunity and show that a travelling wave occurs and represents antigenic drift process 
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with strains dying out and being replaced by new ones at new point on the strain space. 
Clusters emerge and die out. In case, cross-immunity acts to reduce individuals from 
getting infected with two neighbouring strains (Type 3), we not only show that cross-
immunity does not inﬂuence the wave speed by comparing the numerical results with 
other type of cross-immunity and considering the minimum wave speed formula, but 
also by analyzing the presence of heteroclinic orbits. The latter shows mathematical 
support with the conclusion so that the conclusion is not just from the numerical results. 
We next propose a metapopulation model for two communities. This model is based 
on a status-based framework by Gog and Grenfell (2002). We investigate stability of 
the disease-free steady state by the next-generation matrix and numerical results from 
the simulations. This work should be further investigated to include controls such as 
isolation or vaccination, or stochastic process that strains die out locally. 
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Chapter 3 
Modelling vector-borne diseases 
We devote this chapter to study the transmission dynamics of malaria which is a vector-
borne disease. Each year, malaria kills over a million people, infects more than a billion 
people worldwide, and dampens the economics of its endemic regions (Snow et al., 2005; 
Guerra et al., 2006). Malaria is a mosquito-borne infectious disease caused by protozoan 
parasites in the genus Plasmodium. There are over 120 species of the parasite but only 
four of them commonly infect humans: P. falciparum, P. vivax, P. malariae, and P. 
ovale. Recent study shows that P. knowlesi can also infect humans although it is 
mainly transmitted in monkeys (Cox-Singh et al., 2008; Cox-Singh and Singh, 2008) so 
it might be counted as the ﬁfth species that infects human (White, 2008). Clinically, 
P. falciparum is the deadliest one while P. vivax is the most widespread. The malaria 
parasites are endemic in Africa, tropical and sub-tropical regions of Asia, North and 
South America, and the Middle East, for instance. Over 300 million people suﬀer 
from malaria every year. P. falciparum is common in Africa and is the main cause of 
malaria deaths. Some evidences show that P. vivax causes up to 65 % of malaria in 
India and more people were at risk from it in 2005 than any other species (Mendis et al., 
2001; Guerra et al., 2006). The symptoms of P. vivax is excruciating but not fatal. It 
involves cyclical fever and chills, headache, vomiting, diarrhea, and the enlargement of 
the spleen. However, in P. falciparum, there might be complications including acute 
anaemia and cerebral malaria. 
The life cycle of malaria parasites begins with female Anopheles mosquitoes inoculating 
sporozoites of the parasites from their salivary gland either into the skin (Yamauchi 
et al., 2007) or into the peripheral circulation (Rosenberg et al., 1990) during their 
blood meal. The sporozoites then travel in the bloodstream to the liver to infect the 
hepatocytes and undergo asexual multiplication to produce schizonts in approximately 
2-10 days (Mota et al., 2002). Each schizont, containing over 30000 merozoites, ruptures 
and releases the merozoites into the human bloodstream (Doolan et al., 2009). After 
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the merozoites are introduced, they infect red blood cells (Cowman and Crabb, 2006). 
The malaria symptoms appear when they burst these cells. Some of the merozoites 
are transformed into male and female gametocytes, which are ingested by mosquitoes 
during their blood meal (Drakeley et al., 2006). The gametocytes multiply themselves 
to produce sporozoites that make their way to the salivary gland of mosquitoes (Doolan 
et al., 2009). The cycle is perpetuated by inoculation of the sporozoites into new hosts. 
It has been known that acquired immunity for malaria is achievable after a single 
infection, but especially in P. falciparum it often requires repeated infections (Day 
and Marsh, 1991; Gupta et al., 1999; Hviid, 2005). Children in endemic areas become 
infected early in life and experience more severe symptoms during the ﬁrst ﬁve years 
in life. As the immunity develops the disease becomes less severe and the number 
of parasites circulating in blood declines (Doolan et al., 2009). This immunity is not 
fully acquired and declines with time (Collins et al., 1968). Without new exposures, 
individuals may lose their immune memory gained from previous infections. Also, 
individuals lose immunity easily by moving out of the endemic area. 
A mathematical model of malaria was introduced by Ross and extended by MacDonald 
(Ross, 1916; Macdonald, 1952, 1957). In the Ross-McDonald model, hosts are assumed 
to be immune to further infection during the infection period only. The model with 
acquired immunity was proposed later by Dietz et al. (1974) and extended by Bailey 
(1975); Aron (1988). In those models, the immunity is boosted by additional infec­
tions. After that several authors have attempted to study the dynamics of malaria by 
considering many key factors such as the latent period in hosts (Yang, 2000; Ngwa, 
2004), partial immunity (Chiyaka et al., 2007b), and incubation time in mosquitoes 
(Wei et al., 2008), for instance. It has been shown that vector-borne diseases like 
malaria are antigenically diverse (Contacos et al., 1972; Gupta, Trenholme, Anderson 
and Day, 1994). Hence, modelling a single strain might not be enough to explain the 
dynamics of the diseases. Although models of multi-strain diseases have been fruitfully 
introduced, (Castillo-Chavez et al., 1989; Gupta et al., 1996; Andreasen et al., 1997; 
Gupta et al., 1998; Lin et al., 1999; Gog and Swinton, 2002; Gog and Grenfell, 2002; 
Lin et al., 2003; Restif and Grenfell, 2006a; Adams and Sasaki, 2007) models of malaria 
transmission with cross-immunity are not numerous (Gupta, Swinton and Anderson, 
1994; Abu-Raddad and Ferguson, 2004). Multi-strain models of vector-borne diseases 
have concentrated more in dengue transmission (Feng and Velasco-Hernandez, 1997; 
Ferguson et al., 1999; Esteva and Vargas, 2003; Adams et al., 2006). 
In this chapter, we propose models to explain the dynamics of multi-strain malaria. 
We do not include the disease-induced death rate in hosts in the models, assuming that 
either the mortality due to the disease is small enough not to aﬀect the host demography 
or the disease is not fatal. In the ﬁrst model, we apply a status-based framework in a 
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host population to describe hosts according to their current immune status to a strain 
of malaria. For simplicity, we only study either two co-circulating strains of malaria in 
the same species or two diﬀerent species. In the second model, we study the dynamics 
of two diﬀerent species of malaria by considering the diﬀerent types of cross-species 
immunity between them. We assume that cross-species immunity acts in the similar 
way with suppression during coinfection of both species. Hence, the coinfection model 
is ﬁrst introduced and then reduced to another model that encapsulates partial cross-
immunity between diﬀerent species. The model is particularly used for studying P. 
falciparum and P. vivax in the endemic area. Controlling vector-borne diseases based 
on the models will be introduced later in Chapter 4. 
In addition, we study two single-strain models of P. falciparum in the last two sections. 
We concentrate on life-histories of mosquitoes in both of the SIS and SIRS models for 
hosts while the SI model is used for mosquitoes. These studies are to emphasize that 
certain factors in mosquitoes might inﬂuence the dynamical behaviours of the system. 
Those factors are such as seasonality, incubation time, and attractiveness of infectious 
individuals to mosquitoes. 
3.1 Mathematical model of host’s immune status to malaria 
We propose the model that can be used to describe the dynamics of either two co­
circulating strains of P. falciparum or two co-circulating species of P. falciparum and P. 
vivax, for instance. By applying the status-based framework with polarized immunity 
and the reduced-transmission assumption (Gog and Grenfell, 2002), only one immune 
class is needed to describe hosts with respect to each strain or species. We introduce 
the status-based model (Gog and Swinton, 2002) for the interactions of humans and 
mosquitoes with two strains or species of the disease. For the rest of this work, we 
refer to an interaction between two diﬀerent strains although the interaction between 
two species is similar. 
3.1.1 Formulation of the model 
We start with introducing a status-based model with polarized immunity in a vector-
borne disease with two co-circulating strains and then we reduce the number of equa­
tions by an additional assumption of partial cross-immunity acting as reduced trans­
mission. A status-based model with polarized immunity is introduced by Gog and 
Swinton (2002) for describing a diﬀerent form of cross-immunity from a history-based 
model with cross-immunity acting as reduced susceptibility (Andreasen et al., 1997). 
The idea is by categorizing a susceptible population according to their current immune 
38
 
status. With the polarized-immunity assumption, an individual is either entirely sus­
ceptible to a strain, or totally immune to it. A partial cross-immunity parameter in 
the model determines the destination category of immunity after the exposure to the 
pathogen strain. Each host is in one of immune classes although it is currently infec­
tious. It is assumed that there is no removal of infected so that infectious individuals 
move to their susceptible state directly. Our model is based on the same idea, but with 
two populations interacting. Our notation follows that of Gog and Swinton. We only 
apply a status-based framework with a human population, so we divide it into four im­
mune classes which are non-immune (S∅), immune to strain 1 but susceptible to strain 
2 (S{1}), immune to strain 2 but susceptible to strain 1 (S{2}), and immune to both 
strains (S{1,2}). Infectious individuals are divided into two classes which are infectious 
with strain 1 (I1) and infectious with strain 2 (I2). So each infectious individual is 
counted twice corresponding to the immune state and the infectious class. We assume 
that a total size of the human population (N) is at equilibrium with µ as the per capita 
birth and death rate and � 
SJ = N. (3.1.1) 
J 
In the model, νi is a recovery rate from strain i. Cross-immunity is described through 
a parameter C(K, J, i) which represents the probability of hosts having started with 
state K, been exposed to strain i, and entered to state J . Note that C is not deﬁned 
unless i ∈ J , K ⊂ J , and since there is no death due to the disease, � 
C(K, J, i) = 1 (3.1.2) 
J 
where the sum is taken over all subsets J ⊂ L = 1, 2 such that K ⊂ J , i ∈ J , and 
K ∪ {i} ⊂ J . In this work, we do not include the latent period in humans. 
We assume 1) that the parasites are not harmful to the mosquitoes 2) that once a 
mosquito has ingested a particular strain of malaria, it carries that strain, and that 
strain only for the rest of its life (Gupta, Swinton and Anderson, 1994; Feng and 
Velasco-Hernandez, 1997; Esteva and Vargas, 2003; Supriatna et al., 2008). We do not 
consider incubation time of P. vivax in mosquitoes in the model. The vector population 
is separated into three classes which are susceptible (U), infectious with strain 1 (V1), 
and infectious with strain 2 (V2). The transmission rate from infectious mosquitoes 
with strain i to susceptible humans is described by βi which implicitly depends on the 
biting rate of mosquitoes (b) and the probability of successful infection with strain i in 
human (phi ). The transmission rate from infectious human with strain i to susceptible 
mosquitoes is denoted by αi which is a function of the biting rate of mosquitoes and the 
probability of successful infection with strain i in mosquito (pmi ). The total population 
size of mosquitoes (M) is assumed to be at equilibrium. With the recruitment rate of 
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mosquitoes equal to B and the death rate equal to η, M is B/η. The model takes the 
form 
S˙ ∅(t) = µN − µS∅ − C(∅, {1}, 1)β1V1S∅ − C(∅, {1, 2}, 1)β1V1S∅−
 
C(∅, {2}, 2)β2V2S∅ − C(∅, {1, 2}, 2)β2V2S∅,
 
˙
S{1}(t) = C(∅, {1}, 1)β1V1S∅ − C({1}, {1, 2}, 2)β2V2S{1}−
 
C({1}, {1, 2}, 1)β1V1S{1} − µS{1},
 
˙
S{2}(t) = C(∅, {2}, 2)β2V2S∅ − C({2}, {1, 2}, 1)β1V1S{2}−
 
C({2}, {1, 2}, 2)β2V2S{2} − µS{2},
 
˙
S{1,2}(t) = C(∅, {1, 2}, 1)β1V1S∅ + C(∅, {1, 2}, 2)β2V2S∅+ 
C({1}, {1, 2}, 2)β2V2S{1} + C({2}, {1, 2}, 1)β1V1S{2} − µS{1,2}, 
I˙1(t) = β1V1(S∅ + S{2}) − (µ + ν1)I{1}, 
I˙2(t) = β2V2(S∅ + S{1}) − (µ + ν2)I{2}, 
U˙(t) = B − ηU − α1I1U − α2I2U,
 
V˙1(t) = α1I1U − ηV1,
 
V˙2(t) = α2I2U − ηV2.
 
(3.1.3) 
In the model, we have : C(∅, {1}, 1) + C(∅, {1, 2}, 1) = 1, C({2}, {1, 2}, 1) = 1, 
C(∅, {2}, 2) + C(∅, {1, 2}, 2) = 1, and C({1}, {1, 2}, 2) = 1. Because S{1,2} does not 
appear in the other equations, its derivative equation can be omitted from the system. 
By the additional assumption of reduced transmission in a status-based framework with 
polarized immunity (Gog and Grenfell, 2002) and that the probability of acquiring fur­
ther immune memory to the other strain of the naive individual and the infectious 
individual with the current strain is equal (C(∅, {1, 2}, 2) = C({2}, {1, 2}, 2) = σ12 and 
C(∅, {1, 2}, 1) = C({1}, {1, 2}, 1) = σ21), all hosts have the same chance of acquiring 
immunity to a strain so that only one variable is enough to describe host’s immunity 
to each strain. Consequently, we introduce two new variables, S1 = S∅ + S{2} and 
S2 = S∅ + S{1}, which represent the number of susceptible individuals to strain 1 and 
the number of susceptible individuals to strain 2 respectively. Hence, for example, by 
the assumption that C(∅, {1}, 1) + C(∅, {1, 2}, 1) = 1 and C({2}, {1, 2}, 1) = 1, we have 
S˙1 = µN − µS1 − β1V1S1 − C(∅, {1, 2}, 2)β2V2S∅ − C(2, {1, 2}, 2)β2V2S{2}. 
Because we assume that (C(∅, {1, 2}, 2) = C({2}, {1, 2}, 2) = σ12, 
S˙1 = µN − µS1 − β1V1S1 − σ12β2V2S1. 
The diﬀerential equation of S2 can also be derived in the similar way. For simplicity, 
we further assume that σ12 = σ21 = σ. Also, the diﬀerential equation for U in the 
system (3.1.3) can be removed by substituting U = M − V1 − V2 in the other equations. 
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The system (3.1.3) is reduced to 
S˙1(t) = µN − µS1 − β1V1S1 − σβ2V2S1, 
I˙1(t) = β1V1S1 − (µ + ν)I1, 
S˙2(t) = µNh − µS2 − β2V2S2 − σβ1V1S2, (3.1.4)
I˙2(t) = β2V2S2 − (µ + ν)I2, 
V˙1(t) = α1I1(M − V1 − V2) − ηV1, 
V˙2(t) = α2I2(M − V1 − V2) − ηV2 
with strains assumed to have the diﬀerent transmission rate but share the same recovery 
rate. 
For strain i, the number of vectors that become infectious when we introduce an infec­
tious host into the susceptible population of vectors is αiM(1/(µ + ν)). The number 
of hosts who become infectious when we introduce an infectious mosquito into the sus­
ceptible pool of hosts is βiN(1/η). Hence, the basic reproductive ratio of strain i in 
the system (3.1.4) is 
αiβiNM 
R0i = .(µ + ν)η 
where M = B/η. 
3.1.2 Analysis 
The steady states 
There are four types of steady states of the system (3.1.4): 
1. the disease-free steady state 
P 0 = (S1, I1, S2, I2, V1, V2) = (S1
0, I1
0, S2
0, I2
0, V 1
0, V 0) = (N, 0, M, 0, 0, 0),2 
2. the single-strain steady state of strain i for i = 1, 2 
P i = (S1, I1, S2, I2, V1, V2) = (S1
i , I1
i , S2
i , I2
i , V 1 
i, V i)2 
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where 
µN−(µ+ν)IiSi = µ , 
µ[αiβiNM−(µ+ν)η]Ii =	 ,αi(µ+ν)[βiM+µ] 
µN(αiIi+η)Sj =	 ,µ(αiIi+η)+σβiαiMIi 
Ij = 0 
αiIiMVi = (αiIi+η) 
Vj = 0 
where i �= j, 
3. the coexistent steady state 
P ∗ = (S1, I1, S2, I2, V1, V2) = (S1 
∗ , I1 
∗ , S2 
∗ , I2 
∗ , V1 
∗ , V ∗)2 
where 
µ(α1I1+α2I2+η)NS∗ = 1 µ(α1I1+α2I2+η)+β1α1MI1+σβ2α2MI2 
µη[(R1−1)(µα2+β2α2M)−(R2−1)(µα2+σβ2α2M)]I∗ = 1 (µα1+β1α1M)(µα2+β2α2M)−(µα1+σβ1α1M)(µα2+σβ2α2M) 
µ(α1I1+α2I2+η)NS∗ = 2	 µ(α1I1+α2I2+η)+β2α2MI2+σβ1α1MI1 
µη(R2−1)−(µα1+σβ1α1M)I1I∗ = 2 (µα2+β2α2M ) 
α1MI1V ∗ = 1 (α1I1+α2I2+η) 
α2MI2V ∗ = 2	 (α1I1+α2I2+η). 
Stability analysis 
Stability conditions of each steady state can be found by considering signs of eigenvalues 
of the Jacobian matrix of the system at the steady state or applying the Routh-Hurwitz 
criteria. The Jacobian matrix of the system (3.1.4) is 
⎡ −µ − β1V1 − σβ2 V2 0 0 0 −β1 S1 −σβ2S1 ⎤ 
β1V1 −(µ + ν) 0 0 β1S1 0 
J = 
0 0 −µ − β2V2 − σβ1 V1 0 −σβ1S2 −β2S2 . 
⎢⎢⎢⎢⎢⎢⎢⎣ 0 0 0 α1(M − V1 − V2) β2V2 0 −(µ + ν) 0 0 −α1I1 − η β2S2 −α1I1 
⎥⎥⎥⎥⎥⎥⎥⎦ 
0 0 0 α2(M − V1 − V2) −α2I2 −α2I2 − η 
(3.1.5) 
At the disease-free steady state, two eigenvalues of the Jacobian matrix are −µ, −µ, 
and the rests are those of of the characteristic equation 
(λ2 +(µ + ν + η)λ + η(µ + ν) − α1β1NM)(λ2 +(µ + ν + η)λ + η(µ + ν) − α2β2NM) = 0 
The ﬁrst polynomial has two negative real roots (the increment is always positive) if 
and only if 
α1β1NM 
R01 = < 1 
η(µ + ν) 
42
 
0.5 1 1.5
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
R2
m
a
x(λ
)
R1 = 0.7
at P0
at P1
at P2
at P*
5 6 7 8 9 10 11 12
0
0.5
1
1.5
2
2.5
R2
m
a
x(λ
)
R1 = 7
at P0
at P1
at P2
at P*
(a) (b) 
Figure 3-1: (a) A bifurcation graph when R01 = 0.7 of R02 against max (λ) (b) A graph 
when R01 = 7 of R02 against I2 at the steady states 
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Figure 3-2: (a) A bifurcation graph when R01 = 7 of R02 against max (λ) (b) A graph 
when R01 = 0.7 of R02 against I2 at the steady states 
and the second polynomial has two negative real roots (the increment is always positive) 
if and only if 
α2β2NM 
R02 = < 1. 
η(µ + ν) 
Hence, the disease-free steady state is stable if and only if R01 < 1 and R02 < 1. Simi­
larly, the stability conditions of the other steady states can be found by considering the 
signs of eigenvalues of the Jacobian matrix or using the Routh-Hurwitz criteria. Be­
cause the non disease-free steady states and their characteristic equations are unwieldy 
to deal with, we instead study them numerically. 
Numerical Analysis 
We assume that a human lifetime (1/µ) is 70 years and a mosquito lifetime (1/η) 
is 20/365 years. An infectious period of malaria in human (1/ν) is assumed to be 
14/365 years. The total size of human population (N) is 10,000,000 and the total size 
of mosquito population (M) is 50,000,000. The transmission probability of infection 
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Figure 3-3: A three dimensional bifurcation graph of R2, I1, and I2 at the steady states 
to mosquitoes (α1, α2) is 1.5e − 5 for both strains. The transmission probability of 
infection to humans (β1, β2) of each strain depends on its basic reproductive ratio. The 
cross-immunity parameter (σ) is ﬁxed at 0.7, otherwise it is as stated. 
We choose the basic reproductive ratio of strain 2 (R02) to be a bifurcation parameter 
and separate the basic reproductive ratio of strain 1 (R01) into two cases: 1) R01 < 1, 
and 2) R01 > 1. R02 is varied by varying β2 while other parameters are ﬁxed. We 
consider the maximum of the eigenvalues (max (λ)) of the Jacobian matrix at each 
steady state. If it is less than zero, all the eigenvalues of the Jacobian matrix at that 
steady state are negative, which implies that the steady state we consider is stable. If 
it is greater than zero, it is enough to say that the steady state is unstable even though 
the other eigenvalues are all negative. A point where two steady states exchange their 
stabilities (max (λ) of one steady state changes sign from negative to positive and the 
other changes sign from positive to negative) is where transcritical bifurcation occurs. 
We also show a cross-section graph from a three dimensional plot of the number of 
infectious individuals with strain 1 and strain 2 at the steady states against R02 along 
with bifurcation graphs. We note here that points, where 1) the number of infectious 
individuals with strain 2 at the single-strain steady steady state of strain 2 (I2) changes 2 
its value from negative to positive when R01 < 1, 2) the number of infectious individuals 
with strain 2 at the coexistent steady state (I∗) changes its value from negative to 2 
positive when R01 > 1, 3) the intersection of the number of infectious individuals with 
strain 2 at the coexistent steady state (I∗) and the single-strain steady state of strain 2 2 
(I2) when R01 > 1, should be compared with the bifurcation graphs where bifurcation 
occurs in both cases (See Figure 3-1,3-2, and 3-3). 
1. Case I: R01 < 1 
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Figure 3-4: (a) A numerical result when R01 = 7 and R02 = 4 (strain 1 persists) (b) A 
numerical result when R01 = 7 and R02 = 7.5 (both strains coexist) 
We choose R01 = 0.7. In Figure 3-1(a), the max (λ) of the Jacobian matrix at the 
disease-free steady state changes sign at R02 = 1 from negative to the positive 
while the max (λ) of the Jacobian matrix at the single-strain steady state of strain 
2 changes sign from positive to the negative. Hence we have the interchange of 
stability of two steady states at R02 = 1. Therefore, R02 = 1 is a transcritical 
bifurcation value. In long term, both strains die out when R02 < 1 and strain 2 
persists when R02 > 1. Also R02 = 1 is where the value of I2 changes its value 2 
from negative to positive (See Figure 3-1(b)). 
2. Case II: R01 > 1 
We choose R01 = 7. In this case, the max (λ) of the Jacobian matrix at the 
single-strain steady state of strain 1 changes the value from negative to positive 
while the max (λ) of the Jacobian matrix at the coexistent steady state changes 
sign form positive to negative at R02 ≈ 5.8 (See Figure 3-2(a)). So R02 ≈ 5.8 is 
where a ﬁrst transcritical bifurcation occurs. Also R02 = 5.8 is where the value 
of I∗ changes its value from negative to positive (See Figure 3-2(b)). A second 2 
transcritical bifurcation occurs when R02 ≈ 8.5, which is where the max (λ) of the 
Jacobian matrix at the coexistent steady state changes its sign from negative to 
positive and the max (λ) of the Jacobian matrix at the single-strain steady state 
of strain 2 changes its sign from positive to negative (See Figure 3-2 (a)) and 
at the same bifurcation point, the coexistent steady state intersects the single-
strain steady state of strain 2 (See Figure 3-2(b)). In conclusion, we have that; 
1) strain 1 only persists whenever R02 < 5.8; 2) both strains coexist whenever 
5.8 < R02 < 8.5; and 3) strain 2 persists if and only if R02 > 8.5. We show 
examples of numerical results when R01 = 7 and R02 = 4 in Figure 3-4(a) such 
that strain 1 persists and when R01 = 7 and R02 = 7.5 in Figure 3-4(b) such that 
both strain coexist. 
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Figure 3-5: (a) A bifurcation diagram of R01 and R02 when 0 < σ < 1 (b) A bifurcation 
diagram of R01 and R02 when σ = 1 
Similarly, we can consider the case when R01 is vary while R02 is ﬁxed for the bifurcation 
graphs on R01 −max (λ) plane. All in all, by considering the eﬀect of cross-immunity in 
the model, the bifurcation diagrams on R01 − R02 plane can be described by Figure 3­
5(a)-(b). In Figure 3-5(a), the bigger the cross-immunity is, the smaller the area of the 
coexistence. When cross-immunity gives full protection to the other strain coexistence 
of the two strains is impossible (See Figure 3-5(b)). 
3.1.3 Conclusion and discussion 
A model of host-immune status is developed for transmission of two strains or species of 
malaria in which cross-immunity plays an important role. By the status-based frame­
work with polarised immunity and the assumption that cross-immunity is conferred 
by exposure to the disease via an infective mosquito, rather than developing the full 
infection itself, the model becomes tractable with only one immune variable to describe 
host immunity to each strain. We study the system analytically and numerically for 
bifurcation analysis. We propose the threshold condition that can be used to predict 
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the dynamics of the strains, such that the ﬁrst strain of malaria dies out whenever
 
α1β1NM 
R01 = < 1 
η(µ + ν) 
and the second whenever 
α2β2NM 
R02 = < 1. 
η(µ + ν) 
Also, we investigate the system numerically when cross-immunity is present and one 
strain has the basic reproductive ratio greater than 1, whether another strain dies 
out, coexists, or drives out the other (see Figure 3-5(a)). For example, when strain 1 
has the basic reproductive ratio (R01), 7, only strain 1 persists whenever R02 < 5.8; 
both strains coexist whenever 5.8 < R02 < 8.5; and only strain 2 persists whenever 
R02 > 8.5. 
3.2	 From suppression during coinfection to cross-species 
immunity:can it happen on malaria transmission? 
Maitland et al. (1997) ﬁnd that although the prevalence of P. falciparum and P. vivax 
in Vanuatu ﬂuctuates, the burden of malaria remains constant. This suggests that there 
is direct interaction between P. falciparum and vivax. In this study, we propose a novel 
model that captures the presence of both malaria species, P. falciparum and P. vivax, 
suppression between them, and possible cross-species immunity. We introduce the 
single-species models, the coinfection model, and the cross-immunity model adjusted 
from the coinfection model by omitting mixed infection of both species. We then 
investigate the relations between these two species and their dynamical behaviours. 
3.2.1	 Single-species models 
Malaria transmission occurs through interactions between two populations, human and 
mosquito. Each species has diﬀerent characteristics such as a transmission rate, a 
recovery rate, relapse, and incubation time. In this section, we study single-species 
models of P. falciparum and P. vivax. 
A malaria transmission model for P. falciparum 
A human population is divided into three categories: susceptible (S), infectious to P. 
falciparum (I1), and recovered from P. falciparum (R1), under the assumption that 
a recovered individual acquires immunity from recovering (Koella and Antia, 2003; 
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Koella and Boete, 2003; Smith et al., 2005; Keeling and Rohani, 2008; Gaudart et al., 
2009) but that immunity wanes with time (Collins et al., 1968; Burattini et al., 1993). 
It is often assumed that immunity depends on exposure and it is boosted by additional 
infections (Koella and Antia, 2003; Koella and Boete, 2003). Here, for simplicity, an 
individual is assumed to acquire immunity within a single infection (Gupta et al., 1999). 
Also, we assume that immune individuals can be reinfected with the parasites but they 
cannot transmit the disease (Doolan et al., 2009) due to low densities of parasitaemia 
or protection during curative treatment (Gaudart et al., 2009). 
A mosquito population is divided into two categories: susceptible (U), and infectious 
to P. falciparum (V1). It is assumed that infectious mosquitoes do not recover. Once 
infected, they remain infected for life. The model for malaria transmission caused by 
P. falciparum takes the forms: 
S˙(t) = µN − βN 1V1S − µS + γ1R1, 
I˙1(t) =
 1βN V1S − (µ + ν1)I1, 
R˙1(t) = ν1I1 − (µ + γ1)R1, (3.2.1) 
U˙(t) = ηM − αN 1 I1U − ηU, 
1αV1(t) N 
where β1 
˙
 =
 I1U − ηV1, 
= bph, α1 = bpm, b is the biting rate, ph is the probability of successful 
infection in humans, pm is the probability of successful infection in mosquitoes. A 
study of this model in details can be found in the section 3.3.1. 
A malaria transmission model for P. vivax 
It has been known that relapses often occur in individuals who are infected with P. vivax 
or P. ovale (Cogswell, 1992). Clinically, relapse means a return of disease symptoms 
after its apparent cessation. During a primary attack, some hypnozoites might remain 
dormant in the liver instead of transforming into schizonts, and hence later cause a 
relapse or another attack of parasitemia (Ishikawa et al., 2003). Natural relapse malaria 
might be induced by Anopheles mosquitoes (Hulden et al., 2008). Mathematical models 
for studying P. vivax are not numerous (Ishikawa et al., 2003; Pongsumpun and Tang, 
2007). Here, we propose a basic model for simplistic use when coinfection occurs in the 
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next study in Section 3.2.3 as follows
 
S˙(t) = µN − β2 V2S − µS + γ2R2,N 
β2I˙2(t) = V2S − (µ + ν2 + ω21)I2 + ω22D2,N 
D˙2(t) = ω21I2 − (µ + ω22)D2, (3.2.2)
R˙2(t) = ν2I2 − (µ + γ2)R2, 
U˙(t) = ηM − α2 I2U − ηU, N
 
˙ α2
V2(t) = I2U − ηV2,N 
where some infectious individuals from the compartment I2 enter the compartment D2 
when some of their hypnozoites remain dormant and they do not acquire immunity from 
their primary infection. Under the assumption that individuals in the D2 compartment 
do not acquire the immunity, they either die due to the natural causes or reenter the 
I2 compartment from relapse. The detail of ﬂows of other compartments is similar to 
the model (3.2.1) in the previous section in describing the dynamics of P. falciparum. 
A ﬂow diagram of (3.2.2) is shown in Figure 3-6. It is important to understand when 
an epidemic can take place, hence to calculate the basic reproductive ratio. We use the 
next-generation matrix K = [kij ] (Diekmann and Heesterbeek, 2000). We deﬁne the 
three infected types-at-birth; I2: type 1; D2 : type 2; V2 : type 3; where type-at-birth 
refers to the birth of the infection in the individual rather than the individual. We 
deﬁne kij = E{# of type-at-birth i that a type-at-birth j gives rise to in its life time 
( as a type-at-birth j)}. So, 
k11 = 0, 
ω21k21 = ,µ+ν2+ω21 
α2qk31 = ,µ+ν2+ω21 
ω22k12 = ,µ+ω22 
k22 = 0, 
k32 = 0, 
k13 = βη 
2 , 
k23 = 0, 
k33 = 0. 
Hence,
 ⎤⎥⎦ , 
whose principal eigenvalue λ is easily calculated. Here, we deﬁne the basic reproductive 
ratio of the system (3.2.2) as the square of the maximum eigenvalue of K. Therefore, 
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ω22 β20 µ+ω22 η 
K =
 ω21 0 0 µ+ν2+ω21 
α2q 0 0
 µ+ν2+ω21 
     I2     S
     D2
     U      V2
     R2
µ µµ
µ
µ β2V2/N ν2
γ2
ω21 ω22
η
η η
α2I2/N
the basic reproductive ratio is
 
β2α2q ω21 ω22
R0
2 = + . 
η(µ + ν2 + ω21) (µ + ν2 + ω21) (µ + ω22)
From the formula, R2 has two components: one is from infectious individuals; the 0 
other one comes from infections due to relapses. The latter takes into account the 
infectious individuals that do not die in the infectious class and become inactive with 
the parasites. Note that some authors deﬁne R2 to be a square root of this term. The 0 
study of the system (3.2.2) in detail can be found in the next section. 
Figure 3-6: A ﬂow diagram for malaria transmission by P. vivax 
3.2.2 A study of the mathematical model for transmission of P.vivax 
We introduce the new variables as follows 
S I2 D2 R2 U V2 
s = , i2 = , d2 = , r2 = , u = , v2 = . 
N N N N M M 
Hence, the system (3.2.2) can be rewritten by 
s˙(t) = µ − β2qv2s − µs + γ2(1 − s − i2 − d2), 
i˙2(t) = β2qv2s − (µ + ν2 + ω21)i2 + ω22d2, (3.2.3)
d˙2(t) = ω21i2 − (µ + ω22)d2, 
v˙2(t) = α2i2(1 − v2) − ηv2, 
where q = M/N , β2 = bph2 , α2 = bpm2 , b is the biting rate of mosquitoes, ph2 is the 
probability of successful infection of P. vivax in humans, and pm2 is the probability of 
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successful infection of P. vivax in mosquitoes. The diﬀerential equations for r2 and u 
are omitted and they can be found from r2 = 1 − s − i2 − d2 and u = 1 − v2, directly. 
The system (3.2.3) has two steady states: 
1. the disease-free steady state 
0P 0 = (s 0, i2
0, d02, v ) = (1, 0, 0, 0)2 
2. the disease-present steady state 
∗ P ∗ = (s ∗ , i 2
∗ , d ∗ 2, v )2
where 
∗ µ(µ+ω22)+γ2(µ+ω22)−[γ2(µ+ω21+ω22)+(µ+ν2)(µ+ω22)+µω21]i2 ∗ s =	 ,(µ+γ2)(µ+ω22) 
d∗	 ω21i2 
∗ 
= 2 (µ+ω22) , 
α2i∗ ∗ 2v2 = (η+α2i∗) , 2
and i∗ is in the following form: 2 
β2α2q(µ + γ2)(µ + ω22) − η(µ + γ2)[(µ + ν2)(µ + ω22) + µω21]∗ 
i =	 .2 
β2α2 q[γ2(µ + ω21 + ω22) + (µ + ν2)(µ + ω22) + µω21] + α2(µ + γ2)[(µ + ν2)(µ + ω22) + µω21 ] 
Since the system is unwieldy to deal with, we numerically show that vivax malaria 
dies out when R0
2 < 1 and is endemic when R0
2 > 1. Parameters in the model can be 
found in Table 3.1. Otherwise, they are stated. Figure 3-7 shows that P. vivax dies 
Table 3.1: Lists of parameters for malaria transmission 
Parameter Description	 Value References 
β2 transmission rate in humans bph2 ­
α2 transmission rate in mosquitoes bpm2 ­
µ birth and death rate 1/70 (year−1) estimated 
b biting rate 100-182 (year−1) Gupta, Swinton and Anderson (1994) 
ph2 probability of successful infection 0.1 Gupta, Swinton and Anderson (1994) 
in humans 
pm2	 probability of successful infection 0.2 estimated 
in mosquitoes 
ν2	 recovery rate 2.34 (year
−1 ) Ishikawa et al. (2003) 
γ2	 rate of losing immunity 1/16 (year
−1) Ishikawa et al. (2003) 
ω21	 rate of entering hypnozoite stage 0.51 (year
−1 ) Ishikawa et al. (2003) 
ω22	 rate of relapse 365/42 (year
−1) Anstey et al. (2009) 
η	 natural death rate of mosquitoes 365/20 (year−1) Anderson and May (1991) 
q	 the number of mosquitoes per individual 1-2 Gupta, Swinton and Anderson (1994) 
Note that for estimation of ν2 and ω21, it is assumed that rate of losing infectiousness per year (ν) is 365/128 and the probability 
that an individual injected with sporozoites develops the hypnozoites (ξ) is approximately 0.18 (Ishikawa et al., 2003). Hence, 
νi2 = (1 − ξ)νi2 + ξνi2, so that ν2 = (1 − ξ)ν and ω21 = ξν. We also assume that the probability of successful infection in 
humans is equal in both P. falciparum and P. vivax. Due to the limited reproductive capacity from the preference of infecting 
young RBCs only, the fewer merozoites produced, and low level of parasitemias in vivax malaria (Anstey et al., 2009), we assume 
that the probability of successful infection in mosquitoes is less than one in falciparum malaria, which is approximately 0.3 
(Drakeley et al., 2006). 
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Figure 3-7: (a) P. vivax dies out when R
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0.1, ν2 = 3.5) (b) P. vivax is endemic in the host population when R20 = 4 (from data)
 
> 1. 
3.2.3 Formulation of the coinfection model and its study 
In several malaria endemic areas such as Asia, or South America, there are normally 
more than two species coexisting, in particular P. falciparum and P. vivax (Snounou 
and White, 2004). Many studies in the past have only concentrated on the transmission 
of P. falciparum due to its malignancy, although P. vivax is the most wide-spread and 
they often coexist. Here, we propose a mathematical model for studying the spread of 
malaria in an endemic area where both P. falciparum and P. vivax are present. We 
ﬁrst propose a coinfection model that accounts for a host who harbours two diﬀerent 
species at the same period. In the model, cross-species immunity is absent. A ﬂow 
diagram of the model is shown in Figure 3-8. 
Susceptible individuals are recruited to the host population by birth or immigration 
and by loss of acquired immunity to the species they previously infected with. The 
naive population is diminished by infection to P. falciparum and P. vivax, or natural 
death. 
The infectious population to P. falciparum is increased by infection of the susceptible 
population and it is reduced by recovery, natural death, or coinfection with P. vivax. 
Similarly, the infectious population to P. vivax is increased by infection of susceptible 
individuals to P. vivax. Individuals move out from this class by recovery, natural death, 
relapse, or coinfection with P. falciparum. 
Individuals infected with P. vivax move into the relapse class when some of their hypno­
zoites remain dormant in their livers instead of transforming into schizonts. They move 
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out from the relapse class by natural death, when another attack of parasitemia occurs 
so that they become infectious again, or when they get infected with P. falciparum 
while they still remain dormant with P. vivax. 
S
I1
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µ
µ
µ
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µ
µ
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Individuals acquire immunity to P. falciparum or P. vivax after recovering. They move 
out of immune classes by natural death, waning of immunity, infection with the other 
species. 
The movement into the coinfection class is by becoming infected with both species at 
the same period. Individuals move out from this class by natural death, and when they 
recover and acquire the immunity from the parasites, either immune to P. falciparum 
or P. vivax. They also move out from this class because P. vivax becomes dormant. 
Figure 3-8: A ﬂow diagram for a malaria transmission coinfection model 
Individuals who were primarily infected with P. falciparum and became immune to it 
may become infected with P. vivax and enter the I{1}2 class. Individuals who were 
previously infected with both species might become immune to P. falciparum and also 
enter this class. They move out from it when they die due to natural death, acquire 
immunity to P. vivax, or become dormant with P. vivax. Similarly, individuals immune 
to P. vivax may get infected with P. falciparum or ones who are infected with both 
species may become immune to P. vivax, so that they enter the I{2}1 class. The 
movement out of this class is either from natural death or recovery. 
For the I1D2 class, which represents individuals who are infectious to P. falciparum but 
dormant with P. vivax, the movement into this class is from individuals who remain 
dormant with P. vivax getting infected with P. falciparum or individuals coinfected 
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with both species becoming dormant with P. vivax. The individuals move out this class 
by natural death, relapse, or recovering from P. falciparum. 
Another dormant class relating to secondary infection is D{1}2, representing individuals 
who successfully acquired immunity to P. falciparum and infected with P. vivax but 
become dormant with it. Individuals who enter this class are either previously dormant 
with P. vivax and then infected and immune with P. falciparum, or primarily infected 
and acquired immunity to P. falciparum and secondarily infected with P. vivax and 
become dormant with it. The ﬂow out of this class is from relapse and natural death. 
Individuals in the class R are immune to both P. falciparum and P. vivax but the 
immunity wanes with time and they become completely susceptible from losing it. 
Mosquitoes become infectious with P. falciparum or P. vivax when they bite infectious 
humans and get infected with the parasites. 
In the presence of active infection with P. falciparum, the emergence of P. vivax blood-
stages may be prevented by cross-species regulation and suppression (William et al., 
1996; Maitland et al., 1997; Bruce et al., 2000; Bruce and Day, 2002). Hence, we assume 
that the number of individual infected with P. falciparum to become infected with P. 
vivax in the subsequent infection is reduced and P. vivax becomes more inactive when 
individuals coinfect with both species. On the other hand, infection with P. vivax 
may not protect individuals from developing subsequent infection with P. falciparum 
(Maitland et al., 1997). However, complications and clinical symptoms may be reduced 
comparing with those who had not suﬀered P. vivax infection (Looareesuwan et al., 
1987). Here, we assume that infection with P. vivax helps individuals to recover from 
P. falciparum more quickly than individuals who had not experienced with P. vivax. 
Furthermore, it has been observed that infection with P. falciparum might suppress 
subsequent infection with P. vivax that emerges from the liver (Maitland et al., 1997; 
Ord et al., 2008). Consequently, we assume that relapses are reduced in individuals 
actively infected with P. falciparum but remaining inactive with P. vivax. 
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The model takes the following form: 
S˙(t) = µ(N − S) − β1 V1S − β2 V2S + γ1R1 + γ2R2 + γR, N N
 
β1
I˙1(t) = V1S − (1 − σ1) β2 V2I1 − (µ + ν1)I1,N N
 
β2
I˙2(t) = V2S − β1 V1I2 − (µ + ν2 + ω21)I2 + ω22D2,N N 
D˙2(t) = ω21I2 − β1 V1D2 − (µ + ω22)D2,N 
R˙1(t) = ν1I1 − β2 V2R1 − (µ + γ1)R1,N 
R˙2(t) = ν2I2 − β1 V1R2 − (µ + γ2)R2,N 
I˙ 12(t) = (1 − σ1) β2 V2I1 + β1 V1I2 + (1 − σ3)ω22I1D2 − (µ + ν1 + ν2 + (1 + σ2)ω21)I12,N N (1−σ4) 
β1I˙1D2 (t) = V1D2 + (1 + σ2)ω21I12 − (µ + ν1 + (1 − σ3)ω22)I1D2 ,N
 
β2 ν1
I˙ {1}2(t) = V2R1 + I12 + ω22D{1}2 − (µ + ν2 + ω21)I{1}2,N (1−σ4)
 
β1
I˙ {2}1(t) = V1R2 + ν2I12 − (µ + ν1)I{2}1,N 
D˙{1}2(t) = ω21I{1}2 + ν1I1D2 − (µ + ω22)D{1}2,
 
˙
R(t) = ν2I{1}2 + ν1I{2}1 − (µ + γ)R,
 
˙
U(t) = ηM − α1 (I1 + I12 + I1D2 + I{2}1)U − α2 (I2 + I12 + I{1}2)U − ηU, N N
 
˙ α1
V1(t) = (I1 + I12 + I1D2 + I{2}1)U − ηV1,N
 
˙ α2
V2(t) = (I2 + I12 + I{1}2)U − ηV2,N 
(3.2.4) 
where 0 < σ1, σ2, σ3, σ4 < 1. The basic reproductive ratio of each species is similar to 
the single-species model in the previous section. Hence, 
β1α1q β2α2q ω21 ω22
R1 = , and R2 = + .0 0η(µ + ν1) η(µ + ν2 + ω21) (µ + ν2 + ω21) (µ + ω22)
The system is unwieldy to deal with, so we study it numerically. In addition, P. fal­
ciparum parasites replicate better in the warmer climate while P. vivax has ability in 
completing its sporogonic cycle so that it can be multiplied in lower temperature (Cui 
et al., 2003; Hoshen and Morse, 2004). Some studies support that P. vivax parasites 
tend to turn into inactive state during the highly transmission of P. falciparum (Mait­
land et al., 1997; Ord et al., 2008). Also mosquitoes tend to feed more often when 
the weather is warmer (Githeko et al., 2000). Here, we ﬁrst introduce seasonality as 
a sinusoidal function in transmission rates of humans and mosquitoes of P. falciparum 
under the assumption that there is a season in each year that P. falciparum is highly 
transmitted. Hence, 
β1 = β1
0(1 − β11 cos2πt), and α1 = α10(1 − α11 cos2πt). 
Figure 3-9(a) shows the transmission rates of P. falciparum depending on time. The 
transmission of P. falciparum is assumed to be highest in the middle of each year. Fig­
ure 3-9(b) and Figure 3-10 show the synchronization of the prevalence of P. falciparum 
in the human population with the sinusoidal transmission rates of P. falciparum. How­
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Figure 3-9: (a) Transmission rates of humans and mosquitoes in sinusoidal functions 
(min(β1) = 10, max(β1 = 18.25), min(α1) = 30, max(α1) = 73) (b) This graph shows 
the number of infectious individuals with P. falciparum and P. vivax when transmission 
rates in both humans and mosquitoes of P. falciparum is in term of the sinusoidal 
function 
ever, the prevalence of P. vivax is high between every two peaks of P. falciparum. This 
result suggests that during high transmission of P. falciparum, P. vivax might maintain 
lower transmission (relating to relapse mechanism) and it may highly been transmitted 
later when the prevalence of P. falciparum is low. This result corresponds to some 
real data of malaria transmission from other literatures (Syafruddin et al. (2009), for 
instance). In conclusion, by our results, the prevalence and incidences of P. falciparum 
and P. vivax, that seem to vary in each season in many parts of the world, may relate 
to mechanisms driven by malaria parasites and seasonality in mosquitoes. 
Figure 3-10: The proportions of infectious humans and mosquitoes with seasonality in 
P. falciparum 
We incorporate the increase of rate of becoming inactive and the reduction of rate 
of relapsing of P. vivax of individuals infected with P. vivax in the presence of P. 
falciparum (William et al., 1996; Maitland et al., 1997) by introducing both of them in 
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terms of sinusoidal functions such that in each year during the time that P. falciparum 
is highly present, P. vivax is suppressed and becomes less present. Note that from above 
we also introduce transmission rates of P. vivax as sinusoidal functions. Consequently, 
P. vivax, we have 
(1+β1 2 cos2πt), α2 α
0 
2(1+α
1 
2cos2πt), ω21 ω
0 
21(1−ω1 21cos2πt), ω22 ω0 22(1+ω1 22)cos2πt. 
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Figure 3-11: (a) Comparison of transmission rates of P. falciparum and P. vivax 
(min(β1) = min(β2) = 10, max(β1) = max(β2) = 18.25, min(α1) = 30, max(α1) = 
73, min(α2) = 20, max(α2) = 36.5) (b) Rate of becoming inactive with P. vivax and 
rate of its relapsing (min(ω21) = 0.51, max(ω22) = 1, min(ω22) = 8.69, max(ω22) = 10) 
Comparison of transmission rates between P. falciparum and P. vivax in terms of 
sinusoidal functions can be found in Figure 3-11(a). Rate of becoming inactive with 
P. vivax and rate of relapsing with seasonal ﬂuctuation are shown in 3-11(b). By 
incorporating all those terms into the model (3.2.4), the numerical result is shown in 
Figure 3-12(a). We ﬁnd that the prevalence of P. falciparum is synchronized with 
its transmission rate which is peak at the middle of each year and the prevalence of 
P. vivax is also synchronized with its transmission rate which is peak between every 
two peaks of transmission rate of P. falciparum. By comparing the proportion of 
infectious individuals in Figure 3-10 and 3-12, without including seasonality in P. vivax, 
the prevalence of P. vivax is high slightly before the highly transmitted season of P. 
falciparum while including seasonality in P. vivax, its prevalence is high in the middle 
of every highly transmitted season of P. falciparum. We introduce a simple version of 
this model and study the relation between two cross-immunity values, σ1 and σ4 in the 
next section. Comparing proportions of the number of infectious individuals to P. vivax 
from Figure 3-10 and Figure 3-12(a), we see that an outbreak (a jump) happens ﬁrst 
in each year in the second case where rate of relapsing and rate of becoming inactive 
are sinusoidal (see Figure 3-12(b)). 
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Figure 3-12: (a) The proportions of infectious humans and mosquitoes with seasonality 
in P. falciparum and P. vivax (b) Comparison of proportions of infectious humans with 
P. vivax from Figure 3-10 and Figure 3-12(a) 
3.2.4 Formulation of the cross-species immunity model and its study 
The cross-species immunity model in this section is a simplistic version of the coin­
fection model (3.2.4) that coinfection between P. falciparum and P. vivax is omitted. 
We assume that cross-species immunity is present and acts in the similar way with 
suppression during subsequent infection in the coinfection model. Hence, individuals 
immune to P. falciparum may have cross-species immunity that reduces transmission 
of P. vivax while individuals immune to P. vivax may have cross-species immunity that 
reduces complications and recovery time to P. falciparum. The ﬂow diagram is shown 
in Figure 3-13. The governing equations can be described by 
S˙(t) = µ(N − S) − β1 V1S − β2 V2S + γ1R1 + γ2R2 + γR, N N 
β1I˙1(t) = V1S − (µ + ν1)I1,N
 
β2
I˙2(t) = V2S − (µ + ν2 + ω21)I2 + ω22D2,N 
D˙2(t) = ω21I2 − (µ + ω22)D2,
 
R˙1(t) = ν1I1 − (1 − σ1)β2 V2R1 − (µ + γ1)R1,
N 
R˙2(t) = ν2I2 − β1 V1R2 − (µ + γ2)R2,N 
I˙ {1}2(t) = (1 − σ1)β2 V2R1 + ω22D{1}2 − (µ + ν2 + ω21)I{1}2, (3.2.5)N
 
β1 ν1
I˙ {2}1(t) = V1R2 − (µ + )I{2}1,N (1−σ4) 
D˙{1}2(t) = ω21I{1}2 − (µ + ω22)D{1}2, 
˙ ν1R(t) = ν2I{1}2 + I{2}1 − (µ + γ)R, (1−σ4) 
U˙(t) = ηM − α1 (I1 + I{2}1)U − α2 (I2 + I{1}2)U − ηU, N N
 
˙ α1
V1(t) = (I1 + I{2}1)U − ηV1,N
 
˙ α2
V2(t) = (I2 + I{1}2)U − ηV2,N 
We study asymptotic solutions of the system (3.2.5) numerically. By ﬁxing σ4 at 0.2 
and varying σ1, we ﬁnd that both species coexist when σ1 < 0.9 and P. vivax dies out 
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Figure 3-13: A ﬂow diagram for a malaria transmission cross-species immunity model 
σ1 ≥ 0.9 (see Figure 3-14(a)). This is also true when σ4 is 0 or when there is no 
cross-species immunity to P. falciparum. Hence, when cross-species immunity that acts 
to reduce transmission of P. vivax is very high (> 0.9), P. vivax may die out. Figure 
3-14(b) shows that both species coexist for all the possible range of σ4 (0 ≤ σ4 < 1) 
σ1 is ﬁxed at 0.5. This is also true when 0 ≤ σ1 < 0.9. Thus, both species of 
malaria still coexist although cross-species immunity that acts to reduce complications 
and recovery time of P. falciparum is very high. However, when cross-immunity of 
P. falciparum becomes very large (> 0.9), both species die out. The proportions of 
infectious humans to P. falciparum and P. vivax when both σ1 and σ2 vary are shown 
in Figure 3-15. Note that R1 0 = 8 and R
2 
0 = 4 for all cases. 
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Figure 3-14: (a) Asymptotic solutions of infectious humans with P. falciparum and 
P. vivax when σ1 varies between 0 and 1 (R1 = 8, R2 = 4, σ4 = 0.2) (b) Asymptotic 0 0 
solutions of infectious humans when σ4 varies between 0 and 0.95 (σ1 = 0.5) 
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We next study the mean age at infection of humans. We calculate it by considering 
the mean time an individual remains susceptible to each species (Keeling and Rohani, 
2008). By ignoring the small natural mortality term, the mean age at infection of P. 
falciparum is approximated by 
1 1 
A1 = = ,∗β1V ∗/N β1qv 1 1 
∗where V1 ∗ , v 1, q are the number of mosquitoes infected with P. falciparum at the steady 
state, its proportion, and the number of mosquitoes per human, respectively. Note that 
in this case there are two possible steady states of the system (3.2.5), the single-species 
steady state of P. falciparum and the coexistence steady state. Similarly, the mean age 
at infection of P. vivax is approximated by 
1 1 
A2 = = ,∗β2V ∗/N β2qv 2 2 
∗where V ∗ and v are the number of mosquitoes infected with P. vivax at the steady 2 2 
state and its proportion. In Figure 3-16(a), we show that the mean age at infection of 
P. falciparum relates to cross-species immunity. In the presence of both cross-species 
immunities (σ1 > 0, σ4 > 0), the mean age at infection of P. falciparum is increased 
so that susceptible individuals averagely become infected after when the cross-species 
immunities are both absent. The mean age at infection of P. falciparum is shortest 
when cross-immunity of P.falciparum to P. vivax is present but cross-immunity of P. 
vivax to reduce complications of P. falciparum is absent (σ1 > 0, σ4 = 0). On the 
other hand, when the later is present and the former is absent (σ1 = 0, σ4 > 0), the 
mean age at infection is longest. Consequently, the presence of cross-species immunity 
of P. vivax that reduces the complications of P. falciparum helps with the longer 
mean age at infection of P. falciparum but the presence of cross-species immunity 
of P. falciparum to reduce transmission of P. vivax reduces it to be shorter. Figure 
3-16(b) shows the mean age at infection of P. vivax. When both of the cross-species 
immunities are present, the mean age at infection of P. vivax is increased. It is shortest 
when cross-immunity that reduces the falciparum complication in term the recovery 
time is present while cross-immunity of P. falciparum to reduce transmission of P. 
vivax is absent (σ1 = 0, σ4 > 0). In contrast, it is longest when the latter is absent 
while the former is present. In conclusion, the presence of cross-species immunity of 
P. falciparum to P. vivax lengthens the mean age at infection of P. vivax while the 
presence of cross-species immunity of P. vivax to P. falciparum alone shortens it. This 
conclusion only clearly occurs when the basic reproductive ratios of P. falciparum and 
P. vivax are quite small (R10 < 4, R0
2 < 2.5). Whenever the basic reproductive ratios of 
the malaria species become much bigger, the presence of cross-immunity does not help 
much with reducing the mean age at infection. 
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We note here that in hyperendemic areas, people become infected with malaria in an 
5 year old) (Gupta and Day, 1994). In our simulation, from real data 
in Table 3.1 and 3.2, we have R1 0 ≈ 8 and R2 0 ≈ 4. Our estimation for the mean 
P. falciparum is 2 year old and it is 4 year old for P. vivax. In 
contrast, if we know the mean age at infection of the population, we can approximate 
the basic reproductive ratio of each species of malaria. From our model, if the mean 
age at infection is approximately less than 5 year old, the basic reproductive ratio for 
should be greater than 4 while the basic reproductive ratio for P. vivax 
should be greater than 3.5. 
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3.2.5 Conclusion and discussion
 
In this work, we propose two single-species models for P. falciparum and P. vivax.
 
We study the model for P. falciparum transmission in detail in the next section. For
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the transmission model of P. vivax, there are two steady-states, the disease-free steady 
state and the disease-present steady state. We introduce the basic reproductive ratio 
of the system and show that P. vivax dies out when it is less than 1 and endemic when 
it is greater than 1 numerically. 
We next introduce a novel model that accounts for coinfection of both species and 
suppression during their subsequent infection. Under the assumption that transmission 
of P. falciparum is seasonal and can be described by a sinusoidal function such that the 
highest transmission occurs in the middle of each year, we ﬁnd that the prevalence of P. 
falciparum is synchronized with its transmission so that it is peak in the middle of every 
year. Moreover, we ﬁnd that the highest prevalence of P. vivax takes place between 
every two peaks of P. falciparum and slightly before where the highest prevalence of P. 
falciparum. Next, we introduce sinusoidal functions in transmission of P. falciparum 
and P. vivax, rate of becoming inactive to P. vivax, and rate of relapsing to capture 
interactions and suppressions between these two species. In this case, the highest 
prevalence of P. vivax occurs in the middle of every highly transmitted season of P. 
falciparum. Let us assume that P. falciparum is highly transmitted in wet season. 
Hence, without including seasonality in P. vivax, the prevalence of P. vivax is high 
slightly before the wet season while including seasonality in P. vivax, its prevalence is 
high in dry season (in the middle of every wet season). In each area, P. vivax may 
interact with P. falciparum diﬀerently. For example, in where hot season is short and 
winter is long, it may try to avoid interaction with P. faciparum via relapse mechanism, 
suppression during infections, and capability of multiplying in cold weather. In this 
case, the model including seasonality in transmission and relapse rate might be suitable 
for using. In contrast, where hot and wet seasons are long and winter is short, P. vivax 
may not be able to avoid encountering with P. falciparum. Hence, the high prevalence 
of P. vivax might occur close the same season with P. falciparum which is when the 
environments are most suitable for the parasites for multiplying and surviving. In this 
case, the model including only the seasonality in P. falciparum might be enough to 
describe the dynamical behaviours of the system and the prevalence of malaria. 
We further investigate the relation between cross-immunity values σ1 and σ4, cross-
immunity of P. falciparum to reduce transmission of P. vivax and cross-immunity 
of P. vivax to reduce complication of P. falciparum (a shorter recovery time in this 
case), in a cross-immunity species model that the presence of cross-species immunity 
is assumed and acts in the similar way with suppression during subsequent infection. 
We ﬁnd that when σ1 is very high, P. vivax may die out from the population while 
both coexist no matter how large σ4 is unless σ1 is very high (> 0.9). Cross-immunity 
of P. falciparum to reduce transmission of P. vivax may be an important mechanism 
in reducing the number of infectious individuals to P. vivax. 
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In the study of the mean age at infection in the cross-species immunity model, cross-
immunity of P. vivax to reduce the recovery time in P. falciparum increases the mean 
age at infection of P. falciparum (as more humans become immune to P. falciparum) 
while cross-immunity of P. falciparum to reduce transmission of P. vivax reduces it 
to be shorter (as humans become immune to P. vivax but still susceptible to P. falci­
parum). On the other hand, cross-immunity of P. falciparum to P. vivax increases the 
mean age at infection of P. vivax (as individuals become immune to P. vivax ) while 
cross-immunity of P. vivax to P. falciparum reduces it (as individuals become immune 
to P. falciparum quickly but still susceptible to P. vivax ). This obviously occurs when 
the basic reproductive ratios of P. falciparum and P. vivax are quite small. However, if 
the basic reproductive ratios of the malaria species become much bigger, the presence 
of cross-immunity does not much alter the mean age at infection. From this study, we 
can also estimate the mean ages at infection for P. falciparum and P. vivax as 2 year 
old and 4 year old. The formula can also be adjusted to ﬁnd the basic reproductive 
ratios of both species when the mean age at infection of each species is known. 
All in all, our goal for this work is to try to understand the interactions and suppression 
between P. falciparum and P. vivax when they are commonly present in the endemic 
area. The models we proposed capture suppression during subsequent infection and 
the presence of cross-species immunity. They help us to understand more about the 
seasonal prevalence of each species, relations between cross-species immunity, and the 
mean age at infection of each species. This work can be extended to cover disease 
controls, or incubation time of each species, for example. 
3.3 Additional work on a single-strain/species model 
Anopheles mosquitoes were identiﬁed as malaria vectors over 100 years ago. In one 
endemic area, many species of them might be present. For example, in Africa, An. 
gambiae Giles sensu stricto, An. funestus Giles sensu stricto, and An. arabiensis Patton 
play major roles in malaria transmission in human (Coetzee et al., 2000; Okello et al., 
2006; Kent et al., 2007). The ﬁrst two species are strikingly anthropophilic while the 
latter is more zoophilic (Githeko et al., 1994). It has been known that several blood-
seeking mosquitoes search for their meal by making use of host odours (Takken and 
Knols, 1999). Moreover, carbon dioxide from a vertebrate’s exhalation also acts as a 
kairomone for the mosquito recipients (Costantini et al., 1996; Mukabana et al., 2004). 
A recent study shows that malaria parasites manipulate a host to be more attractive 
to mosquitoes (Lacroix et al., 2005). In many endemic regions, seasonal variation in 
temperature and rainfall aﬀects the abundance of mosquitoes, rainfall increases the 
numbers of mosquitoes and the incubation time of the malaria parasites in mosquitoes 
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is reduced when the temperature is warmer (Hoshen and Morse, 2004).
 
Several mathematical models have been created to study the dynamics of malaria 
transmission. Many are focused on mechanisms in human such as immunity, waning of 
immunity, symptomatic and asymptotic infection, and incubation time. In this work, 
we concentrate on the dynamical behaviour of malaria transmission driven by various 
factors in mosquitoes including seasonality, incubation time, and attractiveness to in­
fectious humans. In this section, we discuss two diﬀerent single-strain models. In the 
ﬁrst model, we use the SIRS model for describing the dynamics of hosts while the SI 
model is used in mosquitoes (Koella and Antia, 2003; Koella and Boete, 2003; Smith 
et al., 2005; Gaudart et al., 2009). Then we introduce each factor that might aﬀect 
mosquitoes into the model (seasonality, incubation time, and attractiveness to infec­
tious individuals, respectively) to study the dynamical behaviours due to the presence 
of each factor to the system. In many malaria transmission model with the presence of 
immunity in hosts, it is known that the duration of immunity depends on exposure, so 
that immunity is boosted by additional infections (Koella and Antia, 2003; Koella and 
Boete, 2003). Immune individuals can be reinfected with the parasites but they only 
carry low densities of parasitaemia so that they cannot transmit the disease (Doolan 
et al., 2009). Also, it can be thought that immune individuals are those who are resis­
tant to the disease during curative treatment (Gaudart et al., 2009). For simplicity, in 
this work, we assume that an individual can acquire immunity from high-density para­
sitaemia after a single infection, and immunity acts against high-density parasitaemia 
but it wanes with time (Collins et al., 1968; Burattini et al., 1993). In the second 
model, we introduce a vector-bias term in the SIS and SI framework to model the 
host population and the mosquito population. In this case, infectious hosts are as­
sumed to be susceptible immediately after recovering. Hence, infections can repeatedly 
occurs in the same individual. Then, we introduce incubation time in mosquitoes into 
the vector-bias model, and discuss a travelling wave of malaria propagation. 
3.3.1	 Modelling complex life-histories of mosquitoes on the eﬀect of 
malaria transmission 
This work is organized as follows. First, we introduce the basic model, that hosts 
acquire immunity but that it wanes with time (SIRS). We keep the model for hosts quite 
simple so as to concentrate on the biology of mosquitoes. Mosquitoes are assumed to be 
either susceptible or infected with malaria (SI). Once infected, they remain infected for 
life. Second, we incorporate the seasonal forcing into the mosquito population to study 
the eﬀects of it on malaria transmission, when the size of mosquito population and the 
transmission rate depend on seasonality. Third, since an extrinsic incubation period in 
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mosquitoes is important to the parasites in determining whether the mosquitoes can 
transmit the parasites during their lifetime, a time delay due to incubation is introduced 
into the mosquito population, and the delay system is studied. Fourth, behaviours of 
mosquitoes are translated into mathematical terms and encapsulated into the model to 
study the spread of malaria. Fifth, we discuss the system when controls in mosquitoes 
are present. Finally, we close this work by commenting on the role of immunity, the 
behaviours of mosquitoes, and controls on mosquitoes, on the dynamics of malaria. 
Formulation of the model 
Malaria transmission consists of interactions between two populations, human and 
mosquito. A human population is categorized into three compartments: susceptible 
(S), infectious (I), and recovered (R), while a mosquito population is divided into 
two compartments: susceptible (U) and infectious (V ), under the assumption that the 
parasites are not harmful to mosquitoes and mosquitoes do not recover from them. 
Individuals are protected from further infections while they are infectious. Recovered 
individuals acquire immunity, but the immunity wanes with time. To be precise, we 
deﬁne recovered individuals as persons who can be reinfected with the parasites but 
only carry low densities of parasitaemia (Doolan et al., 2009), and for simplicity in this 
work, the level of parasitaemia in blood is assumed to be low enough not to transmit 
the disease. We also assume that humans and mosquitoes are born disease-free, so 
there is no vertical transmission in either population. The ﬂow diagram is shown in 
Figure 3-17. The model takes the form: 
S˙(t) = µN − f1(V )S − µS + γR,
 
I˙(t) = f1(V )S − (µ + ν)I,
 
R˙(t) = νI − (µ + γ)R, (3.3.1)
 
U˙(t) = B − f2(I)U − ηU, 
V˙ (t) = f2(I)U − ηV, 
where N is the total size of the human population and we denote M here as the total 
size of the mosquito population. In the model, f1(V ) and f2(I) represent forces of 
infection in human and mosquito, respectively, which we deﬁne in the next section. 
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Figure 3-17: A ﬂow diagram for the SIRS-SI model
 
Analysis and numerical results of a basic model 
For simplicity, we treat forces of infections in human and mosquito to be frequency 
dependent as follows: 
βV bphV 
f1(V ) = = , (3.3.2)
N N 
αI bpmI 
f2(I) = = (3.3.3)
N N 
where β, α, b, ph, and pm represents transmission rate in human and mosquito, the biting 
rate, and the probability of successful infection in human and mosquito, respectively. 
Since the total size of each population is constant, we may introduce new variables, 
S I R U V 
s = , i = , r = , u = , v = ,
N N N M M 
and a parameter q = M/N . The system (3.3.1) becomes 
s˙(t) = µ − βqvs − µs + γ(1 − s − i),
 
i˙(t) = βqvs − (µ + ν)i, (3.3.4)
 
v˙(t) = αi(1 − v) − ηv.
 
Note that the derivative equations of r and u are omitted as the solutions can be found 
directly from r = 1 − s − i and u = 1 − v. The basic reproductive ratio of the system is 
βαq b2phpmq
R0 = = 
η(µ + ν) η(µ + ν) 
(Note: some authors deﬁne R0 to be the square root of this expression.). Parameter 
values can be found in Table 3.2 The system has two steady states: 
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1. the disease-free steady state: 
P 0 = (s 0, i0 , v 0) = (1, 0, 0), 
2. the disease-present steady state: 
P ∗ = (s ∗ , i ∗ , v ∗) 
where 
η(µ + γ)(R0 − 1) (µ + γ) − (µ + γ + ν)i∗ αi∗ ∗ ∗ i ∗ = , and s = , v = .
(µ + γ)α + (µ + γ + ν)ηR0 (µ + γ) αi∗ + η 
By considering the eigenvalues of the jacobian matrix of the system (3.3.4), it may 
be shown that the disease-free steady state is stable if and only if R0 < 1. Moreover, 
whenever R0 > 1, the disease-present steady state exists and is stable. The proof uses 
the Routh-Hurwitz criteria, but it is omitted here. A transcritical bifurcation, where 
two steady states exchange their stability, occurs at R0 = 1 (see Figure 3-18). From 
the expression for i∗ above or Figure 3-18, we can see that the proportion of infectious 
humans (i∗) is an increasing function of γ and hence a decreasing function of the period 
of immunity 1/γ. 
Figure 3-18: A transcritical bifurcation diagram 
Seasonality 
Because the abundance of mosquitoes can be increased due to rainfall, we incorporate 
a sinusoidal function into the basic recruitment rate to describe the high number of 
mosquitoes during the wet season (Muir, 1988; Anderson and May, 1991). We assume 
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Table 3.2: Lists of parameters for malaria transmission
 
Parameter Description	 Value References 
B	 recruitment rate of mosquitoes ηqN ­
β	 transmission rate in humans bph ­
α	 transmission rate in mosquitoes bpm ­
N	 the total size of human population 200000 estimated 
µ	 birth and death rate 1/70 (year−1) estimated 
b	 biting rate 100-182 (year−1) Gupta, Swinton and Anderson (1994) 
ph	 probability of successful infection 0.1 Gupta, Swinton and Anderson (1994) 
in humans 
pm	 probability of successful infection 0.3-0.4 Drakeley et al. (2006) 
in mosquitoes 
ν	 recovery rate 365/180 (year−1) Fillipe et al. (2007) 
γ	 rate of losing immunity 1/10 (year−1) Collins et al. (1968) 
η	 natural death rate of mosquitoes 365/20 (year−1 ) Anderson and May (1991) 
q	 the number of mosquitoes per individual 1-2 Gupta, Swinton and Anderson (1994) 
τ	 the incubation time in mosquitoes 10 (days) Collins et al. (1968) 
that the mosquito recruitment is low at the beginning and the end but peaks at the 
middle of every year. For this section, the system we consider is formally the same 
as in section 3.3.1, namely (3.3.1) with forces of infection given by (3.3.2) and (3.3.3). 
However, a seasonal ﬂuctuation in the mosquito recruitment rate is in the following 
form: 
B(t) = B0(1 − B1 cos 2πt).	 (3.3.5) 
where the period of the forcing is 1 year (see Figure 3-19(a)). The transmission rate 
is assumed to be a constant. The total size of the mosquito population is now not 
constant but time-dependent, and can be found from the following formula: � 
1 B1 
�
2π 
� 
−γt 
� 
1 B1 
��
M(t) = B0 − cos 2πt + sin 2πt − e −	 . 
γ γ(1 + (2π/γ)2) γ	 γ γ(1 + (2π/γ)2) 
The seasonal ﬂuctuation in the recruitment rate results in annual dynamics of malaria, 
with high prevalence during the rainy season each year according to the abundance of 
mosquitoes (see Figure 3-19(b)). Note that there is a transient outbreak which is then 
followed by the synchronicity of infectious human and mosquito populations relating 
to the recruitment number of mosquitoes. 
In addition, mosquitoes tend to feed more frequently in warmer climates (Githeko 
et al., 2000). This might aﬀect malaria transmission by inducing the higher biting rate 
of mosquitoes (b) during the hot season in the model. Consequently, transmission rates 
in humans and mosquitoes are increased. Moreover, the replication of malaria parasites 
in mosquitoes also increases in warmer temperatures (Hoshen and Morse, 2004) which 
might be represented in the model in term of increasing the probability of successful 
infection in mosquitoes (pm). Hence, the transmission rate in mosquitoes is increased. 
The force of infection in humans is now described by 
β(t)V	 β0(1 − β1cos2πt)V 
f1(V ) = =	 (3.3.6)
N N 
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Figure 3-19: (a) A seasonal ﬂuctuation in the recruitment rate (γ = 1/10, b = 100, ph = 
0.1, pm = 0.3, N = 200, 000, B0 ≈ 5, 400, 000, B1 ≈ 0.33. Note that B0 and B1 are 
approximated from the function B(t) that at min(B(t)), R0 = 8 and q ≈ 1 while at 
max(B(t)), R0 = 16 and q ≈ 2 (b) The annually dynamical results from varying the 
recruitment rate while the transmission rate is ﬁxed. 
where the transmission rate in humans depends on time and it is a sinusoid with the 
period of the forcing 1 year. The force of infection in mosquitoes is: 
α(t)I α0(1 − α1cos2πt)I 
f2(I) = = (3.3.7)
N N 
where the transmission rate in mosquitoes is time-dependent and sinusoidal. The total 
sizes of both populations become time-dependent. By ﬁxing the recruitment rate B 
as a constant, the seasonal ﬂuctuation in the transmission rate for both humans and 
mosquitoes is shown in Figure 3-20(a). In Figure 3-20(b), a big outbreak occurs in 
the ﬁrst two years. After that, the prevalence is synchronized in both populations and 
occurs annually corresponding to the transmission rate that is high in hot season and 
low in the other seasons in each year. 
Assuming that we have higher transmission rate in the hot season, higher numbers of 
mosquitoes in the rainy season, and both of them are described by sinusoidal functions, 
we introduce the fraction 1/3 year to represent a time-gap from the middle of one 
season to another season in each year (such as Thailand that each year consists of 3 
seasons; hot, rainy, and winter) into the time variable in the equations (3.3.6)-(3.3.7) 
so that cos(2πt) is changed to cos(2π(t +1/3)) for the hot season (see Figure 3-21(a)). 
Hence, the peak of transmission rate is 4 months before the peak of the recruitment 
rate in the sinusoidal ﬂuctuations. By comparing the dynamical results of I(t) and 
V (t) from those when B = B(t), β=const (high numbers of mosquitoes in the rainy 
season) and B=const, β = β(t + 1/3) (high transmission in the hot season), and 
B = B(t), β = β(t + 1/3) (high numbers of mosquitoes in the rainy season and high 
transmission in the hot season), the prevalence of malaria in both populations of the 
later case peaks between the hot and the wet season (see Figure 3-21(b)). 
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Figure 3-20: (a) A seasonal ﬂuctuation in the transmission rate (N = 
200, 000, min(β) = b∗ph = 100∗0.1, max(β) = (182)∗0.1, min(α) = b∗pm = (100)∗0.3, 
and min(α) = (182) ∗ 0.4. Note that min(b) = 100, max(b) = 182, min(pm) = 0.3, and 
max(pm) = 0.4. (b) The annually dynamical results from varying the transmission rate 
while the recruitment rate is ﬁxed. 
From our study, we conclude that the prevalence of malaria is high in the wet season due 
to the abundance of mosquitoes and it is high in the hot season due to the higher biting 
rate of mosquitoes and the preferable time of the parasite replications. Furthermore, 
for a country such as Thailand where there is a cool season, a hot season, and a wet 
season, each of roughly equal length, the number of mosquitoes varies between seasons. 
There might be more mosquitoes during the rainy season than in winter and summer, 
malaria parasites multiply better in the hot season, and the mosquitoes then tend to 
bite more often. These factors are taken into account in the model, and it suggests 
that the peak of prevalence is between the hot and the wet season. 
(a) (b) 
Figure 3-21: (a) A seasonal ﬂuctuation in the transmission rate in humans when an 
increment between seasons (1/3 year) is added (b) A comparison of the prevalence of 
the disease aﬀected by diﬀerent seasons. 
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Incubation time in mosquitoes 
Incubation time of the parasites in mosquitoes is one of crucial factors for malaria 
transmission due to the short lifespan of mosquitoes. It approximately takes τ 10 
days after blood feeding for the sporozoites to appear in the mosquito salivary gland 
(Beier, 1998). During those 10 days the mosquito is infected but not infectious, and is 
in a latent state. For simplicity, we omit the incubation time in humans (≈ 5.5 − 15 
days) and introduce only incubation time for mosquitoes in the model (3.3.4) (Koella, 
1991; Wei et al., 2008). We make the following assumptions. On biting an infected 
human and successfully acquiring the malaria parasite, an initially uninfected mosquito 
) immediately enters a latent compartment (W ). It leaves this latent compartment 
a ﬁxed time τ later, and enters the infectious compartment (V ), as long as it does 
not die ﬁrst. Since the death rate for all mosquitoes, including those in the latent 
compartment, is η, the probability that it survives long enough to enter the infectious 
compartment is e−ητ . Hence if the ﬂux onto the latent compartment W at time t is 
(t), the ﬂux out at time t is α N I(t − τ )U(t − τ)e−ητ . The equations in terms of 
proportions become 
s˙(t) µ − βqv(t)s(t) − µs(t) + γ(1 − s(t) − i(t)), 
i˙(t) βqv(t)s(t) − (µ + ν)i(t), 
u˙(t) η − αi(t)u(t) − ηu(t), 
v˙(t) αi(t − τ)u(t − τ )e−ητ − ηv(t) 
(3.3.8) 
B ηM (see Figure 3-22). 
U       V
B
η
Mosquito population :
η
W
η
τ
α IU/N α I(t−τ)U(t−τ)e−ητ/N
=
 
(U
α I(t)UN 
=
 
=
 
=
 
=
 
where = 
Figure 3-22: A ﬂow diagram for the model including incubation time in mosquitoes 
The basic reproductive ratio of the system is 
−ητ βαqe−ητ b2phpmqe
Rτ = = .0 η(µ + ν) η(µ + ν) 
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The disease-free steady state is 
0 0 0P 0 = (sτ , iτ 
0 , uτ , v ) = (1, 0, 1, 0),τ τ 
and the disease-present steady state is as follows 
∗ ∗ ∗ P ∗ = (sτ , iτ 
∗ , uτ , v ),τ τ 
where ∗ 
τ= ∗ (µ+γ)−(µ+ν+γ)is
 ,
τ (µ+γ) 
η(µ+γ)(Rτ = 0 −1)i∗ τ R0∗τη(µ+ν+γ)−α(µ+γ) , 
∗ η=u
 
τ +η) 
,∗ 
τ e
τ (αi
∗ −ηταi∗ v = τ ∗ 
τ +η) 
By considering the properties of the the characteristic equation from the linearised 
system at the disease-free steady state, we can prove that the disease-free steady state 
is stable if and only if Rτ < 1. The linearised system at the disease-free steady state0 
of the system (3.3.8) is 
s˙(t) = −βqv(t) − (µ + γ)s(t) − γi(t), 
i˙(t) = βqv(t) − (µ + ν)i(t), 
(3.3.9) 
u˙(t) = −αi(t) − ηu(t), 
v˙(t) = αi(t − τ)e−ητ − ηv(t). 
This system can be rewritten in the following form: 
dx 
= J0x + J1x(t − τ )
dt 
where x(t) = (s(t), i(t), u(t), v(t))T , ⎡ 
−(µ + γ) −γ 0 −βq 
⎤ ⎡ 
0 0 0 0 
⎤ 
0 −(µ + ν) 0 βq 0 0 0 0 
J0 = , and J1 = . 
0 −α −η 0 0 0 0 0 
⎢⎢⎢⎢ ⎥⎥⎥⎥ ⎢⎢⎢⎢ ⎥⎥⎥⎥⎣ ⎦ ⎣ ⎦
0 0 0 −η 0 αe−ητ 0 0 
λtˆAssuming that x = e v, we obtain 
λvˆ = (J0 + e −λτ J1)vˆ. 
The characteristic equation is 
|J0 + e −λτ J1 − λI| = 0 
(αi
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or 
(λ + µ + γ)(λ + η)(λ2 + (µ + ν + η)λ + η(µ + ν) − βαqe−(η+λ)τ ) = 0. 
Obviously, two of the eigenvalues are λ1 = −(µ + γ) and λ2 = −η which always 
give stable manifolds. Hence stability of the disease-free steady state depends on the 
following function 
F (λ, τ) = λ2 + (µ + ν + η)λ + η(µ + ν)(1 − R0 τ e −λτ ) = 0. (3.3.10) 
We consider the properties of this function so as to prove that the disease-free steady 
state is stable if and only if R0 < 1 by following the steps of proof from Ruan et al. 
(2008) and Wei et al. (2008). We separate τ into two cases:A) τ = 0, and B) τ > 0. 
A) For τ = 0, we have 
F (λ, 0) = λ2 + (µ + ν + η)λ + η(µ + ν)(1 − R0) = 0.0
By the Routh-Hurwitz criteria, the disease-free steady state is stable if R0 < 1 and 0 
unstable if R0
0 > 1. Moreover, when R0
0 < 1, we have two real and negative eigenvalues, 
which are 
−(µ + ν + η) ± 
�
(µ + ν + η)2 − 4η(µ + ν)(1 − R0)
λ± =	 0 .2 
B) For τ > 0, we consider three cases of Rτ : 1) R0 
τ < 1, 2) Rτ = 1, and 3) R0 
τ > 1. We 0	 0 
also rearrange F (λ, τ) in the following form: 
λ2 + (µ + ν + η)λ = η(µ + ν)(R0 
τ e −λτ − 1). (3.3.11) 
We deﬁne 
K(λ) = λ2 + (µ + ν + η)λ, and 
G(λ, τ ) = η(µ + ν)(R0 
τ e −λτ − 1). 
1.	 R0 
τ < 1. 
Suppose λ is real. Because K(λ) is an increasing function for λ ≥ 0 (K(0) = 
∂K 0, = 2λ + (µ + ν + η) > 0, ∀λ ≥ 0) and G(λ, τ) is a decreasing function for ∂λ 
∂G λ ≥ 0 (G(0, τ ) = η(µ+ν)(R0 τ −1) < 0, = η(µ+ν)(−τR0 τ e−λτ −1) < 0, ∀λ ≥ 0).∂λ 
These two functions do not intersect for any non-negative λ. Hence, there is no 
real and non-negative solution, λ, of F (λ, τ) = 0. Consequently, if (3.3.10) has 
two roots with non-negative real parts, they must be complex conjugates crossing 
the imaginary axis. Figure 3-23(a) shows that there are two negative and real 
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eigenvalues at τ = 0. When 0 < τ << 1, two eigenvalues are a pair of conjugates 
with negative real parts as shown in Figure 3-23(b). For (3.3.10) to have a pair 
of conjugates with positive real parts changed from the complex conjugates with 
negative real parts (as we know each τ leads to diﬀerent λ), there must have a 
pair of imaginary solution satisfying (3.3.10). Hence, for some τ > 0, (3.3.10) 
must have the purely imaginary solutions. Without loss of generality, we assume 
that one of that purely imaginary solutions is λ = iω and 
ω4 + [(µ + ν)2 + η2]ω2 + (µ + ν)2η2(1 − Rτ2) = 0.0 
Let z = ω2 . We have 
z 2 + ((µ + ν)2 + η2)z + (µ + ν)2η2(1 − Rτ2) = 0. (3.3.12)0 
Since Rτ < 1, both of the coeﬃcients of this quadratic equation are positive. 0 
Both roots are either real and negative or complex conjugates with negative real 
parts. Hence, (3.3.12) does not have positive real roots that leads to a positive 
ω. Consequently,there is no ω such that iω is a solution of (3.3.10). By Rouche’s 
theorem, the real parts of all the eigenvalues at F (λ, τ) = 0 are negative for all 
values of τ > 0 (Theorem 9.17.4 in ?). 
2.	 R0 
τ = 1 
Clearly, zero is a root of (3.3.10). Because F (0, τ ) = 0 and dF (λ, τ)/dλ > 0 for 
all λ ≥ 0 and τ > 0, zero is a simple root and there is no positive root. Hence, 
the disease-free steady state is degenerate. 
3.	 R0 
τ > 1 In this case, we expect (3.3.10) to have a positive root and the disease-free 
steady state to be unstable. Suppose λ is real. We have that K is increasing with 
K(0) = 0 and G is decreasing with G(0, τ) = η(µ + ν)(R0 
τ − 1) > 0. The two 
functions must intersect for λ∗ > 0. We see that every τ ≥ 0, we can always 
ﬁnd a positive real λ∗ that is one of the roots of (3.3.11). Hence, (3.3.10) has a 
positive real solution and it is enough to say that the disease-free steady state is 
unstable. 
In conclusion, from all three cases, the disease-free steady state is stable if and only 
if Rτ < 1, ∀τ ≥ 0. The linearised system at the disease-present steady state of the 
system (3.3.8) is 
s˙(t) = −βqs∗ v(t) − βqv∗ s(t) − (µ + γ)s(t) − γi(t), 
i˙(t) = βqv∗ s(t) + βqs∗ v(t) − (µ + ν)i(t), 
(3.3.13) 
u˙(t) = −αu∗i(t) − αi∗ u(t) − ηu(t), 
v˙(t) = αu∗i(t − τ)e−ητ + αi∗ u(t − τ)e−ητ − ηv(t). 
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Figure 3-23: (a) Two eigenvalues are real and negative when τ = 0. (b) The eigenvalues 
are a pair of conjugates with negative real parts and they are very close to those two 
real and negative when 0 < τ << 1. (c) The eigenvalues are a pair of conjugates when 
τ > 0 and for them to change from complex conjugates with negative real parts to 
positive real parts, the roots must cross the imaginary axis. 
The characteristic equation can be derived in the similar way with the linear system 
at the disease-free steady state and it is of order 4. In case we use τ as a bifurcation 
parameter and let λ(τ) = ρ(τ)+iω(τ) be the eigenvalue of the characteristic equation at 
the disease present-steady state, we might be able to ﬁnd τ∗ such that a Hopf bifurcation 
occurs (a family of periodic solutions bifurcates from the disease-present steady state 
as τ passes the value τ∗ such that it loses its stability as a pair of conjugates eigenvalues 
crosses the imaginary axis. However, our characteristic equation at the disease-present 
steady state is in a complicated form and it is beyond the scope of this work. Hence, 
we instead study the dynamical behaviours of the system numerically. 
With the eﬀect of incubation time on the the dynamics of the system, the basic repro­
ductive ratio is reduced exponentially when the incubation time in mosquitoes increases 
(see Figure 3-24(a)). Consequently, in Figure 3-24(b), the numbers of infectious humans 
and mosquitoes at the steady state decrease when the incubation time in mosquitoes 
increases. Note that the incubation time in mosquitoes does aﬀect both populations 
due to the contacts between them. By plotting the asymptotic solutions (i(∞), v(∞)) 
of the system (3.3.8) against τ or incubation time which is allowed to vary while other 
parameters are ﬁxed as Table 3.2, we obtain the bifurcation diagram shown in Figure 3­
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Figure 3-24: (a) An incubation eﬀect from mosquitoes on the basic reproductive ratio 
(b) An incubation eﬀect from mosquitoes on the number of infectious humans and 
mosquitoes (τ is in days) 
25. In long-term dynamics, malaria would die out for an incubation time of 42 days. 
For realistic incubation times, the disease is endemic. However, longer incubation time 
in mosquitoes does decrease the prevalence of malaria. 
∗Figure 3-25: The bifurcation diagram between τ and i∗ and v 
Behaviours of mosquitoes driven by the malaria parasites 
Lacroix et al. (2005) showed that attractiveness might be diﬀerent for individuals who 
carry the parasite’s gametocytes and both uninfected and recovered individuals, due 
to the manipulation of the malaria parasites in hosts. So, we incorporate the bias term 
of vectors into the model to describe this manipulation (Kingsolver, 1987; Chamchod, 
2006; Hosack et al., 2008). We assume that a mosquito arrives at a human at random 
and let it pick a human with the probability p if the human is infectious, l1 if the human 
is susceptible, and l2 if the human is recovered (p > l1, l2). Otherwise, the mosquito 
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arrives at another human at random. Note that recovered humans are assumed to have 
the same chance of getting bitten by the mosquitoes as susceptible humans (l1 = l2 = l) 
but after the exposure, those show no symptoms and are assumed to carry very low 
number of gametocytes so that they are not infectious. Hence, the probability that 
a mosquito picks the ﬁrst human and the ﬁrst human is infectious is (I/N)p. The 
probability that a mosquito picks the ﬁrst human and the ﬁrst human is susceptible is 
(S/N)l and the probability that a mosquito picks the ﬁrst human and the ﬁrst human is 
recovered is (R/N)l. Hence the probability that the ﬁrst human is infectious under the 
condition that a mosquito picks him is pI/(pI +l(S +R)). The probability that the ﬁrst 
human is susceptible and recovered respectively under the condition that a mosquito 
picks him is lS/(pI + l(S + R)) and lR/(pI + l(S + R)). Also, the diﬀusion term 
is introduced in the model to represent the mosquito’s movement as a random walk. 
Attractiveness in humans can expressed in several chemical forms such as sweat, body 
odour, and breath (Skinner et al., 1965; Takken and Knols, 1999; Mukabana et al., 
2004). Hence, we incorporate a chemotaxis term to explain the chemically directed 
movement to humans driven by the malaria parasites (Murray, 1993). With a constant 
population size in humans, R = N − S − I and the system in terms of proportions of 
densities of individuals in each compartment is given by 
∂s µ βq ls µ γ= − v − s + (1 − s − i),∂T (µ+ν) (µ+ν) (p−l)i+l (µ+ν) (µ+ν)
 
∂i βq ls
 = v − i,∂T (µ+ν) (p−l)i+l (3.3.14)
∂u η α pi η u + d∂
2u ∂i = (u + v) − u − − χ ∂ u∂T (µ+ν) (µ+ν) (p−l)i+l (µ+ν) ∂x2 ∂x ∂x ,
 
∂v α pi η v ∂i
 = u − v + d ∂2 − χ ∂ v∂T (µ+ν) (p−l)i+l (µ+ν) ∂x2 ∂x ∂x 
where T = (µ+ν)t, B = η(U +V ), x is a space variable, d is a diﬀusion coeﬃcient which 
is positive, and χ represents a chemotaxis coeﬃcient which is positive. Note that the 
total density of the human population (N) is constant in time and space while the total 
density of the mosquito population (M) depends on time and space variables. Also, 
u = U/M0 , v = V/M0, and q = M0/N , where M0 is the total density of the mosquito 
population at the spatially uniform disease-free steady state. Because malaria parasites 
manipulate hosts to be more aﬀective in terms of sweat or breath, for instance, 
∂ ∂s ∂ ∂i ∂ ∂r ∂ ∂(1−i) ∂ ∂i −χ1 u − χ2 u − χ3 u = −χ1 u − χ2 u∂x ∂x ∂x ∂x ∂x ∂x ∂x ∂x ∂x ∂x 
∂i = −(χ2 − χ1) ∂ u∂x ∂x 
= −χ ∂ u ∂i ∂x ∂x , 
∂v where χ2 > χ1, χ3 > 0, χ1 = χ3, s + r = 1 − i. The chemotaxis term in the equation∂T 
can be derived in a similar way. Moreover, we allow the biting rate of susceptible and 
infectious mosquitoes to be diﬀerent due to the manipulation of malaria parasites in 
mosquitoes that increases the biting frequency (Lacroix et al., 2005). Thus, β = bvph 
77
 
and α = bupm where bv > bu. It can be seen that a primary case in the human 
1population makes infectious contacts with mosquitoes at rate αpM for an expected lN 
time 1/(µ+ν) and a primary case in the mosquito population makes infectious contacts 
with humans at rate β lN for an expected time 1/η. Hence, the basic reproductive ratio lN 
of the system can be derived from the system (3.3.14) and given by 
βαqp 
Rb 0 = η(µ + ν)l
. 
Note that by ﬁxing the parameter in Rb to be the same values with R0 and bu = bv,0 
R0 < R
b because p > l. The spatially uniform disease-free steady state of the system 0 
(3.3.14) is 
0P 0 = (s 0, i0 , u , v 0) = (1, 0, 1, 0) 
and the spatially uniform disease-present steady state is 
∗ P ∗ = (s ∗ , i ∗ , u , v ∗) 
where 
(µ+γ)−(µ+ν+γ)i∗ ∗ s = ,(µ+γ) 
∗ αpi∗ u = 1 − η[(p−l)i∗ +l]+αpi∗ , 
∗ αpi∗ v = η[(p−l)i∗ +l]+αpi∗ , 
and i∗ satisﬁes the equation 
c1i 
∗2 + c2i ∗ + c3 = 0 
with 
c1 = (µ + γ)(µ + ν)(p − l)[η(p − l) + αp],
 
c2 = βα(µ + ν + γ)pl + (µ + γ)(µ + ν)[ηl(p − l) + l(η(p − l) + αp)],
 
c3 = −(µ + γ)(µ + ν)ηl2(Rb − 1).
0 
Obviously, c1 and c2 are positive and c3 is negative when Rb 0 > 1. Hence, the spatially 
uniform disease-present steady state exists (takes a positive real value) if and only if 
Rb > 1. Moreover, i∗ is the biggest root of the polynomial equation. The stability 0 
condition of each steady state can be obtained by considering the Routh-Hurwitz cri­
teria. We found that the disease-free steady state is stable if and only if R0 
b < 1 while 
the disease-present steady state is stable if and only if R0 
b > 1. The proof is omitted 
here. Without including the mosquito movement and the chemotaxis terms, the preva­
lence of malaria is increased when p is increased (see Figure 3-26(a)). Moreover, in 
Figure 3-26(b), when R0 
b > 1, the number of infectious humans and mosquitoes tend 
to the steady states in long term dynamics. 
We further study the propagation of malaria from infected populations to uninfected 
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Figure 3-26: (a) A relation between p and I∗ (0.4 ≤ p ≤ 1,l=0.4) (b) A numerical 
result of I(t) and V (t) (bv = 0.5 ∗ 365, bu = 100, ph = 0.1, pm = 0.3, p = 0.7, l = 0.6) 
populations (infected mosquito population to uninfected human population and in­
fected human population to uninfected mosquito population) when the mosquito move­
ment and the chemotaxis terms are taken into account. As an example, we shall con­
sider a one-dimensional domain [x1, x2] with malaria initially present at its steady state 
1in [x1, x¯] and absent in [x¯, x2], where x¯ = (x1 + x2). Thus initial conditions are given 2 
by 
s(x, 0) = s ∗ + (1 − s ∗)H(x − x¯), x1 ≤ x ≤ x2, 
i(x, 0) = i∗ − i∗H(x − x¯), x1 ≤ x ≤ x2, 
u(x, 0) = u ∗ + (1 − u ∗)H(x − x¯), x1 ≤ x ≤ x2, 
v(x, 0) = v ∗ − v ∗H(x − x¯), x1 ≤ x ≤ x2, 
where H(x) is a heaviside step function (see Figure 3-27(a)). The following boundary 
conditions are assumed as zero ﬂuxes: 
d∂u d∂u (x1, T ) − χu(x1, T ) ∂i (x1, T ) = 0 = (x2, T ) − χu(x2, T ) ∂i (x2, T ),∂x ∂x ∂x ∂x
 
d ∂v d ∂v
 (x1, T ) − χv(x1, T ) ∂i (x1, T ) = 0 = (x2, T ) − χv(x2, T ) ∂i (x2, T ),∂x ∂x ∂x ∂x 
where T1 ≤ T ≤ T2. From Figure 3-27(b), we can see that malaria propagates from 
the infected population to the uninfected population like a travelling wave. The wave 
speed (c) can be calculated from the graph by the formula 
x2 − x1 
c = 
t2 − t1 
where x2 − x1 is the distance on the space and t2 − t1 is the time diﬀerence corre­
sponding to the wave. For example, when p = 0.7 and l = 0.4, the wave speed is 
14.5 space units per year. Other variables also share the same wave speed with v or 
V . Although we do not know exactly what p and l are, by varying the parameter p 
but keeping the diﬀusion coeﬃcient, the chemotactic coeﬃcient, and other parameters 
ﬁxed, we can show that attractiveness of infectious individuals to mosquitoes inﬂuences 
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Figure 3-27: (a) Initial conditions on the domain [0, 200] (b) This graph shows the 
travelling waves of infectious mosquitoes to susceptible humans (T = (µ + ν)t, p = 
0.7, l = 0.4, c = 14.5, d = 1, ψ = 1, l < p) 
the wave speed of malaria infection. Figure 3-28(a) shows that when p and l increase 
but the diﬀerence between them is ﬁxed at 0.1, and l, p → 1, the wave speed of malaria 
propagation decreases. Figure 3-28(b) suggests that the wave speed increases when 
p increases from l which is ﬁxed at 0.4. In conclusion, both results suggest that the 
wave speed of malaria propagation depends on the diﬀerence between p and l or how 
attractive an infectious human is to the mosquito compared with a susceptible human. 
(a) (b) 
Figure 3-28: (a) A relation between the probability that a mosquito picks an infectious 
human (p) and the wave speed (c), when p− l = 0.1 and p varies (b) A relation between 
p and c when l is ﬁxed at 0.4 and p varies (from the numerical result comparing with 
the minimum of the wave speed) 
By introducing solutions of the system (3.3.14) in the travelling wave form and linearis­
ing it at the spatially uniform disease-free steady state, we can calculate the minimum 
wave speed of the disease propagation. We calculate this minimum wave speed by em­
ploying the method in Murray (1993). We look at travelling wave solutions as follows 
s(x, T ) = s(z), i(x, T ) = i(z), u(x, T ) = u(z), v(x, T ) = v(z), z = x − cT. 
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Substituting them into (3.3.14), we obtain the system of ordinary diﬀerential equations
 
� + µ βq ls µ γ cs − v − s + (1 − s − i) = 0,(µ+ν) (µ+ν) [(p−l)i+l] (µ+ν) (µ+ν)
 
βq ls
 ci� + v − i = 0,(µ+ν) [(p−l)i+l] (3.3.15)η α pi ηdu�� − χ(ui�)� + cu� + (u + v) − u − u = 0,(µ+ν) (µ+ν) [(p−l)i+l] (µ+ν) 
α pi ηdv�� − χ(vi�)� + cv� + u − v = 0,(µ+ν) [(p−l)i+l] (µ+ν) 
where the prime denotes diﬀerentiation with respect to z. The system is solved with 
the following conditions 
0 ≤ s(−∞) < s(∞) = 1, i(−∞) = i(∞) = 0, 0 ≤ u(−∞) < u(∞) = 1, v(−∞) = v(∞) = 0, 
to ﬁnd solutions with positive wave speed c and non-negative s, i, u, and v of the 
eigenvalue problem. 
The condition on i and v lead to a pulse wave of infection propagating from infected 
population to uninfected population. We linearise the system (3.3.15) near the leading 
edge of the wave where s → 1, i → 0, u → 1, and v → 0 to obtain 
βq µ γ cs� − v − s − (s + i) ≈ 0,(µ+ν) (µ+ν) (µ+ν) 
ci� + βq v − i ≈ 0,(µ+ν) 
η αp (3.3.16)du�� − χi�� + cu� + v − i ≈ 0,(µ+ν) (µ+ν)l 
αp ηdv�� + cv� + i − v ≈ 0.(µ+ν)l (µ+ν) 
Because the variables s and u do not appear other equations apart from the diﬀerential 
equation corresponding to themselves, the diﬀerential equations of s and u are decou­
pled and the dynamics of the system can be described by the diﬀerential equations of 
i and v. By introducing a new variable w as v�, we can rewrite the system (3.3.16) in 
the system of ﬁrst-order ordinary diﬀerential equations as follows 
di 1 βq = i − v, dz c c(µ+ν) 
dv = w, (3.3.17)dz 
dw αp η= − i + v − c w. dz dl(µ+ν) d(µ+ν) d 
Consequently, the characteristic equation of the system (3.3.17) is 
c 1
� 
η 
�
1
� 
βαqp 
λ 
�
λ + 
��
λ − − λ − − = 0. (3.3.18)
d c d(µ + ν) c cdl(µ + ν)2 
To ﬁnd the minimum wave speed, we diﬀerentiate through out (3.3.18) with respect to 
λ to ﬁnd λ that minimize c. Hence, we have �
2c 2
� � 
1 η 
�
3λ2 + − λ − + = 0 (3.3.19)
d c d d(µ + ν) 
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By solving (3.3.18) and (3.3.19) for c, we can ﬁnd the minimum wave speed of the 
system (3.3.14). The minimum wave speed at some values of p while l is ﬁxed at 0.4 is 
shown in Figure 3-28(b). Note that the time unit is interpreted in years. 
Conclusion and discussion 
Our study shows that some mechanisms in mosquitoes may play an important role in 
malaria transmission. By ﬁrst setting up a general SIRS-SI model for vector-borne 
diseases with acquired immunity in hosts waning with time, we then introduce sea­
sonality, incubation time in mosquitoes, and attractiveness to infectious individuals, 
respectively, in order to study the dynamics of the malaria transmission driven by each 
factor. Without including those factors, the number of infectious humans are increased 
when the protection time from acquired immunity is shortened. 
Firstly, by considering seasonality in mosquitoes, a sinusoidal function is introduced in 
the recruitment rate to explain the high number of mosquitoes during the wet season. 
We found that the number of infectious humans and mosquitoes are synchronized with 
the number of mosquitoes, so malaria is highly transmitted during the rainy season. 
Similarly, by considering that mosquitoes bite more often and malaria parasites are 
replicated better during the hot season, we incorporate a sinusoidal function into the 
transmission rate in both humans and mosquitoes. In this case, the malaria transmis­
sion is high during the hot season. In case there are three seasons in each year (hot, 
rainy, winter), we combine those two seasonal forcing and arrive at the conclusion that 
malaria might be highly transmitted between hot and rainy season. 
Secondly, the mosquito’s lifespan is short so that incubation time of the malaria para­
sites might take more than half of their lifetime. Hence, it may be important to include 
incubation time in the study to understand the dynamic behaviours of malaria. By as­
suming that mosquitoes takes a ﬁxed duration τ to be infectious after getting infected, 
the governed system is described by the delay diﬀerential equations with time lag τ . 
The prevalence of malaria is reduced when the incubation time takes longer. 
Thirdly, due to the manipulation of the malaria parasite, infectious humans might be 
more attractive to mosquitoes than others in terms of breath and sweat. Hence, we 
introduce the vector-bias term into the model to account for this mechanism. Without 
including spatial terms, malaria is highly prevalent if infectious individuals are more 
attractive to the mosquitoes. Since mosquitoes move spatially toward the chemicals, 
diﬀusion term and chemotactic term are included in the model. We study the prop­
agation of malaria from infected populations to uninfected populations. It results in 
the travelling wave of the disease propagation. Moreover, the speed of the waves de­
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pends on the attractiveness of infectious individuals. The more attractive they are, the 
faster the disease travels and spreads. We also calculate the minimum of wave speed 
analytically and compare it with the numerical results. A vector-bias model based 
on SIS (susceptible-infectious-susceptible) in humans and SI in mosquitoes on malaria 
transmission and its full analysis is investigated in the next section. Note that the 
SIS-SI model is another type of models that has been used to study malaria. It is in 
more simplistic form that the SIRS-SI framework by omitting the presence of acquired 
immunity completely. 
3.3.2 Analysis of a vector-bias model on malaria transmission 
In this section, we incorporate a vector-bias term into a malaria-transmission model to 
account for the greater attractiveness of infectious humans to mosquitoes in terms of 
diﬀering probabilities that a mosquito arriving at a human at random picks that human 
depending on whether he is infectious or susceptible. We prove that transcritical bifur­
cation occurs at the basic reproductive ratio equaling 1 by projecting the ﬂow onto the 
extended centre manifold. Consequently, we can conclude that the disease-free steady 
state is stable if and only if R0 < 1 and the disease-present steady state is stable if 
and only if R0 > 1 (although the linearised system at the disease-present steady state 
is unwieldy to analyse for stability conditions). We next study the dynamics of the 
system when incubation time of malaria parasites in mosquitoes is included, and ﬁnd 
that the longer incubation time reduces the prevalence of malaria. Also, we incorpo­
rate a random movement of mosquitoes as a diﬀusion term and a chemically directed 
movement of mosquitoes to humans expressed in terms of sweat and body odour as a 
chemotaxis term to study the propagation of infected population to uninfected popu­
lation. We ﬁnd that a travelling wave occurs; its speed is calculated numerically and 
estimated for the lower bound analytically. 
A vector-bias model 
A vector-bias model in malaria was ﬁrst introduced by Kingsolver (1987). The model 
is extended from the Ross-Macdonald model to account for the greater attractiveness 
of infectious humans to mosquitoes (Macdonald, 1952, 1957). Following Kingsolver’s 
work, Hosack et al. (2008) incorporate an extrinsic incubation time in mosquitoes to 
study the dynamics of the disease in term of a reproduction number. Here we include 
the recruitment rate and the natural death rate and deﬁne the attractiveness in a 
diﬀerent way. In the model, hosts might get repeatedly infected due to not acquiring 
complete immunity so the population is assumed to be described by the SIS model. 
Mosquitoes are assumed not to recover from the parasites and the parasites are not 
83
 
harmful to them so the mosquito population can be described by the SI model. The 
model takes the form: 
˙ lS S(t) = µN − β V − µS + νI, pI+lS 
lS I˙(t) = β V − (µ + ν)I, pI+lS (3.3.20)
U˙(t) = ηM − α pI U − ηU, pI+lS 
V˙ (t) = α pI U − ηV, pI+lS 
where S, I, U, V, N and M represent the number of susceptible humans, infectious hu­
mans, susceptible mosquitoes, infectious mosquitoes, the total size of the human popu­
lation and the total size of the mosquito population, respectively, β = bph and α = bpv. 
The description of the parameters can be found in Table 3.2 (in the previous section). 
From the model, we assume that searching for a blood meal is equally likely to arrive 
at any human in the population, but bites that human with probability p if the human 
is infectious, l if the human is susceptible. Otherwise, the mosquito arrives at another 
human at random. Hence, the probability that a mosquito picks the ﬁrst human and 
the ﬁrst human is infectious is (pI/N). The probability that a mosquito picks the ﬁrst 
human and the ﬁrst human is susceptible is (lS/N). Hence the probability that the 
ﬁrst human is infectious under the condition that a mosquito picks him is pI/(pI + lS). 
The probability that the ﬁrst human is susceptible under the condition that a mosquito 
picks him is lS/(pI + lS). Similarly arguments hold for all subsequent humans. At 
l = p, the model is without vector-bias. Since infectious individuals are more attractive 
to the mosquitoes (Lacroix et al., 2005), p > l. The basic reproductive ratio is similar 
to the previous model, 
βαpq 
Rb = 0 lη(µ + ν)
. 
Stability analysis 
We introduce the new variables in term of proportions as follows 
S I U V 
s = , i = , u = , v = . 
N N M M 
Since s + i = 1, u + v = 1, the system (3.3.20) is reduced to 
di l(1−i)= βq v − (µ + ν)idt pi+l(1−i) (3.3.21)
dv pi= α (1 − v) − ηv dt pi+l(1−i) 
The system consists of two steady states which are 
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1. the disease-free steady state 
(i, v) = (i0 , v 0) = (0, 0), (3.3.22) 
2. the disease-present steady state �
αpi∗ 
�
(i, v) = (i ∗ , v ∗) = i ∗ , , (3.3.23)
η(pi + l(1 − i∗)) + αpi∗ 
where i∗ satisﬁes the equation 
a2i 
∗2 + a1i ∗ + a0 = 0 (3.3.24) 
with 
a2 = (µ + ν)(p − l)[αp + η(p − l)], 
a1 = (µ + ν)l[αp + 2ηl(p − l)] + βαqpl, 
a0 = (µ + ν)ηl2 − βαqpl = l2η(µ + ν)(1 − Rb ).0
Because p > l, a1 and a2 are always positive and a0 is positive when Rb 0 < 1, negative 
when Rb > 1. Hence, if Rb < 1 there is no positive root of (3.3.24), while if Rb > 10 0 0 
there is one positive and one negative root. If Rb 0 > 1, we deﬁne i
∗ to be the positive 
root of (3.3.24). 
The linearised system at the disease-free steady state is given by 
di = βqv − (µ + ν)idt (3.3.25)
dv α p= i − ηv dt l 
Therefore, the characteristic equation is 
λ2 + (µ + ν + η)λ + η(µ + ν)(1 − Rb ) = 0.0
Two eigenvalues are given by 
−(µ + ν + η) ± �(µ + ν + η)2 − 4η(µ + ν)(1 − R0)
λ1,2 = .2 
Both of them are negative whenever R0 < 1. One is positive and one is negative when 
R0 > 1. Hence, the disease-free steady state is stable if and only if R0 < 1. The 
linearised system at the disease-present steady state is given by 
∗ di βqlv∗ + βql(p−l)(1−i
∗)v βql(1−i∗)= − 
� 
+ (µ + ν)
� 
i + vdt (pi∗ +l(1−i∗)) (pi∗ +l(1−i∗))2 (pi∗ +l(1−i∗)) (3.3.26)
dv αp(1−v ∗) αp(p−l)(1−v ∗)i∗ αpi∗ = 
� 
− 
� 
i − 
� 
+ η
� 
v. dt (pi∗ +l(1−i∗)) (pi∗ +l(1−i∗))2 (pi∗ +l(1−i∗)) 
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The system is unwieldy for ﬁnding explicit eigenvalues or stability conditions by the 
Routh-Hurwitz condition. However, at R0 = 1, at the disease-free steady state, the 
system has two eigenvalues λ1 = −(µ+ν+η) and λ2 = 0 and hence is non-hyperbolic, so 
that R0 = 1 may be a bifurcation value. Next, we prove that a transcritical bifurcation 
occurs when R0 = 1 by projecting the ﬂow onto the extended centre manifold. This is 
one of the important techniques for studying bifurcations of nonlinear systems. From 
the proof, we can consequently conclude that the disease-present steady state is stable 
if and only if R0 > 1. 
Bifurcation analysis 
In order to prove that the transcritical bifurcation occurs at (R0
b , (i, v)) = (1, (0, 0)), 
we write βq in terms of Rb and other parameters. So, the linearised system (3.3.25) is 0 
now 
Rb η(µ+ν)ldi = 0 v − (µ + ν)idt αp (3.3.27)
dv α p= i − ηv dt l 
The proof is done by projecting the ﬂow onto the extended centre manifold. It fol­
lows the similar steps with Glendinning (1999). The eigenvectors corresponding the 
eigenvalues λ1 = −(µ + ν + η) and λ2 = 0 when Rb = 1 are 0 � 
−l(µ + ν) 
� � 
lη 
� 
e¯1 = , and e¯2 = , respectively. 
αp αp 
The matrix P with its column vector as the eigenvector is � 
−l(µ + ν) lη 
� 
P = , 
αp αp 
so that 
lη(µ+ν)
� 
−(µ + ν) 
� � 
−(µ + ν + η) 0 
� 
αp P = P .
αp 
l −η 0 0 
By setting � 
z 
� � 
i 
� 
= P −1 , 
w v 
we obtain the linear part of the equation in terms of z and w as follows: � 
z˙ 
� 
= 
� 
−(µ + ν + η) 0 
� � 
z 
� 
. 
w˙ 0 0 w 
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The inverse matrix of P is 
P −1 
−1 
� 
αp −lη 
� 
= 
αpl(µ + ν + η) −αp −l(µ + ν) . 
Hence, � 
z 
� � 
i 
� 
1 
� 
−αpi + lηv 
� 
= P −1 = , (3.3.28) 
w v αpl(µ + ν + η) αpi + l(µ + ν)v 
and � 
i 
� � 
z 
� � 
−l(µ + ν)z + lηw 
� 
= P = . (3.3.29) 
v w αpz + αpw 
We deﬁne a new parameter r that Rb = 1 + r so that investigating the bifurcation at 0 
Rb = 1 is equivalent to investigating it at r = 0. Hence r can be treated as small as 0 
we want in the local investigation. By substituting di/dt and dv/dt from the system 
(3.3.21) (where βq is substituted by Rb (1 − p)η(µ + ν)/(αp)) and then i and v in0
terms of z and w into ﬁnding dz/dt and dw/dt obtained from the equation (3.3.28), 
consequently, the extended system is 
dz 1= {−(µ + ν + η)2z + η(µ + ν)[αp − (2p − l)(µ + ν)]z2+dt (µ+ν+η) 
η[p(µ + ν)(η − µ − ν) − αpη + αp(µ + ν) + 2(p − l)η(µ + ν)]zw+ 
η2[p(µ + ν) − αp − (p − l)η]w2 − η(µ + ν)zr − η(µ + ν)wr},
 
dw 1 2+
= {(µ + ν)2[pη + αp − (p − l)(µ + ν)]zdt (µ+ν+η) 
(µ + ν)[−αpη + αp(µ + ν) + 2(p − l)η(µ + ν) − pη(η − µ − ν)]zw− 
η(µ + ν)[pη + αp + (p − l)η]w2 + η(µ + ν)zr + η(µ + ν)wr},
 
dr 0.
= dt 
(3.3.30) 
Note that in ﬁnding di/dt and dv/dt in terms of z and w, we make an approximation 
as follows 
1 1 
�
(p − l) �≈ 1 − i + h.o.t
l + (p − l)i l l 
where 0 < (p − l)/l < 1, i < 1, and i is in terms of z and w in the equation (3.3.29). 
Because r is treated in the similar way with z and w, there is only a linear term in the 
equation dz/dt. The linear centre manifold is 
Ec(0) = {(z, w, r)|z = 0} 
and the linear stable manifold is 
Es(0) = {(z, w, r)|w = r = 0.} 
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An approximation of the nonlinear centre manifold is in the following form
 
z = h(w, r) with 
∂h 
∂w 
(0, 0) = 
∂h 
∂r 
(0, 0) = 0 
and that 
h(w, r) = aw 2 + bwr + r 2 + . . . . 
Thus, 
dz dh dw dh dr 
= + 
dt dw dt dr dt 
By substituting h, dw/dt, dr/dt in terms of w and r and then comparing the coeﬃcients 
2of w , wr, and r2 with those from the equation dz/dt in (3.3.30) after the substitution, 
we obtain 
a = η
2 
[p(µ + ν) − (αp + (p − l)η)]
(µ+ν+η)2 
η(µ+ν)b = −
(µ+ν+η)2 
c = 0. 
Therefore, the centre manifold is 
η2 η(µ + ν) 
z = [p(µ + ν) − (αp + (p − l)η)]w 2 − wr + cubic terms.
(µ + ν + η)2 (µ + ν + η)2 
We substitute z back into the equation of dw/dt to get the projection of the motion on 
the centre manifold onto the w axis: 
dw η(µ + ν)
= [−(pη + αp + (p − l)η)w 2 + wr] + cubic terms. 
dt (µ + ν + η)
Note here that the expression for the centre manifold does not contribute any quadratic 
terms so the calculation of the centre manifold is not exactly required. On the centre 
manifold, we have 
dw 
= G(w, r)
dt 
with 
G(0, 0) = Gw(0, 0) = Gr(0, 0) = 0, 
2η(µ + ν) η(µ + ν)
Gww = − [pη + αp + (p − l)η], Gwr = , Grr = 0.(µ + ν + η (µ + ν + η)
Since p > l and all of the parameters are positive, Gww is negative while Gwr is 
positive. By the centre manifold theorem and the transcritical bifurcation theorem, 
the disease-free steady state is stable when Rb < 1(r < 0) and there is a separate 0 
unstable branch (from the disease-present steady state), and when Rb > 1(r > 0)0 
the disease-free steady state becomes unstable while the separating branch becomes 
stable (Glendinning, 1999). Note that when Rb = 1(r = 0), the centre manifold is 0 
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approximated by 
dw η(µ + ν)≈ − [pη + αp + (p − l)η]
dt (µ + ν + η)
so that the disease-free steady state is stable if it is approached from w > 0 and unstable 
when it is approached from w < 0. The proof is completed. Hence, we conclude that 
there is a transcritical bifurcation occurring at the bifurcation value Rb = 1. Therefore, 0 
the disease-free steady state is stable if and only if R0 
b < 1 and the disease-present steady 
state is stable if and only if R0 
b > 1. 
Incubation time in mosquitoes 
Because mosquitoes have a short lifespan, including the incubation time of malaria 
parasites in the model might be important in studying dynamic behaviours of the 
disease. It approximately takes τ = 10 days after blood feeding for the sporozoites to 
appear in the mosquito salivary gland (Beier, 1998) and for those 10 days the mosquito 
is infected but not infectious, and so it is in a latent state. For simplicity, we omit the 
incubation time in humans (≈ 5.5−15 days, a negligible fraction of a human lifetime) to 
study only incubation time for mosquitoes in the model. We assume that the mosquito 
that has just bitten the infectious human moves immediately to the latent compartment 
(W ). As long as it still survives, it becomes infectious after duration τ and enters the 
infectious compartment (V ). Hence, at time t, the ﬂux into the latent compartment is 
αpi(t)u(t)/[l +(p − l)i(t)] and the ﬂux out is αpi(t − τ)u(t − τ)e−ητ /[l +(p − l)i(t − τ)]. 
The equations can be described by the following system: 
di l(1−i)= βq v − (µ + ν)i,dt (p−l)i+l 
du pi= η − α u − ηu, (3.3.31)dt (p−l)i+l 
dv pi(t−τ)= α u(t − τ)e−ητ − ηv(t),dt (p−l)i(t−τ )+l 
Consequently, the basic reproductive ratio of the system is 
βαqpe−ητ 
R0 
τ = . 
η(µ + ν)l 
Note that by including incubation time of malaria parasites in humans (ω), the system 
leads to the basic reproductive ratio into the following form 
−ητ βαqpe−µωe
0R
ωτ = 
η(µ + ν)l
. 
Since human life span is long comparing with incubation time of the parasites, e−µω 
is close to 1. Hence, the incubation time in humans does not much alter the basic 
reproductive ratio which helps to determine whether the disease spreads. Consequently, 
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we can omit the incubation time in human in the model for simplicity in the analysis. 
The system (3.3.31) has two steady states, which are 
1. the disease-free steady state
 
(i, u, v) = (0, 1, 0)
 
2. the disease-present steady state 
∗(i, u, v) = (i ∗ , u , v ∗) 
with 
∗ η[(p−l)i∗ +l]u = η[(p−l)i∗ +l]+αpi∗ , 
−ητ ∗ αpi∗ ev = η[(p−l)i∗ +l]+αpi∗ 
where i∗ satisﬁes 
(µ+ν)(p−l)[η(p−l)+αp]i ∗2+{βαqple−ητ +(µ+ν)[αpl+2ηl(p−l)]}i ∗+(µ+ν)ηl2−βαqple−ητ = 0. 
The linearised system of (3.3.31) at the disease-free steady state is 
di = βqv − (µ + ν)i,dt 
⎤⎥
du = −αp i − ηu, (3.3.32)dt l 
⎦ . 
⎤⎥
dv = αp i(t − τ)e−ητ − ηv. dt l 
The system can be written in matrix form as follows: 
dx 
= J0x(t) + J1x(t − τ ),
dt 
where x(t) = (i(t), u(t), v(t))T , 
⎦ , 
⎡ ⎢⎣
 
⎡ ⎢⎣
 −(µ + ν) 0
 0 0 0
βq
 and J10
 0 0 0
−αp lJ0 −η
=
 =
 
−ητ 0 0
 0
αp l−η
 e

−λt ˆBy assuming that the solution of the system is x = e v, we obtain 
λvˆ = (J0 + e −λτ J1)vˆ 
and the characteristic equation is 
|J0 + e −λτ J1 − λI| = 0 
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or 
(λ + η)[λ2 + (µ + ν + η)λ + η(µ + ν) − βαq ppe −(λ+η)τ ]. 
l 
Clearly, one of the eigenvalues is λ1 = −η, that always give a stable manifold. Hence, 
the stability of the disease-free steady state depends upon the following function 
F (λ, τ) = λ2 + (µ + ν + η)λ + η(µ + ν)(1 − R0 τ e −λτ ) = 0. (3.3.33) 
In order to prove that the disease-free steady state is stable if and only if Rτ < 1, we 0 
consider the properties of the function F and follows the steps of proof by Ruan et al. 
(2008) and Wei et al. (2008). The function F is analytic with F (0, τ ) = η(µ+ν)(1−Rτ )0 
and F (λ, 0) = λ2 + (µ + ν + η)λ + η(µ + ν)(1 − R0). We separate the proof into three 0
cases according to the basic reproductive ratio: 
1. Rτ < 1 For all positive λ and τ , F (0, τ) > 0 and ∂F (λ, τ)/∂λ > 0 so that F0 
is an increasing function for λ > 0. Consequently, there is no zero root and no 
positive root for any positive τ . In the similar way with the previous section, we 
show that F has no imaginary roots by assuming that ±iω are imaginary roots 
of F . This follows the start of the real and negative eigenvalues on the complex 
plane that become a pair of complex conjugates with negative real parts when 
0 < τ << 1. For the eigenvalues to become a pair of complex conjugates with 
positive real parts, there must be a pair of purely imaginary eigenvalues as a 
solution of (3.3.33). So, ω must be a positive root of the following equation: 
ω4 + [(µ + ν)2 + η2]ω2 + (µ + ν)2η2(1 − Rτ2) = 0.0 
Obviously, this equation does not have nonnegative real roots. A contradiction 
is found and hence F does not have purely imaginary roots. Moreover, F (λ, 0) 
has two negative real roots which are 
−(µ + ν + η) ± �(µ + ν + η)2 − 4η(µ + ν)(1 − Rτ )
λ± = 0 2 
and ∂F (λ±, 0)/∂λ � 0.= By the implicit theorem and the continuity of F , we 
conclude that F (λ, τ) has no root with positive real parts for positive τ . The 
disease-free steady state is stable if R0 
τ < 1. 
2. Rτ = 1 Because F (0, τ) = 0 and dF (λ, τ)/dλ > 0 for all λ ≥ 0 and τ > 0, zero 0 
is a simple root and there is no positive root. In the similar way with 1), we 
can show that there is no positive root. Hence, the disease-free steady state is 
degenerate. 
3. R0 
τ > 1 Since F (0, τ) < 0 and ∂F (λ, τ)/∂λ > 0, for all λ ≥ 0 and τ > 0, F has a 
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positive root. Thus, the disease-free steady state is unstable. 
The proof is completed. Therefore, the disease-free steady state is stable if and only if 
1. 
The linearised system at the disease-present steady state is 
di 
dt 
βql(v−i∗ v−v ∗i) 
[(p−l)i∗ +l] − βql(p−l)(v 
∗ +i∗ v ∗)i 
[(p−l)i∗ +l]2] − (µ + ν)i, 
du 
dt −αp(u 
∗i+i∗ u) 
[(p−l)i∗ +l] + 
αp(p−l)i∗ u ∗i 
[(p−l)i∗ +l]2 − ηu, 
dv 
dt 
αpe−ητ (u ∗i(t−τ )+i∗ u(t−τ )) 
[(p−l)i∗ +l] − αp(p−l)e
−ητ i∗ u ∗i 
[(p−l)i∗ +l]2 − ηv. 
(3.3.34) 
The characteristic equation can be derived in the similar way with the linear system 
at the disease-free steady state and it is of order 3. Here, we study the dynamics of 
the disease-present steady state numerically. In Figure 3-29(a), the basic reproductive 
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Figure 3-29: (a) An incubation eﬀect from mosquitoes on the basic reproductive ratio 
(p = 0.7, l = 0.6) (b) An incubation eﬀect from mosquitoes on the number of infectious 
humans and mosquitoes (τ is in days, p = 0.7, l = 0.6) 
ratio is plotted against the incubation time in mosquitoes. It is decreased when the 
incubation time is increased. In other words, when parasites need longer time to 
appear in bloodstream, the disease transmission is reduced. In Figure 3-29(b), we 
study the solution of the system (3.3.31) at some values of τ . As we can see, the 
proportions of infectious humans and mosquitoes decrease when the incubation time 
of the malaria parasites in mosquitoes increases. The solution tends to the disease-
present steady state ﬁnally. By studying the asymptotic solutions, we have found 
that with p = 0.7, q = 1, Rτ = 9.4, the incubation time τ that two steady states 0 
exchanging the stability is approximately 45 days which is normally longer than the 
lifespan of mosquitoes (see Figure 3-30). Hence, the disease is endemic no matter what 
the incubation time in mosquitoes is 
92
 
0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18 0.2
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
τ (year)
i(∞
), v
(∞
)
i(∞)
v(∞)
Figure 3-30: The bifurcation diagram between τ and i(∞) and v(∞) (q = 1, p = 0.7, l = 
0.6, Rτ = 9.4)0 
The study of travelling waves 
In this section, we introduce the diﬀusion term to represent the mosquito’s movement 
as a random walk. Also, because attractiveness of humans to mosquitoes is expressed 
in chemical forms such as sweat, body odour, and breath (Skinner et al., 1965; Takken 
and Knols, 1999; Mukabana et al., 2004), we incorporate a chemotaxis term to explain 
the chemically directed movement to humans (Murray, 1993). The governed system 
after rescaling becomes 
∂i βql(1−i)= v − i,∂T (µ+ν)[(p−l)i+l]
 
∂u η(u+v) αpi η u ∂i
 = − u − u + d∂2 − χ ∂ u (3.3.35)∂T µ+ν (µ+ν)[(p−l)i+l] µ+ν ∂x2 ∂x ∂x , 
∂v αpi η v + d ∂
2v ∂i = u − − χ ∂ v∂T (µ+ν)[(p−l)i+l] µ+ν ∂x2 ∂x ∂x 
where the total density of the human population (N) is constant in time and space 
and the total density of the mosquito population (M) depends on the time and space 
variables, T = (µ + ν)t, x is the space variable, d is the diﬀusion coeﬃcient (d > 0), 
and χ is the chemotaxis coeﬃcient (χ > 0). Note that u = U/M0 , v = V/M0, and 
q = M0/N where M0 is the total density of the mosquito population at the spatially 
uniform disease-free steady state. Also note that 
∂ ∂s ∂ ∂i ∂i −χ1 u − χ2 u = −(χ2 − χ1) ∂ u∂x ∂x ∂x ∂x ∂x ∂x 
= −χ ∂ u ∂i ∂x ∂x 
where s = 1 − i, and χ2 > χ1 > 0 because malaria parasites manipulate hosts to be 
more attractive to mosquitoes via sweat and body odour, for instance. 
We study the propagation of malaria from the infected population into the uninfected 
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population (infected human population to uninfected mosquito population and in-
fected mosquito population to uninfected human population) by introducing the initial 
conditions as step functions in one-dimensional domain [x1, x2] with malaria initially 
present at its spatially uniform steady state in [x1, x¯]) and absent in [x¯, x2], where 
1 + x2)/2. This the initial conditions are given by 
i(x, 0) i∗ − i∗H(x − x¯), x1 ≤ x ≤ x2, 
u(x, 0) u ∗ + (1 − u ∗)H(x − x¯), x1 ≤ x ≤ x2, 
v(x, 0) v ∗ − v ∗H(x − x¯), x1 ≤ x ≤ x2, 
H(x) is a heaviside step function, u ∗ = 1 − v ∗ , i∗ and v ∗ correspond to (3.3.23) 
and it is shown in Figure 3-31(a). The boundary conditions are assumed as zero ﬂuxes: 
∂u 
∂x (x1, T ) − χu(x1, T ) ∂i ∂x (x1, T ) 0 d∂u ∂x (x2, T ) − χu(x2, T ) ∂i ∂x (x2, T ), 
∂v 
∂x (x1, T ) − χv(x1, T ) ∂i ∂x (x1, T ) 0 d ∂v ∂x (x2, T ) − χv(x2, T ) ∂i ∂x (x2, T ), 
T1 ≤ T ≤ T2. 
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Figure 3-31: (a) Initial conditions in the one-dimensional domain [0, 200] (b) This 
graph shows the travelling waves of infectious mosquitoes from the endemic area to the 
disease-free area (T = (µ + ν)t, p = 0.7, l = 0.6, c = 11.23, d = 1, χ = 1) 
In Figure 3-31(b), we can see that malaria spreads from infected population to unin­
fected population like travelling waves. The wave speed (c) can be calculated from the 
graph by the formula 
x2 − x1 
c = 
t2 − t1 
where x2 −x1 is the distance on the space and t2 −t1 is the time diﬀerence corresponding 
to the wave. When p = 0.7 and l = 0.4, the wave speed is 14.5 space unit per year, 
for example. Other variables also share the same wave speed with v or V (see Figure 
3-31). When p is larger, for example, p = 0.8, the speed of travelling waves becomes 
bigger, which is 15.7. Hence, it suggests that the more the infectious hosts become 
attractive to the mosquitoes, the faster of the propagation of the disease from the 
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infected population to the uninfected population is. 
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Figure 3-32: (a) A relation between the probability that a mosquito picks an infectious 
human (p) and the wave speed (c) when p − l = 0.1 and p varies (b) A relation between 
p and c, when l is ﬁxed at 0.4 while p varies, from a numerical simulation comparing 
with the minimum wave speed 
We further study the wave speed c numerically by considering the relation between p 
and l. Note that the wave speed is expressed in space unit per year. In Figure 3-32(a), 
when p and l increase but the diﬀerence between them is ﬁxed at 0.1, or in other words 
when l/p becomes larger (l/p → 1), the wave speed of malaria propagation decreases. 
Figure 3-32(b) shows that wave speed of the disease increases when p increases while 
l is ﬁxed at 0.4. Both results also suggest that wave speed depends on how diﬀerent 
between p and l or how attractive the infectious human to the mosquito comparing 
with the susceptible human is. 
Next, we calculate the lower bound of wavespeed by employing the method in Murray 
(1993). We look for travelling wave solutions by setting 
i(x, T ) = i(z), u(x, T ) = u(z), v(x, T ) = v(z), z = x − cT. (3.3.36) 
By substituting them into (3.3.35), we obtain the ordinary diﬀerential equation system 
βql(1−i)vci� + − i = 0,(µ+ν)[(p−l)i+l] 
η αpiu ηu du�� − χ(ui�)� + cu� + (u + v) − − = 0, (3.3.37)(µ+ν) (µ+ν)[(p−l)i+l] (µ+ν) 
αpiu ηv dv�� − χ(vi�)� + cv� + − = 0,(µ+ν)[(p−l)i+l] (µ+ν) 
where the prime denotes diﬀerentiation with respect to z. Our goal is to ﬁnd solutions 
with positive wave speed c and nonnegative i, u and v of the eigenvalue problem such 
that 
i(−∞) = i(∞) = 0, 0 ≤ u(−∞) < u(∞) = 1, v(−∞) = v(∞) = 0. 
The conditions on i and v lead to a pulse wave of infection that propagates into the
 
uninfected population. We linearise the system (3.3.37) near the leading edge of the
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wave where i → 0, u → 1, and v → 0 to have 
ci� + βq v − i ≈ 0,(µ+ν) 
du�� − χi�� + cu� + η v − αp i ≈ 0, (3.3.38)(µ+ν) (µ+ν)l 
αp ηdv�� + cv� + i − v ≈ 0.(µ+ν)l (µ+ν) 
Since the variable u does not appear in the other two equations (decoupled), we can 
omit the diﬀerential equation of u and hence the dynamics of the system are governed by 
the diﬀerential equations of i and v, the dynamics of the wave solutions of the system 
(3.3.38) can be described by the following ﬁrst-order ordinary diﬀerential equation 
system 
di 1 βq = i − v, dz c c(µ+ν) 
dv = w, (3.3.39)dz 
dw αp η= − i + v − c w. dz dl(µ+ν) d(µ+ν) d 
The characteristic equation of the system (3.3.39) is 
c �� 1� η � 1� βαqp 
λ 
�
λ + λ − − λ − − = 0. (3.3.40)
d c d(µ + ν) c cdl(µ + ν)2 
In order to ﬁnd the minimum value of the wave speed (cl), we diﬀerentiate through out 
the equation (3.3.40) with respect to λ to ﬁnd λ that minimize c and the equation is 
given by �
2c 2
� � 
1 η 
�
3λ2 + − λ − + = 0 (3.3.41)
d c d d(µ + ν) 
By solving the equations (3.3.40) and (3.3.41) for c, we can ﬁnd the minimum value 
of the wave speed of the system (3.3.35). The minimum value of the wave speed at 
some values of p and l is shown in Figure 3-32(b) in space units per year. Note that 
this minimum wave speed for a travelling wave shares the same value with our previous 
study when immunity is present. 
Conclusion and discussion 
Lacroix et al. (2005) suggest that infectious humans may be more attractive to mosquitoes 
than susceptible humans due to the manipulation of the malaria parasites in them. Pre­
viously, Kingsolver (1987) introduce a model that takes account for this manipulation. 
Here, we introduce the model in a diﬀerent way from previous authors and analyse it 
relating to certain factors in mosquitoes to the spread of malaria such as incubation 
time, random movement, and chemically directed movement to humans. 
First, we introduce the model with the dynamics of malaria in humans and mosquitoes 
described by SIS (susceptible-infectious-susceptible) and SI (susceptible-infectious) com­
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partment models, respectively. The vector-bias term is expressed in terms of diﬀerent 
probabilities that a mosquito arriving at a human at random and picks that human 
depending on whether that person is infectious, or susceptible. 
Second, we prove that a transcritical bifurcation occurs at the basic reproductive ra­
tio equaling 1 (R0 = 1) by projecting the ﬂow onto the extended centre manifold. 
Consequently, the disease-free steady state is stable if and only if R0 < 1 and the 
disease-present steady state is stable if and only if R0 > 1. The greater attractiveness 
of infectious humans to mosquitoes aﬀects malaria transmission that the populations 
favor high prevalence of the parasites. 
Due to short the lifespan of mosquitoes, we incorporate the incubation of malaria 
parasites that might play an important role in studying the dynamics behaviours of 
the disease. From our study, it suggests that the malaria transmission, the proportion of 
infectious humans and mosquitoes, decreases when incubation time of malaria parasites 
in mosquitoes increases. We show that the disease-free steady state is stable if R0 
τ < 1 
analytically and the disease-present steady state is stable if R0 
τ > 1 numerically. Also, 
for our parameter ranges, we show that malaria is endemic no matter how long the 
incubation time is. 
Finally, we include the random movement of mosquitoes in term of a diﬀusion term 
and attractiveness of humans to mosquitoes in chemical forms such as sweat and body 
odour in term of chemotaxis term into the model. We then study the propagation of 
the infected population to the uninfected population. We show that travelling waves 
occurs as a pulse wave and the wave speed can be calculated from the numerical results. 
We also approximate the minimum wave speed analytically and compare it with the 
numerical result. By comparing this minimum wave speed with one from the vector-
bias model based on SIRS (susceptible-infectious-recovered-susceptible) in humans and 
SI in mosquitoes on malaria transmission in the previous section, we ﬁnd that it shares 
the same minimum wave speed. 
All in all, this work should be further studied by approximating the values of p and 
l from real data from a malaria endemic area, or including control measures into the 
model. 
3.4 Conclusions and Discussion 
In this chapter, we study mathematical models for malaria. In Section 3.1, we propose a 
mathematical model based on a status-based framework for two strains of malaria in the 
same species or two strains from diﬀerent species. By the status-based framework, the 
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model becomes more tractable (comparing with the model in Section 3.2, for example). 
We then study the long-term dynamical behaviours by stability analysis and bifurcation 
analysis. The goal of this study is to introduce a model that can be used to study 
malaria transmission when controls are available in Chapter 4. 
In Section 3.2, we propose two novel models, the coinfection and cross-immunity mod­
els, for studying two diﬀerent species of malaria, P. falciparum and P. vivax. The 
coinfection model takes into account of suppression during coinfection of both species, 
that infection with P. falciparum reduces susceptibility to P. vivax and infection with 
P. vivax helps to reduce complications to infection with P. falciparum. In many parts 
of the world, malaria incidences and prevalence are diﬀerent between species in each 
season. We investigate this matter by considering seasonality in each species. Due to 
certain factors in mosquitoes and parasites, it suggests that there is seasonality in trans­
mission of P. falciparum. Hence, we introduce the transmission rate of P. falciparum 
as a sinusoidal function. We ﬁnd that the prevalence of P. falciparum is very high in 
one season of each year while the prevalence of P. vivax is high before that season of 
P. falciparum. This result is corresponding to the data in some literature (Syafrud­
din et al., 2009). By considering the relapse mechanism of P. vivax such that rate of 
becoming inactive increases while rate of relapsing decreases in individuals previously 
infected with P. falciparum and currently infected with P. vivax and by considering 
the ability of P. vivax that can multiply better in colder weather than P. falciparum, 
we introduce seasonality in both P. vivax and P.falciparum with highly transmission 
happening in diﬀerent seasons. In this case, the prevalence of P. vivax is peak in the 
middle of every highly transmitted season of P. falciparum in each year. 
By omitting coinfection between P. falciparum and P. vivax and assuming that cross-
species immunity exists and acts in the similar way with suppression during coinfection, 
we can derive the cross-immunity model that can be used to study relations between 
cross-species immunities σ1 and σ4, cross-immunity that acts to reduce susceptibility to 
P. vivax and cross-immunity that acts to reduce complications to P. falciparum. In this 
study, we show that when σ1 is very high, P. vivax may die out. However no matter how 
high σ4 is (unless σ1 is high), both species still coexist. Consequently, cross-immunity 
of P. falciparum to P. vivax may beneﬁt human population more than cross-immunity 
of P. vivax to P. falciparum. We further investigate mean ages at infection to both 
species of malaria from this model. We ﬁnd that cross-immunity of P. vivax to reduce 
the recovery time in P. falciparum increases the mean age at infection of P. falciparum 
while cross-immunity of P. falciparum to reduce transmission of P. vivax reduces the 
mean age to be shorter. On the other hand, cross-immunity of P. falciparum to P. 
vivax increases the mean age at infection of P. vivax while cross-immunity of P. vivax 
to P. falciparum reduces it. This result is clearly observed when the basic reproductive 
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ratio is small. However, when it becomes much bigger, cross-immunity does not much 
help reducing the mean age at infection. In our study, we can also estimate the mean 
age at infection for P. falciparum as 2 year old and for P. vivax as 4 year old. This 
result is based estimations of the basic reproductive ratios from real data. In case the 
mean age at infection of each species is known, we can estimate the basic reproductive 
ratio, which is an important quantity in studying disease dynamics, from the formula. 
In Section 3.3 and 3.4, we additionally study two single-strain models of malaria trans­
mission. In the ﬁrst model, we use the SIRS framework for describing a human popula­
tion while we use the SIS framework for hosts in the second model. In the ﬁrst model, 
we introduce each factor driven by mosquitoes one by one to study the disease dynam­
ics relating to mosquito’s behaviours. These factors are seasonality, incubation time in 
mosquitoes, the greater attractiveness of infectious humans, the random movement of 
mosquitoes, and the chemically directed movement toward humans. Diﬀerently, by as­
suming that rate of waning immunity is very big (γ →∞), the SIRS model for humans 
can be approximated by the SIS model. The second model becomes more tractable so 
that we can analyse the system analytically. Consequently, we can introduce a model 
that takes into account the greater attractiveness of infectious humans since the be­
ginning of the study and then study the system when incubation time and random 
movement of mosquitoes, and the chemically directed movement toward humans, are 
taken into account. 
For the ﬁrst model in Section 3.3, we ﬁnd that the proportion of infectious individuals is 
increased when rate of waning immunity becomes bigger. By incorporating seasonality 
in the recruitment rate of mosquitoes due to their abundance during rainy season, 
seasonality in the transmission rates due to the higher bitting rate of mosquitoes and 
parasite replications in warmer weather, malaria can be highly transmitted in every 
hot and wet season (in case there are three seasons in each year:hot, rainy, and winter). 
This corresponds to some malaria data that it is highly endemic in hot and rainy 
season. This work can be further investigated when controls are present. For example, 
when should sterlise mosquitoes and genetically modiﬁed mosquitoes be released to 
eﬀectively control malaria transmission. We then introduce the incubation time in 
mosquitoes. The basic reproductive ratio and the prevalence of malaria are reduced 
when the incubation time in mosquitoes increases. Since it may take longer for malaria 
parasites to appear in salivary glands of mosquitoes when the weather is cold (τ is 
big when the temperature is cold) (Pascual et al., 2006; Patz and Olson, 2006), our 
result suggests that malaria in temperate regions may be less transmitted and less 
prevalent than tropical regions. Next, we incorporate the greater attractiveness of 
infectious individuals to mosquitoes. By including a random movement of mosquitoes 
as a diﬀusion term and a chemically directed movement as a chemotaxis term, we 
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ﬁnd that travelling waves occur and their speed can be approximated. Hence, malaria 
propagates from the disease-present areas to the disease-free areas. We are also able to 
calculate the minimum wave speed and compare it with our numerical results. We can 
also ﬁnd that the more attractive the infectious humans are, the faster malaria travels 
and spreads. 
In Section 3.4, we ﬁrst introduce an SIS-SI model by incorporating the greater attrac­
tiveness of infectious humans to mosquitoes. We then prove that the disease-free steady 
state is stable if and only if R0 < 1 by Routh-Hurwitz criteria and the disease-present 
steady state is stable if and only if R0 > 1 by the proof of transcritical bifurcation. 
Next, incubation time in mosquitoes is taken into account. We show that the disease-
free steady state is stable if and only if Rτ < 1 . Numerically, we show that when 0 
Rτ > 1 the solutions tend to the disease-present steady state. We study propagation 0 
of malaria by including a diﬀusion term and a chemotaxis term to represent a random 
movement and a chemically directed movement of mosquitoes. Travelling waves occur 
and we can calculate the wave speed of malaria dissemination and it lower bound. 
By comparing the wave speed calculated from numerical solutions when p and l are 
varied in Figure 3-28 & 3-32, we see that both models lead to the same wave speed 
of malaria propagation and so do the minimum wave speed. However, when time 
passes and malaria becomes endemic (hence solutions tend to the disease-present steady 
state), the ﬁrst model predicts signiﬁcantly less numbers of infectious individuals than 
the second model. Hence, the presence of immunity helps to reduce the prevalence of 
malaria but does not alter malaria dissemination (see Figure 3-27(b) & 3-31(b)). 
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Chapter 4 
Controls in multi-strain diseases
 
In this chapter, we study multi-strain models in the presence of controls. The aim of 
control application is generally to reduce the spread of the disease and minimize the 
loss. For inﬂuenza, we consider a two-strain model with a status-based framework in 
the presence of isolation and vaccination. In the ﬁrst model, infected individuals are 
isolated to prevent further transmission to others. Vaccination is assumed to be given to 
newborns with the objective to reduce the prevalence of inﬂuenza. In the second model, 
we study inﬂuenza based on the waning of immunity in cross-immune individuals when 
vaccination is launched. Vaccination is assumed to be given to susceptible pool. We 
investigate both constant and time-dependent rate of vaccination in the model. 
For malaria, control in hosts can be achieved by applying drugs and treatments. Since 
2002 scientists can access genome sequences of Plasmodium freely (Gardner et al., 
2002; Carlton, 2003), and vaccination research has been improved signiﬁcantly. In the 
future, a malaria vaccination might be available. Hence the study of malaria in terms of 
population dynamics in the presence of vaccination might provide public health a future 
insight into the use of a vaccine eﬃciently to eradicate malaria. Vaccination models in 
malaria (Chiyaka et al., 2007a, 2008) are still scant, especially multi-strain ones. Here 
we consider the two-strain host-vector model with status-based framework in both with 
and without age classes. The model is previously introduced in Chapter 3. We propose 
threshold conditions for eradicating the disease. Another eﬀective way of controlling 
malaria is by controlling mosquitoes (Takken and Knols, 2005). Several means aﬀect 
mosquitoes diﬀerently. For example, destroying the mosquito’s habitat and breeding 
sites, the use of larvicide, and introducing sterile mosquitoes help to reduce the number 
of new coming mosquitoes (Fillinger and Lindsay, 2006; Fillinger et al., 2009; Scott 
et al., 2002). The use of repellents and bed nets does not kill mosquitoes but helps to 
decrease the biting rate (Bradley et al., 1986). By spraying the walls and ceilings of 
the house with insecticide, the survival of adult mosquitoes resting indoors is reduced 
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(Pates et al., 2005). Recent reports show improvement of the study that could lead to 
introducing genetically modiﬁed mosquitoes, that could kill 100 per cent of parasites 
in their guts, to replace wild mosquitoes (Ito et al., 2002; Povelones et al., 2009) so 
that the transmission of malaria to humans is reduced by reducing the probability of 
successful infection in a human who gets bitten by an infectious mosquito. Hence, we 
ﬁnally end this chapter by discussing the use of these controlling methods via the basic 
reproductive ratio in the malaria transmission model. 
4.1 Modelling isolation and vaccination in inﬂuenza 
Isolation and vaccination are two of the most eﬀective means to control a disease. Vac­
cination is targeted to susceptible individuals while isolation is focused on the infective 
individuals. Since both means are currently widely used, the study of them in detail 
might clarify the advantages and disadvantages between them and hopefully beneﬁt us 
to use them eﬃciently. In this section, we introduce isolation and vaccination into a 
multi-strain model for inﬂuenza. We then study the stability analysis and the bifur­
cation analysis in each strategy. We propose criteria that might be useful for public 
health in terms of the parameters of the disease. We illustrate some of the results by 
numerical simulations. Moreover, we study the dynamics of the systems numerically 
when there is a delay in isolation. The impact of cross-immunity is also mentioned 
in some parts of this work. In terms of comparison of the models, we compare the 
reproductive ratio of the strain in the absence of interventions, the isolation reproduc­
tive ratio, and the vaccination reproductive ratio. Furthermore, we compare the host’s 
mean age at infection, rate of invasion of the novel strain, and the results in terms of 
economic points of view. Additionally, we combine those two means into the model 
and then study it numerically. 
4.1.1 Model formulation 
Three models are mentioned in this section. The ﬁrst model is the basic model before 
introducing an intervention. The second model is developed by considering the presence 
of isolation. The third model is formulated for describing the dynamics of the host 
population when vaccination is present. 
Without intervention 
The model before introducing the intervention is formulated by Gog and Grenfell 
(2002). The model assumes polarized susceptibility, i.e. each individual is either com­
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pletely immune or completely susceptible to each strain of a disease. Immediately on 
infection with a strain of a disease, an individual is assumed to become immune to 
that strain with probability 1 and immune to related strains with reduced probabil­
ities. For a disease with two co-circulating strains, each individual, whether infected 
or not, has one of four possible immune repertoires ∅, {1}, {2}, {1, 2}. We assume 
that an individual with immune repertoire ∅ has probability σ of acquiring immunity 
to strain 2 (as well as strain 1) on infection with strain 1, and the same probability σ 
of acquiring immunity to strain 1 on infection with strain 2. Following Gog and Gren­
fell (2002), we assume further that an individual with immune repertoire {1} also has 
probability σ of acquiring immunity to strain 2 on contact with an individual infected 
with strain 1 even though infection with strain 1 is impossible, and similarly when an 
individual with immune repertoire {2} comes into contact with an individual infected 
with strain 2. These assumptions allow us to write down a system of four equations for 
four classes of hosts: susceptible to strain 1, S1 (whether with immune repertoire ∅ or 
{2} and whether or not infected with strain 2); infected with strain 1, I1; susceptible 
to strain 2, S2; and infected with strain 2, I2. Note that these classes are not mutually 
exclusive, and that some individuals do not belong to any of them. We assume that 
the recovery rate from each strain is the same and denote it by ν0, but that each strain 
has a diﬀerent rate of transmission denoted by β1 and β2. The equations are as follows 
S
1(t) = µ0N − µ0S1 − β1S1I1 − σβ2S1I2, 
1(t) = β1S1I1 − (µ0 + ν0)I1,I
 (4.1.1)

S
2(t) = µ0N − µ0S2 − β2S2I2 − σβ1S2I1, 
2(t) = β2S2I2 − (µ0 + ν0)I2.I

It is assumed that there is no death from infection and the birth and death rates are the 
same so that the total size of population (N) is a constant. We normalise the system 
(4.1.1) by introducing the new variables and parameters as follows 
S1 I1 S2 I2 µ0 = , i1 = , s2 = , i2 = , T = (µ0 + ν0)t, µ = ,s1 
N N N N µ0 + ν0 
and the reproductive ratio of strain 1 and strain 2 respectively 
β1N β2N 
R1 = and R2 = . 
µ0 + ν0 µ0 + ν0 
The model becomes 
(T ) = µ(1 − s1) − R1s1i1 − σR2s1i2,s
1
1(T ) = R1s1i1 − i1,i
 (4.1.2)

(T ) = µ(1 − s2) − R2s2i2 − σR1s2i1,s
2
2i
 (T ) = R2s2i2 − i2, 
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With isolation
 
Because of similar symptoms and the diﬃculty of clinically distinguishing a viral strain, 
we assume that rate at which infected individuals are detected and removed to quaran­
tine (q0) is the same for strain 1 and strain 2. Removing such individuals to quarantine 
does not change their immune status and they return to the same Si class after re­
covery, so (on the assumption that there are few individuals in quarantine at any one 
time) the equations for S1 and S2 are unchanged. We assume that individuals leave 
the quarantined class at rate κ0. The model takes the form 
S� (t) = µ0N − µ0S1 − β1S1I1 − σβ2S1I2,1
I � (t) = β1S1I1 − (ν0 + µ0 + q0)I1,1
S� (t) = µ0N − µ0S2 − β2S2I2 − σβ1S2I1, (4.1.3)2
I � (t) = β2S2I2 − (ν0 + µ0 + q0)I2,2
Q�(t) = q0(I1 + I2) − κ0Q. 
We normalise the system (4.1.3) by introducing the new variables and parameters as 
follows 
S1 I1 S2 I2 Q 
s1 = , i1 = , s2 = , i2 = , q = ,
N N N N N 
µ0 q0 κ0
T = (µ0 + ν0 + q0)t, µ = , θ = , κ = , 
µ0 + ν0 + q0 µ0 + ν0 + q0 µ0 + ν0 + q0 
and the two isolation basic reproductive ratios for strain 1 and strain 2, 
β1N β2N 
R1q = and R2q = . 
µ0 + ν0 + q0 µ0 + ν0 + q0 
The model is now in the form 
s (T ) = µ(1 − s1) − R1qs1i1 − σR2qs1i2,1
i� (T ) = R1qs1i1 − i1,1
s (T ) = µ(1 − s2) − R2qs2i2 − σR1qs2i1, (4.1.4)2
i� (T ) = R2qs2i2 − i2,2
q�(T ) = θ(i1 + i2) − κq 
We remark here that R1q and R2q can be written in terms of R1 and R2 as 
R1q = (1 − θ)R1 and R2q = (1 − θ)R2. 
With vaccination 
We assume that a vaccine targeted at strain 1 is given to newborns so that a fraction p 
of vaccinated infants acquire immunity to strain 1 and a fraction pτ acquires immunity 
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to strain 2; here τ is the cross-immunity coeﬃcient induced by vaccination. Vaccination 
eﬀectively protects an individual from both strains if τ = 1; we assume that it is less 
than σ which is the cross-immunity coeﬃcient induced by infection to the viral strain. 
The model is 
S� (t) = µ0(1 − p)N − µ0S1 − β1S1I1 − σβ2S1I2,1

I � (t) = β1S1I1 − (ν0 + µ0)I1,
1 (4.1.5)
S� (t) = µ0(1 − pτ )N − µ0S2 − β2S2I2 − σβ1S2I1,2

I � (t) = β2S2I2 − (ν0 + µ0)I2.
2
From the model, the successfully vaccinated newborns enter the vaccination class V 
and 
V �(t) = pµ0N − µ0V (4.1.6) 
Because vaccination gives full protection to strain 1 and cross-immunity to strain 2, 
only a fraction τp of newborns acquire immunity to both strains. Thus, the rest of 
them, a fraction (1 − τ)p of newborns who acquire only immunity to strain 1 and a 
fraction 1−p of newborns who are unvaccinated and acquire no immunity to any strain, 
are susceptible to strain 2 and so the recruitment to the S2 class is at rate µ(1 − pτ)N . 
The equation (4.1.6) is decoupled from the system (4.1.5) and V can be found explicitly 
from the following equation 
V (t) = pN + (V0 − pN)e −µ0t (4.1.7) 
where V0 is the initial condition of V at time t = 0. The system (4.1.5) is normalised 
by introducing a set of variables and parameters as follows 
S1 I1 S2 I2 µ0 
s1 = , i1 = , s2 = , i2 = , T = (µ0 + ν0)t, µ = ,
N N N N µ0 + ν0 
and the model becomes 
s (T ) = µ(1 − p) − µs1 − R1s1i1 − σR2s1i2,1

i� (T ) = R1s1i1 − i1,
1 (4.1.8) 
s (T ) = µ(1 − τp) − µs2 − R2s2i2 − σR1s2i1,2
i� (T ) = 2 R2s2i2 − i2, 
From the model, the vaccination basic reproductive ratios for strain 1 and strain 2 are 
R1p = (1 − p)R1 and R2p = (1 − pτ)R2. 
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4.1.2 Stability analysis 
By setting the right-hand sides of the system (4.1.2),(4.1.4), and (4.1.8) equal to zero, 
we have four steady states for each model. 
Without intervention 
1) The disease-free steady state 
0 0P 0 = (s1, i1
0 , s 2, i
0) = (1, 0, 1, 0).2
2) The single-strain steady state of strain 1 � 
1 µ 1 
�
1 1P 1 = (s1, i
1
1, s 2, i
1) = , (R1 − 1), , 02 R1 R1 1 + σ(R1 − 1)
which is positive if and only if 
R1 > 1. (4.1.9) 
3) The single-strain steady state of strain 2 � 
1 1 µ 
�
2 2P 2 = (s1, i
2
1, s 2, i
2) = , 0, , (R2 − 1)2 1 + σ(R2 − 1) R2 R2 
which is positive if and only if 
R2 > 1. (4.1.10) 
4) The coexistent steady state 
∗ ∗ P ∗ = (s1, i 1
∗ , s 2, i 
∗)2
where 
1 µ∗ s = , i ∗ = [(R1 − 1) − σ(R2 − 1)]1 1R1 (1 − σ2)R1 
and 
1 µ∗ s = , i ∗ = [(R2 − 1) − σ(R1 − 1)] .2 2R2 (1 − σ2)R2 
The coexistent steady state is positive if and only if both of the following conditions 
hold 
(R1 − 1) − σ(R2 − 1) > 0 (4.1.11) 
and 
(R2 − 1) − σ(R1 − 1) > 0. (4.1.12) 
106
 
With isolation
 
1) The disease-free steady state 
0 0 0Pq 
0 = (s1q, i
0
1q, s 2q, i
0
2q, q q ) = (1, 0, 1, 0, 0). 
2) The single-strain steady state of strain 1 
P 1 1 1 1 
� 
1 µ 1 θµ 
� 
q = (s1q, i1
1 
q, s 2q, i2
1 
q, q q ) = , (R1q − 1), , 0, (R1q − 1)R1q R1q 1 + σ(R1q − 1) κR1q 
which is positive if and only if 
R1q > 1. (4.1.13) 
3) The single-strain steady state of strain 2 
2 2 2 
� 
1 1 µ θµ 
�
Pq 
2 = (s1q, i1
2 
q, s 2q, i2
2 
q, q q ) = , 0, , (R2q − 1), (R2q − 1)1 + σ(R2q − 1) R2q R2q κR2q 
which is positive if and only if 
R2q > 1. (4.1.14) 
4) The coexistent steady state 
∗ ∗ ∗ Pq 
∗ = (s1q, i 
∗ 
1q, s 2q, i 
∗ 
2q, q q ) 
where 
1 µ∗ s1q = , i 
∗ 
1q = [(R1q − 1) − σ(R2q − 1)] ,R1q (1 − σ2)R1q
 
1 µ
∗ s2q = , i 
∗ 
2q = [(R2q − 1) − σ(R1q − 1)] ,R2q (1 − σ2)R2q 
and 
θµ ∗ q = [R2q(R1q − 1) + R1q(R2q − 1) − σ [R1q(R1q − 1) + R2q(R2q − 1)]] .q (1 − σ2)κR1qR2q 
The coexistent steady state is positive if and only if both of the following conditions 
hold 
(R1q − 1) − σ(R2q − 1) > 0 (4.1.15) 
and 
(R2q − 1) − σ(R1q − 1) > 0. (4.1.16) 
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With vaccination
 
1) The disease-free steady state 
0 0Pp 
0 = (s1p, i1
0 
p, s 2p, i
0 ) = (1 − p, 0, 1 − pτ, 0).2p
2) The single-strain steady state of strain 1 � 
1 µ 1 − pτ
P 1 = (s 1 , i1 , s 1 , i1 ) = , (R1p − 1), , 0
� 
p 1p 1p 2p 2p R1 R1 1 + σ(R1p − 1)
which is positive if and only if 
R1p > 1. (4.1.17) 
3) The single-strain steady state of strain 2 
P 2 2 2 
� 
1 − p 1 µ � 
p = (s1p, i
2 , s 2p, i
2 ) = , 0, , (R2p − 1)1p 2p 1 + σ(R2p − 1) R2 R2 
which is positive if and only if 
R2p > 1. (4.1.18) 
4) The coexistent steady state 
∗ ∗ Pp 
∗ = (s1p, i 1
∗ 
p, s 2p, i 
∗ )2p
where 
1 µ∗ s1p = , i 
∗ 
1p = [(R1p − 1) − σ(R2p − 1)]R1 (1 − σ2)R1 
and 
1 µ∗ s2p = , i 
∗ 
2p = [(R2p − 1) − σ(R1p − 1)] . R2 (1 − σ2)R2 
The two-strain steady state is positive if and only if both of the following conditions 
are hold 
(R1p − 1) − σ(R2p − 1) > 0 (4.1.19) 
and 
(R2p − 1) − σ(R1p − 1) > 0. (4.1.20) 
We deﬁne the stability conditions of each steady state in each model by considering 
the eigenvalues of the Jacobian matrix and by using the Routh-Hurwitz criteria. Each 
of the steady states is stable if and only if all eigenvalues of the Jacobian matrix at the 
steady state are negative. In case we cannot determine the eigenvalues of the Jacobian 
explicitly, we consider whether the coeﬃcients of the characteristic equation satisfy the 
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Routh-Hurwitz criteria instead. For example if the characteristic polynomial is of order
 
4, 
λ4 + a1λ3 + a2λ2 + a3λ + a4, 
the steady state is stable if and only if 
2 2 a1 > 0, a3 > 0, a4 > 0, and a1a2a3 > a3 + a1a4. 
Without intervention 
The Jacobian matrix of the system (4.1.2) is ⎡ 
−µ − R1i1 − σR2i2 −R1s1 0 −σR2s1 
⎤ 
J = 
⎢⎢⎢⎢⎣ R1i1 0 
0 
R1s1 − 1 
−σR1s2 
0 
0 
−µ − R2i2 − σR1i1 
R2i2 
0 
−R2s2 
R2s2 − 1 
⎥⎥⎥⎥⎦ . (4.1.21) 
It is straightforward to determine the stability conditions of each steady state so we 
omit their derivation here. 
1) The disease-free steady state is stable if and only if 
R1 < 1 and R2 < 1. 
2) The stability conditions for the disease single-strain steady state of strain 1 are 
R1 > 1 and (R2 − 1) − σ(R1 − 1) < 0. 
3) Similarly, the stability conditions for the disease single-strain steady state of strain 
2 are 
R2 > 1 and (R1 − 1) − σ(R2 − 1) < 0. 
4) By the Routh-Hurwitz criteria, the coexistent steady state is stable if and only if 
i ∗ 1 > 0 and i 
∗ 
2 > 0 or (R1 − 1) − σ(R2 − 1) > 0 and (R2 − 1) − σ(R1 − 1) > 0 
A bifurcation diagram in terms of R1 and R2 for this case is shown in Figure 4-1 (a). 
Without cross-immunity, σ = 0, we have coexistence whenever R1 > 1 and R2 > 1. 
If the cross-immunity is perfect, σ = 1, there is no coexistence of the strains so that 
either strain 1 persists because R1 > R2 and R1 > 1 or strain 2 persists when R2 > R1 
and R2 > 1. 
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With isolation
 
In the similar way, the stability conditions can be derived straightforwardly by consid­
ering the Jacobian matrix of the system (4.1.4) so that we omit their proofs. 
1) The disease-free steady state is stable if and only if 
R1q < 1 and R2q < 1 
or 
1 1 
θ > 1 − and θ > 1 − . 
R1 R2 
2) The single-strain steady state of strain 1 is stable if and only if 
R1q > 1 and R2q − 1 − σ(R1q − 1) < 0 
or 
1 
θ < 1 − and (R2 − 1) − σ(R1 − 1) < (R2 − σR1)θ. 
R1 
3) The single-strain steady state of strain 2 is stable if and only if 
R2q > 1 and R1q − 1 − σ(R2q − 1) < 0 
or 
1 
θ < 1 − and (R1 − 1) − σ(R2 − 1) < (R1 − σR2)θ. 
R2 
4) The coexistent steady state is stable if and only if 
R2q − 1 − σ(R1q − 1) > 0 and R1q − 1 − σ(R2q − 1) > 0 
or 
(R2 − 1) − σ(R1 − 1) > (R2 − σR1)θ and (R1 − 1) − σ(R2 − 1) > (R1 − σR2)θ. 
A bifurcation diagram in terms of R1 and R2 is shown in Figure 4-1 (b). 
With vaccination 
The Jacobian matrix of the system (4.1.8) is in the same form with the system (4.1.2).
 
We have the stability conditions of each steady state as follows;
 
1) The disease-free steady state is stable if and only if
 
R1p < 1 and R2p < 1 
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or 
1 1 
�
1 
� 
p > 1 − and p > 1 − 
R1 τ R2 
2) The single-strain steady state of strain 1 is stable if and only if 
R1p > 1 and R2p − 1 − σ(R1p − 1) < 0 
or 
1 
p < 1 − and (R2 − 1) − σ(R1 − 1) < (τR2 − σR1)p
R1 
3) The single-strain steady state of strain 2 is stable if and only if 
R2p > 1 and R1p − 1 − σ(R2p − 1) < 0 
or 
1 
�
1 
� 
p < 1 − and (R1 − 1) − σ(R2 − 1) < (R1 − στR2)p
τ R2 
4) The coexistent steady state is stable if and only if 
R2p − 1 − σ(R1p − 1) > 0 and R1p − 1 − σ(R2p − 1) > 0 
or 
(R2 − 1) − σ(R1 − 1) > (τR2 − σR1)p and (R1 − 1) − σ(R2 − 1) > (R1 − στR2)p. 
A bifurcation diagram in terms of R1 and R2 is shown in Figure 4-1 (c). 
4.1.3 Transcritical Bifurcation Diagrams 
Since all the steady states and stability conditions can be found explicitly, we can plot 
the bifurcation diagrams according to the characteristics of the parameters in which 
we are interested in each model. We remark here that all the conditions we propose 
are for studying the long-term behaviour of the strains. 
Assume that we know the basic reproductive ratio of strain 1 and 2 when intervention 
is absent. It may be useful for public health if we know which rates of isolation and 
vaccination for both strains to die out, strain 1 to persist, strain 2 to persist, and both 
strains to coexist. Say, if we pick one point on the (R1, R2) plane, will we be able to tell 
what will happen when θ and p vary. To answer this question, we divide the (R1, R2) 
plane into areas corresponding to Figure 4-1(a). 
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Figure 4-1: Bifurcation diagrams in terms of R1 and R2 for the models without inter­
vention (a), with isolation (b), and with vaccination (c) 
With isolation 
We choose θ, the non-dimensionalised quarantine rate to be a bifurcation parameter. 
We then plot it against i1 and i2 at each steady state and determine the stable branches 
and unstable branches by the stability conditions. The bifurcations in the diagram 
are of the transcritical type where two steady states exchange their stability at the 
bifurcation point. We are interested in studying the dynamics of two co-circulating 
strains, so R1 > 1 and R2 > 1 are assumed. We separate the area of parameters R1 
and R2 relating to Figure 4-1(a) when intervention is absent. 
1. (R1 − 1) − σ(R2 − 1) > 0 and (R2 − 1) − σ(R1 − 1) < 0 
The transcritical bifurcation diagram is shown in Figure 4-2(a). Without isola­
tion, only strain 1 persists in this case. Consequently, to eradicate the disease is 
to eradicate strain 1. So if θ < 1 − 1/R1, strain 1 is endemic in the population. 
If not, θ > 1 − 1/R1, the disease dies out. 
2. (R1 − 1) − σ(R2 − 1) > 0 and (R2 − 1) − σ(R1 − 1) > 0 
According to the condition, both strains coexist in the host population when 
isolation is absent. 
On one hand, if R1 > R2, the bifurcation diagram is shown in Figure 4-2(b). Both 
strains coexist if the isolation rate is not high enough (θ < [(R2 − 1) − σ(R1 − 
1)]/(R2 − σR1)). With the cross-immunity and the higher attempt of isolation 
([(R2 − 1) − σ(R1 − 1)]/(R2 − σR1) < θ < 1 − 1/R1), strain 2 becomes extinct 
by the advantage of strain 1 in term of transmission but strain 1 is still endemic 
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Figure 4-2: Bifurcation diagrams with a bifurcation parameter θ: (a) when strain 1 is 
dominant, (b) when both strains can coexist and R1 > R2, (c) when both strains can 
coexist and R2 > R1 and (d) when strain 2 is dominant . 
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in the population. If the isolation rate is high enough so that θ > 1 − 1/R1, it 
promises the extinction the disease. 
On the other hand, if R2 > R1, the bifurcation of the latter case is shown in 
Figure 4-2(c). Coexistence of both strains occurs at the low rate of isolation 
(θ < [(R1 − 1) − σ(R2 − 1)]/(R1 − σR2)). Strain 1 can be driven out from the 
population when isolation is more concerned ([(R1 −1)−σ(R2 −1)]/(R1 −σR2) < 
θ < 1 − 1/R2). If the isolation rate is very high (θ > 1 − 1/R2), the disease is 
eradicated. 
3. (R1 − 1) − σ(R2 − 1) < 0 and (R2 − 1) − σ(R1 − 1) > 0 
The bifurcation diagram can be found in Figure 4-2(d). Without isolation, strain 
2 persists. To eradicate the disease from the population is to drive out strain 2. 
If θ > 1 − 1/R2, strain 2 can be driven out. 
With vaccination 
We are interested in the behaviour of the system in terms of the parameter p so we 
take it to be a bifurcation parameter in the model. We plot bifurcation diagrams on 
the axes p, i1, and i2 by considering the stability conditions at the steady state. Since 
we are interested in only the positive value of p and when R1 > 1 and R2 > 1, the area 
of parameters (R1, R2) is separated into three cases as follows (see Figure 4-1(a)): 
1. (R1 − 1) − σ(R2 − 1) > 0 and (R2 − 1) − σ(R − 1) < 0 
Without vaccination, only strain 1 persists. In this case, we separate it into two 
subcases according with the sign of the following term 
R1(R2 − 1) − τR2(R1 − 1). (4.1.22) 
By considering the relation between R1 and R2 according with the parameter τ 
which is the cross-immunity induced by vaccination (See Figure 4-3). If R1(R2 − 
1) − τR2(R1 − 1) < 0, in the presence of vaccination, strain 1 is facilitated. It 
means that either strain 2 cannot invade the host population or strain 1 can persist 
although the vaccination rate is high. On the other hand, if R1(R2 −1)−τR2(R1 − 
1) > 0, strain 2 is better in the environment. However, by the assumption that 
τ < σ ≤ 1, we cannot have the case when R1(R2 − 1) − τR2(R1 − 1) is negative 
in Case 2) and Case 3) when R2 > R1. 
The transcritical bifurcation diagrams are shown in Figure 4-4(a)-(b). In (a), τ 
plays an important role in this case. If the vaccine coverage is low (p < [σ(R1−1)− 
(R2 −1)]/(σR1 −τR2)), strain 1 is endemic because it has a competitive advantage 
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Figure 4-3: The relation between R1 and R2 with the presence of τ in the term R1(R2 − 
1) − τR2(R1 − 1) 
in the absence of vaccination. When [σ(R1 − 1) − (R2 − 1)]/(σR1 − τR2) < p < 
[(R1 −1)−σ(R2 −1)]/(R1 −στR2), the vaccination starts to aﬀect strain 1 and by 
our assumption that the vaccine is targeted to strain 1 with a higher probability 
than strain 2, the system favors strain 2 so the coexistence of the strains occurs. 
With a higher vaccine coverage ([(R1 − 1) − σ(R2 − 1)]/(R1 − στR2) < p < 
(1 − 1/R2)/τ), strain 1 can be eradicated while strain 2 still persists, but the 
number of infectious individuals to strain 2 is decreased if we increase vaccine 
coverage. If the fraction of vaccinating newborns is very high p > (1 − 1/R2)/τ), 
strain 2 cannot persist any more. Hence the disease dies out. In (b), strain 1 is 
far better than strain 2 in both of the absence and the presence of vaccination. 
Vaccination is very eﬀective (τ is big) so that strain 2 is not preferred by the 
presence of the vaccination. If p < (1 − 1/R1), strain 1 persists. Otherwise, it 
dies out. Overall, vaccination is eﬀective to strain 1 in this case. 
2. (R1 − 1) − σ(R2 − 1) > 0 and (R2 − 1) − σ(R − 1) > 0 
In this case both strains are endemic when there is no vaccination. This case 
only happens when σ2 < τ < σ since the intersection of the lines τR2 − σR1 = 0 
and (R1 − 1) − σ(R2 − 1) = 0 is not in the positive quadrant if τ < σ2 . By the 
assumption that τ < σ, we have R2 > R1. The bifurcation diagram is shown in 
(See Figure 4-5). If p is small (p < [(R1 − 1) − σ(R2 − 1)]/(R1 − στR2)), both 
strains coexist. If [(R1 − 1) − σ(R2 − 1)]/(R1 − στR2) < p < (1 − 1/R2)/τ , strain 
1 is driven out. If p > (1 − 1/R)2)/τ , we can eradicate the disease. 
3. (R1 − 1) − σ(R2 − 1) < 0 and (R2 − 1) − σ(R − 1) > 0 
Without vaccination, only strain 2 persists. The bifurcation diagrams are shown 
in Figure 4-6. Strain 2 is better than strain 1 both with and without vaccination. 
The disease can be driven out by eradicating strain 2. So, if p > (1 − 1/R2)/τ , 
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Figure 4-4: Bifurcation diagrams with a bifurcation parameter p for case 1; (a) strain 
2 is dominant (b) strain 1 is dominant 
Figure 4-5: Bifurcation diagrams with a bifurcation parameter p for case 2
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Figure 4-6: Bifurcation diagrams with a bifurcation parameter p for case 3 where strain 
2 is dominant 
strain 2 is extinct, otherwise it is endemic. 
4.1.4 Numerical studies 
An average lifetime of human (1/µ0) is approximately 70 years. Infectious period of 
inﬂuenza 1/ν0 is around 7 days. Both of these parameters are ﬁxed in all of the simula­
tions. We simulate the models without nondimensionalisation so that the simulations 
give us the number of infected individuals not the fraction of them. Because there 
are many cases according to the study of bifurcations, we only show some numerical 
results from the isolation model (4.1.3) when the parameters of inﬂuenza strains are 
corresponding to case 2. 
We choose to show the numerical results of case 2 when R1 > R2 from the bifurcation 
analysis in section 4.1.3. If R1 = 3.5, R2 = 3, and σ = 0.75, both strains coexist when 
θ < 0.3333; only strain 1 persists when 0.3333 < θ < 0.7143; and both strains die out 
when θ > 0.7143. Figure 4-7(a) shows the numerical result when θ = 0.2, so we have 
the coexistence of the strains. In Figure 4-7(b), θ = 0.5, strain 2 is driven out by strain 
1. In Figure 4-7(c), we have θ = 0.85, so both strains die out from the host population. 
In addition, we assume that the delay in isolation occurs for one month. Instead of 
starting the isolation at the beginning (t = 0), we introduce it one month later and 
compare it with the situation that the delay does not occur. We run the simulation 
with θ = 0 until one month and then continue running it but with θ = 0.5 after that 
and compare it with the result that we run the simulation with θ = 0.5 constantly 
from the beginning. The sample case that we further study here is from the previous 
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Figure 4-7: Numerical result when isolation is launched; (a) Coexistence of the two 
strains occurs (b) Only strain 1 is endemic (c) The disease dies out 
result (See Figure 4-7(b)) where strain 1 is endemic and when R1 = 3.5, R2 = 3, and 
σ = 0.75. The simulations were run until t = 5000 in years but we only choose to 
show the results in some time intervals that the diﬀerence between the models are 
distinguished because the models are synchronized when time becomes very large. By 
starting with the same number of infectious individuals, we simulate the model in the 
situation that we have the delay in isolation to compare it with the situation that we 
start isolation at the beginning of the disease (See Figure 4-8). In Figure 4-8(a), we 
show the number of infectious individuals to strain 1 at the beginning of the disease. 
We can see that with the delay in isolation a high jump appears (or an outbreak) while 
the model without the delay produces the lower jumps. The high jumps continually 
appears but with the lower height when time increases (See Figure 4-8(b)) and ﬁnally 
the number of infectious diseases in both cases tends to i11qN . For strain 2, it dies out 
quickly in the absence of isolation delay while it leads to one outbreak (a high jump) 
and then dies out in the presence of isolation delay (See Figure 4-8(c)). From the 
result, we conclude that the delay in isolation leads to serious outbreaks. 
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Figure 4-8: Numerical result when a delay in isolation occurs: (a) The dynamics of 
strain 1 at the onset of the disease: (b) The dynamics of strain 1 when t ∈ [40, 200] (c) 
The dynamics of strain 2 
4.1.5 Comparisons of the models 
The basic reproductive ratios 
We only show the comparison of R2, R2q, and R2p. The comparison of R1, R1q, and 
R1p can be studied in the similar way. Without intervention, the reproductive ratio of 
strain 2 is 
β2N 
R2 = (µ0 + ν0) 
We can write the isolation basic reproductive ratio and the vaccination basic reproduc­
tive ratio of strain 2 in terms of R2 and other parameters as follows 
R2q = (1 − θ)R2 and R2p = (1 − pτ)R2 
where θ = q0/(µ0 + ν0 + q0). These two reproductive ratios are not only depended 
on R2 but also rate of isolation or the fraction of vaccination. By comparing R2q and 
R2p with R2, we obviously see that for strain 2 to be able to invade the population 
in the presence of isolation and vaccination (R2q > 1, R2p > 1) it needs to be highly 
transmitted or to have a larger basic reproductive ratio than one without intervention. 
We show the critical values of the rate of isolation and the fraction of vaccination in 
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Figure 4-9: The critical rate of isolation and the critical value of the vaccine coverage 
(a) q0 = (µ0 + ν0)(R2 − 1) (b) p = (1 − 1/R2)/τ 
Figure 4-9. 
We further study the comparison via a ﬁxed R1 and a varied R2 of each strategy by 
considering the number of infected individuals. If R1 = 3.2, R2 = 3.5, σ = 0.8, and 
τ = 0.75, the set of parameters are corresponding to Case 2 when R2 > R1 in the 
bifurcation analysis for the model with isolation and Case 2 in the bifurcation analysis 
for the model with vaccination. With isolation, the critical value of q0 where there is a 
change of steady states between the coexistent steady state and the single-strain steady 
cstate of strain 2 is q which is approximately 52.2. If q0 < qc, coexistence of two strains 0 0
occurs. On the other hand, if q0 > qc, only strain 2 can persists. With vaccination, the 0
critical value of vaccination, pc, is approximately 0.182. If p < pc, there is coexistence 
of the strains. If not, strain 2 is endemic. We introduced both critical values so as to 
ensure that at some values of R2 we can ﬁnd q0 and p that either both strains coexist 
or only strain 2 persists. In order to compare the diﬀerence between the strategies by 
the number of infected individuals we choose q0 and p close to the critical value and 
plot the corresponding steady states when R2 is varied. 
First we choose q0 = 52.0 while p = 0.18 (See Figure 4-10(a)). These two numbers 
roughly represent the ﬁnal attempt before strain 1 is driven out from the host popula­
tion when R2 = 3.5. At R2 = 3.5 in the graph, we see that the number of infecteds at 
the steady state resulting from isolation is smaller than ones resulting from vaccination 
and without intervention. Hence, isolation is an eﬃcient way to control the disease 
when R1 = 3.2, R2 = 3.5, σ = 0.8, and τ = 0.75 by comparing the number of infected 
individuals to both strains. By ﬁxing R1, q0, p and varying R2, isolation is still an 
eﬃcient way to control the disease in long term. 
Second, we choose q0 = 52.2 while p = 0.19 (See Figure 4-10(b)). The two numbers 
estimate the initial controls that can be used to drive out strain 1 from the host popula­
tion. At R2 = 3.5, isolation is the better way to control the disease. By varying R2 and 
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comparing the number of infected individuals to strain 2, when the basic reproductive 
ratio of strain 2 becomes big (> 7), vaccination becomes the better way to control the 
disease. 
The mean age of infection 
We only study the mean age of infection to strain 1 here. The mean age of infection to 
strain 2 can be studied in the similar way. We separate the mean age of infection for 
each strategy into two cases: 
1. in the absence of strain 2 
2. in the presence of strain 2 
First, without intervention and in the absence of strain 2, the mean age of infection to 
strain 1 is 
1 1 
A1 = = . 
β1I1 µ0(R1 − 1)1 
In the presence of strain 2, the mean age of infection to strain 1 is 
1 (1 − σ2)
A2 = = . 
β1I∗ µ0((R1 − 1) − σ(R2 − 1))1 
By considering the ratio of A1 and A2, we have 
A2 (1 − σ2)= 
A1 1 − σ(R2 − 1)/(R1 − 1) 
In case R1 − 1 < σ(R2 − 1), coexistence does not occur because strain 2 is dominant, so 
the host’s mean age of infection is the mean age of infection to strain 2. If σ(R2 − 1) < 
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Figure 4-11: The mean age of infection to strain 1 when R2 = 3.5 and σ = 0.8 
R1 − 1 < (R2 − 1)/σ then A2/A1 > 1. The mean age of infection to strain 1 is 
determined by A2 which is when strain 2 is present. Since coexistence occurs in this 
case, the host’s mean age of infection is the minimum of the mean age of infection 
to strain 1 and the mean age of infection to strain 2. By comparing A1 and A2, we 
conclude that coexistence with strain 2 increases the mean age of infection to strain 1. 
In case R1 − 1 > (R2 − 1)/σ, strain 1 is dominant and outcompetes strain 2 from the 
population so that the host’s mean age of infection is the mean age of infection to strain 
1. We remark here that all the conditions that we consider here result from the stability 
conditions. The mean age of infection to strain 1 in the absence of intervention when 
R2 = 3.5 and σ = 0.8 is shown in Figure 4-11. It can be seen that when R1 < 4.125 
strain 2 coexists with strain 1 so the host’s mean age of infection is described by A2 
and when R1 > 4.125 only strain 1 persists so the host’s mean age is described by A1. 
Second, with isolation, the mean age of infection to strain 1 in the absence of strain 2 
is as follows 
1 1 
A1q = = . 
β1I1
1 
q µ0(R1 − 1 − q0/(µ0 + ν0))
By comparing it with A1 we obviously obtain A1q > A1. The mean age of infection to 
strain 1 in the presence of strain 2 is 
1 (1 − σ2)
A2q = = . 
β1I1
∗ 
q µ0((R1 − 1) − σ(R2 − 1) − q0(1 − σ)/(µ0 + ν0))
Clearly, by comparing it with A2, we have A2q > A2. Therefore, isolation helps to 
increase the mean age of infection. The ratio of A1q and A2q is 
A2q (1 − σ2)= . 
A1q 1 − σ(R2 − 1 − q0/(µ0 + ν0))/(R1 − 1 − q0/(µ0 + ν0))
122
 
Coexistence of the strains cannot occur and only strain 2 is endemic when R1 − 1 − 
q0/(µ0 + ν0) < σ(R2 − 1 − q0/(µ0 + ν0)) so that the mean age of infection to strain 1 
does not exist. In case σ(R2 − 1 − q0/(µ0 + ν0)) < R1 − 1 − q0/(µ0 + ν0) < (R2 − 1 − 
q0/(µ0 + ν0))/σ, both strains coexist and we also have A2q/A1q > 1. The mean age of 
infection to strain 1 is A2q. Furthermore, by comparing A1q and A2q we conclude that 
coexistence with the other strain increases the mean age of infection to strain 1. In 
case R1 − 1 − q0/(µ0 + ν0) > (R2 − 1 − q0/(µ0 + ν0))/σ, only strain 1 persists so that 
the host mean age of infection is A1q. 
Third, with vaccination, the mean age of infection to strain 1 in the absence of strain 
2 is 
1 1 
A1p = = . 
β1I1
1 
p µ0((1 − p)R1 − 1)
Obviously, by comparing it with A1, we have A1p > A1. So, in the absence of strain 2, 
the vaccination helps to delay the mean age of infection to strain 1. In the presence of 
strain 2 and vaccination, the mean age of infection to strain 1 is 
1 (1 − σ2)
A2p = = . 
β1I1
∗ 
p µ0(R1 − 1 − σ(R2 − 1) − p(R1 − στR2))
In case R2/R1 < 1/στ , we have A2p > A2 which implies that the mean age of infection 
to strain 1 when two strains are co-circulating is increased by vaccination. Considering 
the ratio of A1p and A2p, we have 
A2p (1 − σ2)= . 
A1p 1 − σ[(1 − pτ)R2 − 1]/[(1 − p)R1 − 1]
Since strain 2 is dominant if (1 − p)R1 − 1 < σ((1 − pτ )R2 − 1), we do not have 
the mean age of infection to strain 1 in this case. Whenever σ((1 − pτ)R2 − 1) < 
(1 − p)R1 − 1 < ((1 − pτ)R2 − 1)/σ, both strains coexist and A2p > A1p. Hence, 
the mean age of infection to strain 1 is increased by the presence of strain 2. Lastly, 
if (1 − p)R1 − 1 > ((1 − pτ )R2 − 1)/σ, strain 1 persists and the host’s mean age of 
infection is A1p. 
By ﬁxing the basic reproductive ratio of strain 2, R2 = 3.5, σ = 0.8, τ = 0.75 and by 
assuming that p = 0.5 and q = 84 so that p > q0/((µ0 + ν0)R1)(See Figure 4-12(a)), 
we have max{1 + (R2 − 1)/σ, 1 + (R2 − 1)/σ − (1/σ − 1)q0/(µ0 + ν0), 1 + (R2 − 1)/σ + 
p(1 − τ)(R2 − (1 − σ)/(1 − τ))/(σ(1 − p))} = 1 + (R2 − 1)/σ + p(1 − τ)(R2 − (1 − 
σ)/(1 − τ))/(σ(1 − p)) = 4.9688. If R1 is higher than this, it guarantees that the host’s 
mean age of infection is A1, A1q, or A1p corresponding to the case without intervention, 
with isolation, or with vaccination respectively. Consequently, we can compare the 
host mean age of infection from each strategy. From Figure 4-12(b), vaccination and 
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Figure 4-12: (a) The relation of q, p and R1 that desires whether vaccination or isolation 
is better for the host’s mean age (b) The comparison of A1, A1q, and A1p 
isolation extends the host’s mean age of infection comparing with the system without 
intervention. Note that by considering the area in Figure 4-12(a), vaccination is chosen 
to be the better strategy to control the disease so that A1p > A1q. The comparison of 
A2, A2q, and A2p can be studied in a similar way. 
In summary, isolation and vaccination help to increase the host’s mean age of infection 
to the strain. In the same way, coexistence with the other strain also increases the 
host’s mean age of infection. However, without cross-immunity this does not happen. 
4.1.6 Rate of invasion of the novel strain 
In this section instead of assuming that we have two strains of inﬂuenza co-circulating 
in the host population to study the long-term dynamics, we consider the situation that 
strain 1 is endemic ﬁrst in the presence of isolation, vaccination or in the absence of 
them and strain 2 is absent. Strain 1 is assumed to be at the single-strain steady state 
of strain 1. The invasion dynamics of strain 2 at the beginning in each strategy can be 
approximated by linearisation about a steady state as follows; 
1. Without intervention, I2 satisﬁes 
I � (t) = β2S2
1I2 − (µ0 + ν0)I22
Since I2 follows an exponential growth, 
(β2S2
1−(µ0+ν0))t kt I2(t) = C1e = C1e 
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where C1 is a positive constant and the invasion rate of strain 2 is 
(µ0 + ν0)((R2 − 1) − σ(R1 − 1))
k = 
(1 + σ(R1 − 1)) 
2. With isolation,
 
I2
� (t) = β2S2
1 
qI2 − (µ0 + ν0 + q0)I2
 
so 
(β2S2
1 
q −(µ0+ν0+q0))t kq tI2(t) = C2e = C2e 
where C2 is a positive constant and the invasion rate of strain 2 in the presence 
of isolation is 
(µ0 + ν0 + q0)(R2q − 1 − σ(R1q − 1))
kq = (1 + σ(R1q − 1)) 
3. With vaccination,
 
I2
� (t) = β2S2
1 
pI2 − (µ0 + ν0)I2
 
Since I2 follows an exponential growth, we obtain 
(β2S2
1 
p −(µ0+ν0))t kptI2(t) = C3e = C3e 
where C3 is a positive constant and the invasion rate of strain 2 in the presence 
of vaccination is 
(µ0 + ν0)(R2p − 1 − σ(R1p − 1))
kp = .1 + σ(R1p − 1) 
Since the rate of invasion of strain 2 (k, kq, or kp) is a linear function of R2, by ﬁxing R1 
and varying R2 we can compare k, kq, or kp by considering the intersection of R2 and 
k, kq, or kp when these three are zeros and the slopes of the lines. We deﬁne the value 
of R2 that k = 0, kq = 0, or kp = 0 as R2k, R2kq, and R2kp respectively. Also the slopes 
of the lines k(R2), kq(R2), and kp(R2) are deﬁned as m, mq, and mp. First, if k = 0, we 
have R2 = R2k = 1+σ(R1 −1). The slope of k, m, is (µ0 +ν0)/(1+σ(R1 −1)). Second, 
q0if kq = 0, we obtain R2 = R2kq = 1+ σ(R1 − 1) + (1 − σ) . The slope of kq, mq, is (µ0+ν0) 
(µ0 +ν0)/(1+σ(R1 −1)−σq0R1/(µ0 +ν0 +q0)). We obviously see that R2kq > R2k and 
mq > m. Hence, the rate of invasion of strain 2 in the presence of isolation is smaller 
than one without any intervention when R2 < R∗ where R∗ is the value of R2 that k2 2 
and kq intersect. Above this value, kq > k. In words, after some value of R2, isolation 
starts to facilitate strain 2 to invade with the higher rate than without intervention. 
Third, if kp = 0, we have R2 = R2kp = 1+σ(R1 −1)+ (1−σ)τp−σ(1−τ)pR1 . The tangent of (1−pτ ) 
the line kp, is (µ0 +ν0)/(1+σ(R1 −1)+[(1−σ)τp−σ(1−τ)pR1]/(1−pτ )). Since strain 
1 is assumed to be endemic in the population before strain 2 is introduced, R1 > 1. 
Also, according to what we assume that the cross-immunity induced by infection is 
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Figure 4-13: The invasion of strain 2 when R1 = 3.2 
always better than the cross-immunity induced by the vaccination, σ > τ . By these 
two assumptions we can prove that 
(1 − σ)τp − σ(1 − τ )pR1 
< 0.
(1 − pτ) 
So, R2kp < R2k and m < mp which implies that the two lines k and kp never intersect 
and xp > x, in the positive quadrant. Hence, vaccination targeted to strain 1 helps 
strain 2 to invade the host population with the faster rate. Note that in case τ = 1, 
a vaccine gives protection against both strains, there are some values of R2 that the 
invasion rate of strain 2 in the presence of vaccination is smaller than one without 
intervention. Other than that, it is larger than the invasion rate of strain 2 when there 
is no intervention. An example of invasion rate of strain 2 in each strategy when R1 is 
3.2 is shown in Figure 4-13. 
In conclusion, if strain 1 is endemic in the population ﬁrst, at some value of the basic 
reproductive ratio of a new strain, isolation reduces the rate of invasion of the new 
strain. Above that, it increases the invasion rate of the new strain. By assumption 
that a vaccine is against strain 1 but it might give cross-protection to the new strain, 
the new strain invades a population with a higher rate of invasion than one without 
intervention. By comparing the numbers of susceptible individuals to strain 2 when 
only strain 1 is endemic in the population in all three cases (S2
1, S2
1 
q, S2
1 
p), we can see 
that S2
1 
q > S2
1 and S2
1 
p > S2
1 . So it can be concluded that isolation and vaccination 
increase the number of susceptible individuals of the new strain so that the rate of 
invasion of the new strain when the intervention is present is higher than one without 
it. However, in isolation, when R2 < R1, isolation is eﬀective to the new strain. 
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4.1.7 Economic points of view 
We ﬁrst study the cost of isolation and vaccination that can be used to eradicate the 
disease. Second we include the cost from infection to compare the loss from each 
strategy. 
The cost of isolation during the time interval [0, T ∗] is C1 
�
0 
T ∗ 
Qdt where C1 is the 
cost of isolation per individual per year. We estimate the isolation cost (£3660 per 
week) as the summation of the hospitalisation cost, the extra fee of intensive cares 
from the consultation, the after-hours visits(Scuﬀham and West (2002); we use £1 = 
e1.15 as an exchange rate), and the average income lost in a week (≈£479). So, C1 is 
approximately £190,320 per year. From the equation 
Q�(t) = q0(I1(t) + I2(t)) − κ0Q(t), 
we integrate both sides of the equation to obtain � T ∗ � T ∗ 
Qdt = [q0 (I1 + I2)dt − (Q(T ∗) − Q(0))]/κ0. 
0 0 
The cost of vaccination during the time interval [0, T ∗] is C2µpNT ∗ where C2 is the 
cost of vaccination per individual. The cost of vaccination (£10) is approximated by 
the summation of a vaccine price and an administering cost (Scuﬀham and West, 2002). 
We assume that R1 = 3.2, R2 = 3.5, σ = 0.8, κ0 = 365/7, τ = 0.75, this set of pa­
rameters is corresponding to case II of the bifurcation analysis part in both isola­
tion and vaccination. Consequently, to control the disease by isolation we must have 
θ > 1−1/R2 ≈ 0.71 (or q0 > 130.4). In the vaccination case, if p > (1−1/R2)/τ ≈ 0.95, 
we can control the disease. This vaccine coverage might not be able to exceed in real 
which implies that we cannot eliminate the disease from the population. However, 
we show the numerical result of the successful case here. We choose θ = 0.72 and 
p = 0.96 as the initial control values that both strategies can be used to control the 
disease to compare the cost between two strategies. From the numerical results, the 
disease dies out within 1 year in both strategies so we calculate the cost of isolation 
and vaccination within 1 year. We start the simulations with the same initial condi­
tions (S1(0) = 9000000, I1(0) = 1000, S2(0) = 9000000, I2(0) = 1500, Q(0) = 0, V (0) = 
0, and N(t) = 10000000). Since we solve the system (4.1.2), (4.1.4), and (4.1.8) by 
MATLAB which uses Runge-Kutta’s method to solve the diﬀerential equations, we 
know the values of S1, I1, S2, I2, Q, and V at some values of t so to estimate the inte­
gration of those values we use the composite trapezoidal rule with diﬀerent step sizes. 
From the simulation, the cost of isolation within 1 year is £18,270,720 and the cost of 
vaccination is £1,371,428. Hence, without concerning with the cost from being sick, 
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vaccination is cheaper. 
Next, we introduce the cost from being sick C3 (£3530 per week or £183,560 per year) 
which is approximated by the summation of the hospitalisation cost and the weekly 
income. With including the cost of being sick, the number of infected individuals 
(I1 + I2) is concerned. Without intervention, the government lose £3.22e+10. With 
isolation, the government needs to pay £17,621,760 for the sickness of infected individ­
uals and £18,270,720 from launching isolation programme so £35,892,480 in total. For 
vaccination programme, it costs the government £3.2188e+10 from citizens being sick 
and £1,371,428 from launching the vaccination programme so £3.2189e+10 in total. 
Therefore, with the sickness cost being included, the isolation is the better choice for 
controlling the disease. However, isolation depends on identifying infectious individu­
als which the symptoms can be ambiguous. In our case q0 is 134.12 (θ = 0.72) which 
means that it takes less than 3 days (365 ∗ (1/q0)) to identify the disease and remove 
the infected individuals to an isolation class. By considering the cost from applying 
the vaccination programme with the cost from being sick of infected individuals when 
there is no intervention, they are very high and close. However, the cost of sickness in 
the future is not included when there is no intervention so that the disease is endemic. 
All in all, without considering the sickness cost, vaccination is a cheaper strategy com­
paring with isolation. With the sickness cost, isolation is cheaper. However, isolation 
needs to be under the condition that detecting and removing an infectious individual 
is very eﬃcient. Furthermore, from the result, we recommend the government to use 
either one of the strategies to control the disease so as to reduce the loss in the future. 
4.1.8 Combination of isolation and vaccination 
In case isolation and vaccination are launched together, the model that describes the 
two circulating strains in the host population becomes 
S� (t) = µ0(1 − p)N − µ0S1 − β1S1I1 − σβ2S1I2,1
I � (t) = β1S1I1 − (ν0 + µ0 + q0)I1,1
S� (t) = µ0(1 − pτ )N − µ0S2 − β2S2I2 − σβ1S2I1, (4.1.23)2
I � (t) = β2S2I2 − (ν0 + µ0 + q0)I22

Q�(t) = q0(I1 + I2) − κ0Q.
 
The dynamic of the variable Q does not aﬀect the dynamics of other variables, so 
the diﬀerential equation of Q can be disregarded from the system. We introduce the 
isolation-vaccination basic reproductive ratios of both strains here which are 
R1pq = (1 − p)R1q = (1 − p)(1 − θ)R1 and R2pq = (1 − pτ )R2q = (1 − pτ)(1 − θ)R2. 
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Figure 4-14: (a) p = 0, θ = 0.2 (b) p = 0.86, θ = 0.2 (c) p = 0.86, θ = 0 
By comparing the basic reproductive ratios of each strategy, we obviously see that 
launching two strategies at the same time is more eﬀective than launching only one of 
them or none of them. We simulate the model (4.1.23) so as to study the number of 
infectious individuals numerically. By assuming that R1 = 3.2, R2 = 3.5, σ = 0.8, τ = 
0.75 and θ = 0.2 (q0 ≈ 13), both strains coexist if vaccination is not launched and both 
strains die out when 0.86 of newborns are vaccinated constantly(See Figure 4-14(a) 
and (b) respectively). In case the isolation is not applied (q0 = 0), at the same vaccine 
coverage (p = 0.86), strain 2 is endemic in the host population (See Figure 4-14(c)) 
and to eradicate it from the host population we need a very high vaccine coverage 
(p > 0.9524). 
In conclusion, controlling the disease is more eﬀective by applying two strategies, iso­
lation and vaccination, together. 
4.1.9 Conclusion and discussion 
Firstly, we introduce three diﬀerent models: (1) the model for two co-circulating strains 
in the absence of intervention, (2) the model with the presence of isolation, and (3) the 
model with the presence of vaccination. The ﬁrst model is based on the status-based 
model by Gog and Grenfell (2002) while in the second and third models we introduce 
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isolation and vaccination into them.
 
Secondly, in each model we determine the steady states and their stability conditions. 
Since all the steady states and the conditions are explicit, we can study the bifurcation 
by drawing the bifurcation diagrams from them. Only transcritical bifurcations occur 
in our case. Because there are many parameters concerning with the conditions, we 
separate them into cases according when there is no intervention. By considering the 
characteristics of strains via their basic reproductive ratios, cross-immunity between 
them, and a value of a bifurcation parameter which is θ (relating to the isolation rate) 
in isolation and p (a vaccine coverage) in vaccination, we propose the conditions that 
help us to predict the long-term dynamics of the strains whether both strains coexist, 
either one of them persists, or the disease dies out. 
Thirdly, we use the numerical simulations to illustrate some of the results from the 
bifurcation part. Some set of parameters for inﬂuenza are used. In addition, we intro­
duce a delay in isolation. By comparing with the result without delay in it, we have 
found that the delay leads to high jumps of the number of infectious individuals which 
represent serious outbreaks. 
Fourthly, we compare epidemic quantities such as a basic reproductive ratio, a mean age 
of infection, an invasion rate of a new strain and an economic cost in each strategy. By 
considering the basic reproductive ratio of each strategy, to invade the host population 
in the presence of isolation and vaccination, each strain needs to be more transmitted 
than when there is no intervention. We also compare the basic reproductive ratio from 
each strategy with the number of infectious individuals numerically. 
We study the mean age of infection to strain 1 when either strain 2 is absent or present 
in each strategy. We show that the host’s mean age of infection to strain 1 is extended 
(so hosts are unlikely to get infected) by isolation, vaccination, or coexistence with the 
other strain. 
By assuming that strain 1 is endemic in the host population ﬁrst, we can study the 
invasion rate of a new strain which is strain 2 in this case. We have found that isolation 
can either reduce the invasion rate of the new strain or support it. It depends on the 
basic reproductive ratio of the novel strain or how highly transmitted of the strain. By 
assumption that a vaccine is against strain 1 but it might give cross-immunity to strain 
2, it leads to the higher rate of invasion of the new strain comparing with the situation 
that no intervention is applied. Hence, the new strain with higher transmission rate is 
more preferred in the presence of isolation or vaccination. 
In term of economics, we study the cost from launching isolation or vaccination pro­
gramme. Without considering the sickness cost of infectious individuals, vaccination is 
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an economical way to control inﬂuenza. With the sickness cost of infectious individu­
als, isolation is an economical way. However, isolation needs to be under the eﬀective 
detecting and removing infectious individuals to quarantine. The study also suggests 
that launching either strategy is better than preventing nothing. 
Finally, we combine two strategies in the model and study it numerically. It shows that 
controlling inﬂuenza by launching both strategies at the same time is very eﬃcient. The 
model might be further used to study the trade-oﬀ between isolation and vaccination 
when the cost of interventions is restricted. Also, optimal control can be further studied. 
All in all, we hope that this work might beneﬁt the public heath and us to understand 
the dynamics of inﬂuenza when a control strategy is applied and to know more about 
the advantages and the disadvantages of the strategy. 
4.2 An inﬂuenza model with optimal vaccination strategy 
When the number of strains of a pathogen increases, many multi-strain models become 
diﬃcult to analyse. As an alternative approach to this problem, a waning immunity 
of a host with time is considered. Since vaccination plays an important role to control 
many diseases, in this work we extend the SIRC (susceptible-infected-recovered-cross­
immune) model, where C represents a compartment for the cross-immune individuals 
who are intermediate between S and R compartments, by introducing a new com­
partment which represents individuals with perfect immunity including ones who are 
vaccinated. We use this new compartment, P , instead of the compartment R from the 
previous model. Then we study the dynamics of the system in order to ﬁnd the ways 
to eradicate the disease. We propose the threshold of eradicating the disease when the 
vaccination rate is constant with time. We then study the optimal control of vaccina­
tion where the vaccination rate depends on time in minimizing the treatment cost of 
inﬂuenza. 
Various multi-strain models for inﬂuenza have been formulated (Andreasen et al., 1997; 
Lin et al., 1999; Gog and Swinton, 2002; Gog and Grenfell, 2002). Many of them are 
diﬃcult to analyze when the number n of strains increases. In this work, we study an 
alternative method to model inﬂuenza by considering waning of immunity with time 
and partial protection according to the change of circulating strains in the same cluster. 
Gupta et al. (1996, 1998) introduced the concept of a cluster of strains and described 
it as a collection of independently transmitted strains with nonoverlapping repertoires 
of dominant polymorphic determinants that organize themselves. Some experimental 
results (Gill and Murphy, 1977; Potter et al., 1977) showed that reinfection of recovered 
individuals from inﬂuenza linearly increases with time from the last infection. Hence 
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the SIRS model might not be suitable for studying inﬂuenza. To solve this problem, 
Gomes et al. (2004, 2005) combined temporary and partial immune protections so that 
individuals do not fall into extreme categories of host immune response. Alternatively, 
Casagrandi et al. (2006) introduced a new compartment for cross-immune individuals, 
C, to model a multi-strain disease like inﬂuenza, where immunity of hosts in this 
compartment can be boosted by infecting with new strains in the same cluster as the 
currently infecting strain. This paper is based on the latter work. We extend the SIRC 
model to study dynamical behaviours when vaccination is present. 
Vaccination is one of the control strategies that are used to control inﬂuenza. The 
vaccination programme is set with an aim to reduce the prevalence of the disease and 
if possible eradicate it. The vaccines trigger the host immune system to respond and 
produce antibodies against the viral strains in them. They are chosen to protect indi­
viduals from strains that are most dangerous and are likely to invade the population. 
Highly changing the molecules on the inﬂuenza viral surface leads to the failure of vac­
cination. Mathematical models have been used to study the impact of the vaccination 
programmes (Gomes et al., 2004; Alexander et al., 2004; Restif and Grenfell, 2006b; 
Raimundo et al., 2007; Gandon and Day, 2007; Martcheva et al., 2008; Billings et al., 
2008). Their goal is to help us to understand the dynamics of inﬂuenza and other 
multiple-strain diseases in the presence of vaccination and to determine eﬃcient ways 
to control them. Likewise, the goal of this work is to try to ﬁnd the way to control in­
ﬂuenza by introducing vaccination to the SIRC model (Casagrandi et al., 2006), which 
is an alternative model for studying multi-strain diseases like inﬂuenza. 
Inﬂuenza virus is divided into subtypes based on the major diﬀerences of the two 
protein molecules on its surface. In each subtype, the virus gradually and continually 
mutates to create new strains and with the host immune selection some strains gather 
together and form a cluster. Our model is based on the SIRC model (Casagrandi et al., 
2006) which is used for explaining the inﬂuenza strains generated by the drift process 
in a human population. Hosts become cross-immune when their immune memories are 
challenged by the new variants that mutate from the strains in the same cluster. So 
they either become infected again or regain perfect immunity. The total loss of host 
immunity is assumed to be by the change of a circulating cluster. 
˜In our model, a host population, N , is divided into four subpopulations subject to a 
currently dominant cluster: susceptible ( S˜), infected (I˜), perfectly immune ( P˜ ), and 
cross-immune ( C˜). 
Susceptible individuals are recruited to the population either by birth or immigration 
and by loss of partial immunity to the incoming strain. The population is diminished 
by infection, vaccination, and natural death or emigration. 
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Figure 4-15: A ﬂow diagram of the SIPC model 
The infected population is increased by infection of susceptibles and reinfection of some 
individuals with partial cross-immunity to the new dominant strain and it is reduced 
by recovery and natural death. 
The infected individuals enter the perfectly immune compartment by recovery. Since 
reinfection with other similar strains of pathogens boosts immunity, some individuals 
in the cross-immune state regain their total immunity so they consequently reenter 
the perfectly immune compartment. Since we cannot clinically distinguish between 
susceptible and perfectly immune or cross-immune individuals easily, we assume that 
vaccines are given to individuals in all three compartments. Immunity will be boosted 
by the vaccines if individuals are in the cross-immune compartment so that they become 
totally immune to the pathogen again, but nothing will happen to perfectly immune 
individuals because they still have perfect immunity to the disease so that the vac­
cination has no eﬀect on it. The population in the perfectly immune compartment 
decreases by the emerging of the new strain created by the drift process and sharing 
the same cluster with the previous strain or by natural death. 
The movement into the cross-immune compartment is by the loss of immunity to the 
new strain that has emerged. The movement out is by reinfection with the currently 
circulating strain, having no immunity to the current strain because of the diﬀerence 
between it and the previously infecting strain, vaccination, or natural death. 
The ﬂow diagram of the model is shown in Figure 4-15. The description of the param­
eters can be found in table 4.1. In the model, an average lifetime of human, 1/µ0, is 
approximately 70 years. Infectious period of inﬂuenza, 1/α0 is around 7 days. Since 
strains can be grouped as a cluster and the new dominant cluster is estimated to ap­
pear in every 1-2 year (Hay et al., 2001) and persists between 2 and 5 years (Cox and 
133
 
Table 4.1: Lists of parameters for inﬂuenza
 
Parameter Description Value 
µ0 birth and death rate 1/70 
α0 rate of recovery 365/7 
δ0 rate of losing immunity of a recovered individual 1/1.5 
γ0 rate of losing immunity of a cross-immune individual 0.5 
σ probability of reinfection of a cross-immune individual (vary) 
R0 the basic reproductive ratio 3-5 
η0 vaccination rate (vary) 
Bender, 1995; Plotkin et al., 2002), we suppose 1/δ0 to be 1.5 years and 1/γ0 to be 
2 years respectively. The probability σ of reinfection of a cross-immune individual is 
assumed to be linearly dependent with time since last infection (Pease, 1987), so 
σ ≈ r(1/δ0 + 1/γ0) 
where r is approximately 0.026 (1/year). Note that when cross-immunity is absent, 
σ = 1, the SIPC model is equivalent to the SIPS model. The model takes the form 
S˜�(t) µ0(N˜ − S˜) − βS˜ ˜ ˜ ˜= I − η0S + γ0C,
 
I˜ �(t) = βS˜I˜ + σβ C˜I˜ − (µ0 + α0)I, ˜
 (4.2.1)˜ C ˜ ˜ ˜ ˜ ˜ ˜P �(t) = (1 − σ)β ˜I + α0I − (µ0 + δ0)P˜ + (η0P − η0P ) + η0S + η0C,
 
C˜ �(t) = δ0P˜ − βC˜I˜ − (µ0 + η0 + γ0)C. ˜

To simplify the equation, we introduce a set of new variables and parameters as follows 
βN µ0 δ0 η0
τ = (µ0 + α0)t, R0 = , µ = , δ = , η = ,(µ0 + α0) (µ0 + α0) (µ0 + α0) (µ0 + α0)
˜ ˜ ˜ ˜S I P C 
S = , I = , P = , C = ,˜ ˜ ˜ ˜N N N N 
where R0 is the basic reproductive ratio of the currently invading strain (Note that 
other authors might have it in term of the square root of this term, and then the 
system 4.2.1 becomes 
S�(τ ) = µ(1 − S) − R0SI − ηS + γC,
 
I �(τ) = R0SI + σR0CI − I,
 (4.2.2)
P �(τ ) = (1 − σ)R0CI + (1 − µ)I − (µ + δ)P + ηS + ηC, 
C �(τ) = δP − R0CI − (µ + η + γ)C. 
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We can substitute P = 1 − S − I − C to make the equation for P redundant. Therefore 
the system that we study from now on is 
S�(τ) = µ(1 − S) − R0SI − ηS + γC,
 
I �(τ ) = R0SI + σR0CI − I, (4.2.3)
 
C �(τ) = δ(1 − S − I − C) − R0CI − (µ + η + γ)C.
 
4.2.1 Analysis of the steady states 
Steady states 
By setting the RHS of (4.2.3) equal to zero, we have two kinds of steady states, the 
disease-free steady state and the disease-present steady state as follows 
1. The disease-free steady state � 
δγ + µ(µ + η + γ + δ) δη 
�
Po0 = (S0 , 0, C0) = , 0,
δγ + (µ + η)(µ + η + γ + δ) δγ + (µ + η)(µ + η + γ + δ) 
We introduce a new quantity here to be used analytically in ﬁnding the disease-
present steady state, 
Rv = R0(S0 + σC0). 
It will be mentioned in detail later in the stability analysis section. 
2. The disease-present steady state 
Po ∗ = (S ∗ , I ∗ , C ∗) 
where
 
1
 
S ∗ = − σC ∗ (4.2.4)
R0 
δ(R0 − 1 − R0I∗)
C ∗ = (4.2.5)
R0(R0I∗ + (µ + η + γ + (1 − σ)δ))
 
and I∗ satisﬁes the following equation
 
f(I ∗) = a(R0I ∗)2 + b(R0I ∗) + c = 0 (4.2.6) 
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Figure 4-16: The maximum values of I∗ from the polynomial f(I∗) are plotted when 
η0 is varying at various values of σ. 
where 
a = 1 + σδ,
 
b = (1 + σδ)(µ + η) + (µ + η + γ + δ) + δγ − (µ + σδ)R0,
 
c = [(µ + η)(µ + η + γ + δ) + δγ](1 − Rv).
 
If c is positive or Rv < 1, both of the roots have negative real parts in which we 
are not interested. If c is negative, we have one positive root and one negative 
root of I∗ . 
Figure 4-16 shows that when η0 is increased, c becomes smaller and so I∗ which 
is the largest root from the equation (4.2.6) is decreased to zero and becomes 
negative ﬁnally. It means that at some rates of vaccination we are able to eradicate 
the disease. Furthermore, the weaker the cross-immunity is, the higher is the rate 
of vaccination to be needed to eradicate the disease. 
Stability analysis 
We analyse the stability of the steady states by considering the signs of eigenvalues and 
by using Routh-Hurwitz criteria. From the system (4.2.3), the Jacobian matrix is 
J
 =
 
⎡ ⎢⎣
 −(µ + η + R0I) −R0I γ R0I R0S + σR0C − 1 σR0I 
⎤ ⎥⎦
 
−δ −(δ + R0C) −(µ + η + γ + δ + R0I) 
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At the disease-free steady state, the characteristic equation of the Jacobian matrix is 
(λ−(R0S0 +σR0C0 −1))(λ2 +((µ+η)+(µ+η+γ +δ))λ+(µ+η)(µ+η+γ +δ)+δγ) = 0. 
Since both roots of the second-order polynomial in the characteristic equation certainly 
have negative real parts, the stability of the disease-free steady state depends on the 
sign of the ﬁrst term. Therefore, the disease-free steady state is stable if and only if 
Rv = R0(S0 + σC0) < 1. 
Rv is the basic reproductive ratio of the disease when the vaccination is present and it 
is equal to R0 if there is no vaccination. 
At the disease-present steady state, we have the characteristic polynomial of order three 
as follows 
λ3 + a1λ2 + a2λ3 + a3 
where 
a1 = (µ + η + R0I ∗) + (µ + η + γ + δ + R0I ∗),
 
a2 = (µ + η + R0I ∗)(µ + η + γ + δ + R0I ∗) + δγ + σR0I ∗(δ + R0C ∗) + R20I 
∗ S ∗ ,
 
a3 = σR0I ∗(δ + R0C ∗)(µ + η + R0I ∗) + R0
2I ∗ S ∗(µ + η + γ + δ + R0I ∗) + γR0I ∗(δ + R0C ∗)
 
−σδR20I ∗ S ∗ . 
Obviously, if (S∗, I∗, C∗) is in the positive orthant, all the coeﬃcients of the polynomial 
are all positive (since σ ≤ 1) and by substituting 
γC ∗ = R0I ∗ S ∗ + ηS ∗ + µS ∗ − µ 
and canceling out all the similar terms we can prove that 
a1a2 > a3. 
On the other hand, if I∗ is negative or in other words (S∗, I∗, C∗) is not in the positive 
orthant, a3 is clearly negative. Therefore, by the Routh-Hurwitz criteria, the disease-
free steady state is stable if and only if it is in the positive orthant. 
4.2.2 Numerical Veriﬁcation 
The model (4.2.3) is analysed numerically to illustrate our study. Figure 4-17 illustrates 
the bifurcation diagram of the bifurcation parameter Rv and R0 with the proportion of 
infectious individuals. The transcritical bifurcation where two steady states exchange 
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Figure 4-17: The bifurcation diagrams between Rv and I and R0 and I when η0 = 0.4 
their stabilities occurs at Rv = 1 or R0 = 1/(S0 + σC0). Next, we explore the implica­
tion of variable vaccination rates. The bifurcation diagram between η0 and I∗ is shown 
in Figure 4-18. Let us deﬁne η∗ to be the value of η0 where the graph intersects the 0 
axis I∗ = 0. The point (η0∗ , 0) is a transcritical bifurcation point and η∗ is η∗(µ0 + α0)0 
where η∗ is the largest root of the polynomial 
η2 + ((µ + γ) + (1 − R0)µ + (1 − σR0)δ)η + (1 − R0)(µ(µ + γ + δ) + δγ). 
Inﬂuenza persists if the rate of vaccination is less than η∗ and dies out if it is greater 0 
than η0
∗ . Moreover, from the polynomial the larger R0 is, the higher is the rate of 
vaccination needed to eradicate the disease. 
By ﬁxing the values of parameter indicated in Table 4.1, the value of η∗ calculated from 0 
the second-order polynomial is approximately 0.54 and from the numerical simulation 
it is approximately 0.54 as well. Figure 4-19(a) shows the result when η0 = 0.25. In 
this case, the rate of vaccination is below our critical rate of vaccination (η∗) so the 0
inﬂuenza persists in the host population and the solutions tend to the disease-present 
steady state as time increases. On the other hand, if the rate of vaccination is large 
enough, η0 = 0.75, the solutions tend to the disease-free steady state in long term so 
the inﬂuenza ﬁnally dies out (See Figure 4-19(b)). 
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Figure 4-18: The bifurcation diagram between η0 and I(∞) when R0 = 3 
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Figure 4-19: (a) η0 = 0.25, R0 = 3, σ = 0.2 (b) η0 = 0.75, R0 = 3, σ = 0.2 
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4.2.3 Optimal Control 
In this section, we study the system (4.2.1) when the vaccination rate is allowed to 
vary with time (η0 = η0(t)) to minimize the cost of treatments from getting infected 
with inﬂuenza. 
We consider an optimal control to minimize an objective functional: � T D 
J(η0) = [AI˜(t) + η2(t)]dt2 0 0 
where A is the cost of treatments and the loss of income from inﬂuenza per individual 
per year. Our main goal is to minimize the total cost of treatments and the loss 
of income during T year of a population by introducing a vaccination control which 
varies with time. In general, the quadratic term of control in the objective functional 
is introduced for avoiding either the singularity of control or the bang-bang control 
(Lenhart and Workman, 2007). In here, for simplicity, we exclude the total cost of 
vaccination which represents by the linear control term that might lead to the bang-
bang control, so the quadratic term helps to prevent the singularity of control in our 
case. For the coeﬃcient D/2 of the quadratic term, we consider its explanation in 
two cases. First, D/2 is treated to be fairly small not to aﬀect the other cost but not 
too small so that they lead to the singularity. Hence, in this case, the objective of 
the use of the control is to minimize the treatment cost and the income loss. Second, 
D/2 represents the waste cost of seeking vaccinated individuals to vaccinate again. So 
the use of the control in the latter is for minimizing the total waste cost of income, 
treatments, and seeks for vaccinated individuals to vaccinate again. 
In mathematical speaking, the goal of this study is to ﬁnd an optimal control η∗ such 0 
that 
J(η ∗) = min {J(η0)},0 
Ω 
≤ ηmaxwhere Ω = {η0 ∈ L1(0, T )|η0min ≤ η0 0 } where L1 is the space of all Lebesgue 
integrable functions. We sequently arrange the variables ˜ I, ˜ C as the 1st-4th S, ˜ P , and ˜
state variables. By following the Pontryagin’s Maximum Principle (Pontryagin et al., 
1962), we introduce a Hamiltonian function for as follows 
4
D 
H = AI˜(t) + 
2 
η0
2(t) + 
� 
λigi 
i=1 
where λi is the adjoint variable corresponding to the state variable i and gi is the right 
hand side of the diﬀerential equation of the ith state variable. By the Pontryagin’s 
Maximum Principle, we arrive at the necessary conditions for the existence of an op­
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timal control η0 
∗ corresponding to the solutions of S˜∗ , I˜∗ , P˜ ∗ , and C˜∗, that they must 
satisfy the system (4.2.1), the adjoint and transversality conditions, and the optimality 
condition. The adjoint conditions for the minimization of the objective functional is as 
follows 
λ� 1(t) = λ1(µ0 + βI˜ + η0) − λ2βI˜ − λ3η0 
λ� (t) = −A + λ1βS˜ − λ2(βS˜ + σβ C˜ − (µ0 + α0)) − λ3((1 − σ)βC˜ + α0) + λ4βC˜2

λ� (t) = λ3(µ0 + δ0) − λ4δ0
3

λ� (t) = −λ1γ − λ2σβ I˜ − λ3((1 − σ)βI˜ + η0) + λ4(βI˜ + µ0 + γ0 + η0)
4
(4.2.7) 
Note that the adjoint conditions are derived from the Hamiltonian function 
∂H 
λ� j (t) = − ∂xj 
where xj is the jth state variable and j = 1, 2, . . . , 4. The transversality boundary 
conditions are assumed to be: 
λ1(T ) = λ2(T ) = λ3(T ) = λ4(T ) = 0. 
Since the control is bounded, the optimality condition can be found by considering 
∂H/∂η0 as follows � 
ηmax 
� 
ηmin 
�
λ1S˜ − λ3(S˜ + C˜) + λ4 ˜
��� 
η ∗(t) = min , max ,
C 
0 0 0 D 
The proof of necessary condition is omitted here. Further details can be found in 
(Pontryagin et al., 1962; Lenhart and Workman, 2007). 
Estimation of costs 
In the objective functional, A is the cost of being sick which is approximated by a 
summation of an income that an individual lose during being sick and a cost of treat­
ment. Because inﬂuenza has an infectious period around 7 days, the income loss of 
an individual is estimated by the average weekly income which is £479. The cost of 
inﬂuenza treatment is estimated as £80 per person per week (Reisinger et al., 2004; 
Burls et al., 2002). This is the basic treatment cost without including the cost of hos­
pitalisation. It is the cost of treating by treatments such as Oseltamivir or Zanamivir, 
a general practitioner visit, a prescription, and a test. Hence, the total cost of being 
sick is £559 per person per week so A is £29148 per person per year. We consider two 
explanations of a weight-cost factor D/2; (1) it is small enough not to aﬀect the other 
costs but not too small so that they lead to the bang-bang control (D/2 < 1) and so 
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Figure 4-20: (a) An optimal control of vaccination when R0 = 5, ηmax = 3.0, ηmin = 0.0,0 0 
A=29148, D=0.01 (b) The number of infectious individual corresponding with the 
optimal control 
we choose it equal to 0.01, or (2) D/2 represents a waste cost of seeking individuals 
who already vaccinated to vaccinate again. In the latter, it can be approximated by 
the cost of health care repeatedly making random phone calls to already-vaccinated 
people to persuade them to vaccinate again. So D/2 is pkN˜ where p is the probability 
of an individual who picks up the call is vaccinated already (≈ 0.1, for instance), k is 
the cost of each call including the staﬀ cost (≈£1). In the simulation, we assume that 
N˜ is 50,000. Hence D/2 can be approximated by £5,000. Since η0 represents rate of 
vaccination and we assume that the public health can manage to vaccinate the whole 
population within 4 months at maximum, ηmax = 3. The minimum rate of vaccination 0 
is set at 0. Also, we study the cost within 10 years and the basic reproductive ratio is 
ﬁxed at 5. Other parameters are ﬁxed as before. 
Numerical results of the optimal control 
The ODE problem is solved by the forward-backward sweep method and the Runge-
Kutta method of order 4. For the small value of D, by varying sigma, the vaccination 
control needs to be higher for eradicating inﬂuenza when σ is increased (see Figure 4­
20(a)). Furthermore, in Figure 4-20(b), the disease dies out quickly within 2 years 
and the number of infectious individuals increases when σ increases. In Figure 4-21(a), 
when D/2 represents the waste cost of phone calls to persuade vaccinated individuals 
to vaccinate again, the control strategy needs to be under higher measure when σ 
increases. Note that when σ is big enough (less cross-immunity), the optimal control is 
broken and the solution blows up in this case. Figure 4-21(b) shows that the number 
of infectious individual is increased when σ is increased. 
From both numerical results, we can conclude that no matter D/2 represents, cross-
immunity plays an important role in controlling inﬂuenza. When cross-immunity is 
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Figure 4-21: (a) An optimal control of vaccination when R0 = 5, ηmax=3.0, ηmin=0.0,0 0 
A=29148, D=10000 (b) The number of infectious individual corresponding with the 
optimal control 
low in individual (1 − σ is small), to minimize the treatment cost of the population by 
vaccination, public health needs a better control measure than when cross-immunity 
is high. Furthermore, the number of infectious individual is increased when cross-
immunity is low. 
4.2.4 Conclusion and discussion 
We propose the vaccination model that describes the dynamics of inﬂuenza. We have 
shown that vaccination can be used to eradicate the disease from the host population. 
By applying the parameter values for inﬂuenza virus, we can ﬁnd the critical vaccination 
rate (η∗) that the disease persists if the vaccination rate is below it and dies out if the 0
vaccination rate is above it. Furthermore, the lowest rate of vaccination that eradicates 
the disease is reduced if the cross-immunity is very strong, σ → 0. On the other hand, 
it is increased when the basic reproductive ratio of inﬂuenza becomes bigger (R0 >> 1). 
For example, inﬂuenza with the basic reproductive ratio equaling 3 and other parame­
ters corresponding with values in the table 4.1, if we apply vaccines to 75% of susceptible 
individuals per year, all of the inﬂuenza viruses in the same cluster will completely die 
out from the host population within 11 months. The more we vaccinate susceptibles 
the quicker the inﬂuenza dies out. However the eﬃcacy of vaccines need to be so high 
that the immunity acquired by them in susceptible hosts needs to be eﬀective as the 
immunity that recovery hosts gain after infection. Cox and Bender (1995) and Plotkin 
et al. (2002) demonstrated that a dominant cluster of virus sequences is tentatively 
replaced by another every 2-5 years and, by phylogenetic techniques, the next season’s 
inﬂuenza sequences can be eﬃciently predicted from the persistence of the circulating 
clusters. Hence, vaccines that match the dominant antigenic properties of circulating 
strains are possibly available. From our model, inﬂuenza can be eradicated at some 
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vaccination rates within the time that is less than the life span of the clusters. In 
summary, in terms of public heath, vaccination is one of the proﬁcient ways to prevent 
and reduce morbidity of humans from inﬂuenza. 
When the vaccination rate depends on time for minimizing the total treatment cost, 
we found that cross-immunity is an important key for the shape of the optimal control. 
The weaker of the cross-immunity is, the stronger of the vaccination control needs. The 
number of infectious individuals corresponding to the optimal control is higher, when 
cross-immunity is weak. 
In conclusion, from both studies either a control is constant or varying with time, 
cross-immunity plays an important role in controlling inﬂuenza. If the cross-immunity 
is weak, the better control strategy is needed than when it is strong. All in all, there 
are variable factors concerning with controlling inﬂuenza, we hope that our work is one 
of the studies that gives public health an insight in eradicating inﬂuenza. 
The model can be further studied by introducing seasonality, modelling diﬀerent sup-
types of pathogens, introducing control strategies depending on time for other ob­
jectives in controlling inﬂuenza. It may also be extended to study the vector-borne 
diseases. 
4.3	 A vaccination model for two-cocirculating strains of 
malaria 
We consider two strategies of vaccination and propose two models based on the host-
vector model with polarized immunity in Section 3.1, Chapter 3. First, vaccination is 
applied in the homogeneous human population with the vaccination rate u. Second, 
host age is important so we separate the human population into two age classes, juvenile 
and adult. Children are vaccinated at rate u. 
4.3.1	 A vaccination model with no age classes 
We start with introducing vaccination into the system (3.1.3) and then reduce the 
number of equations in the similar way with the previous study. Based on the status­
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based framework, our primary model is:
 
S˙ ∅(t) = µNh − µS∅ − C(∅, {1}, 1)β1V1S∅ − C(∅, {1, 2}, 1)β1V1S∅−
 
C(∅, {2}, 2)β2V2S∅ − C(∅, {1, 2}, 2)β2V2S∅ − uSφ,
 
˙
S{1}(t) = C(∅, {1}, 1)β1V1S∅ − C({1}, {1, 2}, 2)β2V2S{1}−
 
C({1}, {1, 2}, 1)β1V1S{1} − µS{1} + τuS∅ − uS{1} + τuS{1},
 
˙
S{2}(t) = C(∅, {2}, 2)β2V2S∅ − C({2}, {1, 2}, 1)β1V1S{2}−
 
C({2}, {1, 2}, 2)β2V2S{2} − µS{2} − uS{2},
 
˙
S{1,2}(t) =	 C(∅, {1, 2}, 1)β1V1S∅ + C(∅, {1, 2}, 2)β2V2S∅+ 
C({1}, {1, 2}, 2)β2V2S{1} + C({2}, {1, 2}, 1)β1V1S{2} − µS{1,2}+ 
(1 − τ)uS∅ + (1 − τ )uS{1} + uS{2} − uS{1,2} + uS{1,2}, 
I˙1(t) = β1V1(S∅ + S{2}) − (µ + ν1)I{1},
 
I˙2(t) = β2V2(S∅ + S{1}) − (µ + ν2)I{2},
 
˙
U(t) = B − ηU − α1I1U − α2I2U,
 
V˙1(t) = α1I1U − ηV1,
 
V˙2(t) = α2I2U − ηV2.
 
(4.3.1) 
In this model, we vaccinate a whole human population with rate u. We assume that 
the vaccine protects completely against strain 1, but partially against strain 2 with the 
fraction 1 − τ . The vaccinated individuals move between immune classes. First, naive 
individuals move out from the naive compartment at rate uS∅. Only a fraction τ of 
these enter the S{1} class and the rest of them (a fraction (1 − τ )) enter the S{1,2} class. 
Second, individuals who are already immune to strain 1 move out of the compartment 
by vaccination at rate uS{1} but a fraction τ of these still have only immunity to strain 
1 so they reenter the same class. The rest of them (a fraction (1 − τ)) have immunity 
to both strain and enter the S{1,2} class. Third, individuals who are already immune to 
strain 2 are vaccinated at rate uS{2} and enter the S{1,2} class. Finally, individuals of 
the S{1,2} remain in that class on vaccination. Because C(∅, {1}, 1)+ C(∅, {1, 2}, 1) = 1 
and C({2}, {1, 2}, 1) = 1, 
S˙1 = µNh − µS1 − β1V1S1 − C(∅, {1, 2}, 2)β2V2S∅ − C(2, {1, 2}, 2)β2V2S{2} − uS1. 
By the assumption that the probabilities of acquiring further immune memory to the 
other strain of the naive individual and the infectious individual with the current strain 
are equivalent, C(∅, {1, 2}, 2) = C({2}, {1, 2}, 2) = σ12, we obtain 
S˙1 = µNh − µS1 − β1V1S1 − σ12β2V2S1 − uS1. 
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Similarly, because C(∅, {2}, 2)+C(∅, {1, 2}, 2) = 1, C({1}, {1, 2}, 2) = 1, and C(∅, {1, 2}, 1) = 
C({1}, {1, 2}, 1) = σ21), we have 
S˙2 = µNh − µS2 − β2V2S2 − σ21β1V1S2 − (1 − τ )uS2. 
Hence, the model takes the following form: 
S˙1(t) = µNh − µS1 − β1V1S1 − σβ2V2S1 − uS1,
 
I˙1(t) = β1V1S1 − (µ + ν)I1,
 
S˙2(t) = µNh − µS2 − β2V2S2 − σβ1V1S2 − (1 − τ)uS2,
 
I˙2(t) = β2V2S2 − (µ + ν)I2, (4.3.2)
 
M˙(t) = Bv − α1I1M − α2I2M − γM,
 
V˙1(t) = α1I1M − γV1,
 
V˙2(t) = α2I2M − γV2.
 
In this model, we assume that σ21 = σ12. In the similar way with the system (3.1.4), 
linear stability of the disease-free steady state of this system can be investigated by 
using the next-generation matrix. By ordering the infected variables as I1, I2, V1, V2, 
the matrix of new infections F is given by � 
0 F12 
� 
F = , 
F21 0 
where � 
β1µNh/(µ + u) 0 
� � 
α1Nv 0 
� 
F12 = , F21 = ,
0 β2µNh/(µ + (1 − τ)u) 0 α2Nv 
and 0 = [0]2×2. The matrix of transfer between classes is 
V = diag{µ + ν, µ + ν, γ, γ}. 
The characteristic equation of the next generation matrix (FV −1) is �
µα1β1NhNv 
��
µα2β2NhNv 
�
λ2 − λ2 − = 0. 
γ(µ + u)(µ + ν) γ(µ + (1 − τu)(µ + ν) 
Hence the threshold condition is 
R0vac < 1 
where 
R0vac = max{R01vac, R02vac}, 
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Figure 4-22: (a) A numerical result of the number of infectious human to both strains 
and the number of infectious mosquitoes when R2 = 7, R2 = 6.5, and the vaccination 01 02 
is absent: both strains coexist in the human population. (b) A numerical result when 
R2 = 7, R2 = 6.5, and the vaccination is present at rate u = 0.3 with the partial 01 02 
immunity to strain 2 τ = 0.7: both strains die out quickly. 
� 
µα1β1NhNv 
� 
µ
R01vac = = R01, and 
γ(µ + u)(µ + ν) (µ + u)� 
µα2β2NhNv 
� 
µ

R02vac = = R02.
 
γ(µ + (1 − τ )u)(µ + ν) (µ + (1 − τ )u)
Since considering R0vac and R2 , R2 , R2 whether they are less , R01vac, R02vac 0vac 01vac 02vac 
than 1 or greater than 1 are equivalent, we instead study the latter for the better scale. 
Consequently, the critical value of the vaccination rate to eradicate both strains from 
the host population is � 
µ(R2 − 1)�02 µ(R2 uc = max 01 − 1), .(1 − τ) 
We study the system for the numerical results. In case there are two strains of malaria 
co-circulating with R2 = 7, R2 = 6.5, and σ = 0.35, both strains coexist when the 01 02 
vaccination is absent (see Figure 4-22(a)). However, when the vaccination is present 
and the parameter of cross-protection induced by vaccination 1 − τ = 0.3, the disease 
is eradicated when u > uc = 0.26 where u is taken to be 0.3 (see Figure 4-22(b)). A 
bifurcation diagram of a parameter u and the asymptotic solutions of I1 and I2 when 
τ is ﬁxed at 0.7 is shown in Figure 4-23(a). It can be seen that when u > 0.26, both 
strains dies out in the the host population. In Figure 4-23(b), we ﬁx u = 0.26 and vary 
the parameter τ for the bifurcation diagram of τ and the asymptotic solutions I1 and I2. 
The disease dies out when τ < 0.7. The number of infectious individuals is increased 
when cross-immunity is weak (τ is big). From the bifurcation diagrams, we conclude 
that high rate of vaccination and strong cross-immunity induced by vaccination can 
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Figure 4-23: (a) A bifurcation diagram of vaccination rate u, and the asymptotic 
solutions of infectious individuals to strain 1 and 2 (R2 = 7, R2 = 6.5, σ = 0.35, τ = 01 02 
0.7) (b) A bifurcation diagram of τ , I1(∞), and I2(∞) (u = 0.26) 
guarantee extinction of the strains. 
4.3.2 A vaccination model with age classes 
Because the morbidity between children and adults infected with malaria can be diﬀer­
ent, it might be economical to vaccinate only children. Hence, we propose the model 
with age classes here to study whether the disease can be eradicated by just vaccinating 
children and how realistic it is to do that. We divide the human population into two 
age classes, children and adults. The juvenile and adult groups are described by the 
superscript 1 and 2, respectively. In each age class, an individual belongs to one of 
the immune classes described in the previous models. There is only a recruitment in 
the juvenile group and there is no vertical transmission, so the individuals are born 
disease-free. The transmission rate from infectious mosquitoes with strain i to suscepti­
ble humans in group j is described by βij for i = 1, 2, j = 1, 2 and the transmission rate 
from infectious humans with strain i in group j to susceptible mosquitoes is described 
by αij . We assume that the recovery rate is diﬀerent according to age but not with 
the strain. The death rate µ is the same for all groups. An individual moving out of 
the juvenile into adult is described by the maturation rate ω. Vaccination is applied to 
children only. It is also applied in both susceptible and infectious children because the 
symptoms can be asymptomatic but individuals are infectious. 
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S˙1(t) = µNh − µS11 − ωS11 − β11V1S11 − σβ21V2S11 − uS11 ,1
 
I˙1
1(t) = β11V1S1
1 − (µ + ν1)I11 ,
 
S˙2(t) = ωS1
1 − β12V1S12 − σβ22V2S12 − µS12 ,
1
 
I˙2(t) = β12V1S1
2 − (µ + ν2)I12 ,
1 
S˙2
1(t) = µNh − µS21 − ωS21 − β21V2S21 − σβ11V1S21 − (1 − τ )uS21 , 
I˙1(t) = β21V2S2
1 − (µ + ν1)I21 , (4.3.3)2
 
S˙2(t) = ωS2
1 − β22V2S22 − σβ12V1S22 − µS22 ,
2
 
I˙2(t) = β22V2S2
2 − (µ + ν2)I22 ,
2
 
M˙(t) = Bv − α11I11M − α12I12M − α21I21M − α22I22M − γM,
 
V˙1(t) = α11I1
1M + α12I1
2M − γV1,
 
V˙2(t) = α21I2
1M + α22I2
2M − γV2,
 
where Nh is the total number of host population, Nj the total number of juvenile 
population, Na the total number of adult population, and Nh = Nj + Na. For the 
µsystem to have a constant total number of population, Nj = Na is assumed. ω 
Linear stability of the disease-free steady state of this system can be investigated by us­
ing the next generation matrix. By ordering the infected variables as I1
1, I1
2, I2
1, I2
2, V1, V2, 
the matrix of new infections F is given by ⎡ 
0 0 F13 
⎤ 
F = 0 0⎢ F23 ⎥⎦ ,⎣ 
F31 F32 0 
where � 
β11 0 
� � 
0 β21S2
10 
� 
F13 = , F23 = , 
β12S
20 0 0 β22S20 1 2 � 
α11M
0 α12M
0 
� � 
0 0 
� 
F31 = , F32 = ,
0 0 α21M0 α22M0 
and 0 = [0]2×2. Also, S10, S20, S10, S20 , and M0 are values of the variables at the 1 1 2 2 
disease-free steady state. The matrix of transfer between classes is 
V = diag{µ + ν1, µ + ν2, µ + ν1, µ + ν2, γ, γ}. 
The characteristic equation of the next-generation matrix (FV −1) is 
λ2 
� � 
α11β11M
0S1
10 α12β12M
0S1
20 
��� � 
α21β21M
0S2
10 α22β22M
0S2
20 
��
λ2 − + λ2 − + = 0. 
γ(µ + ν1) γ(µ + ν2) γ(µ + ν1) γ(µ + ν2) 
Hence, the threshold condition is 
Rage−vac < 1 (4.3.4) 
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Figure 4-24: In the simulation, ω = 1/15, ν1 = 365/20, ν2 = 365/14, γ = 365/20, b = 
v v h0.5 ∗ 365, p = p = 0.85, α11Nv = α12Nv = α21Nv = α22Nv = bpv = 155, p = 1 2 1 11 
h h h0.25, p = 0.15, p = 0.22, p = 0.13 (pij is the probability of successful infec­12 21 22 
tion with strain i in group j), β11Nh = bph = 45, β12Nh = bph = 27, β21Nh = 11 12 
bph = 40, β22Nh = bph = 24, τ = 0.7, and σ = 0.35: (a) both strains coexists with 21 22 
R2 = 5.3, R2 = 4.7, (b) both strains die out by vaccination at rate vac−age(1) vac−age(2) 
u = 3. 
where 
Rage−vac = max 
�
Rage−vac(1), R
� 
,age−vac(2)
α11β11µNhNv α12β12µNhNv
R = +age−vac(1) γ(µ + ν1)(µ + ω + u) γ(µ + ν2)(µ + ω + u) 
and 
α21β21µNhNv α22β22µNhNv
Rage−vac(2) + .= γ(µ + ν1)(µ + ω + (1 − τ)u) γ(µ + ν2)(µ + ω + (1 − τ)u)
The critical vaccination rate to eliminate both strains from the population can be 
derived from the threshold condition. The system is unwieldy to analyse, so here 
we show numerically that by applying a vaccination rate that satisﬁes the threshold 
condition (4.3.4), we can eradicate both strains of the diseases (see Figure 4-24). We 
assume that the transmission rate of infectious human to susceptible mosquitoes are 
equal for both strains. Children group is diﬀerent from adult in the transmission 
rate of infectious mosquitoes to susceptible humans and the recovery rate from each 
strain. Without vaccination and R01 = 5.32 and R02 = 4.66, both strains coexist (see 
Figure 4-24(a)). With the vaccination rate u > 2.6, in the simulation u = 3 is chosen, 
both strains go extinct (see Figure 4-24(b)). It means that a vaccination campaign 
must be eﬀective enough to vaccinate a whole children population within six months. 
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4.3.3 Conclusion and discussion 
In case vaccination for malaria is available, it is important to study the transmission 
dynamics of it to gain an insight and to ﬁnd the eﬀective way to eliminate the disease. 
We propose two diﬀerent models to study the protozoan dynamics in host population 
when vaccination is present. The ﬁrst models considers the homogeneous population 
of humans while the second model takes account for the human population with two 
age classes, children and adults. Only the juvenile group is vaccinated instead of a 
whole human population. The second model captures the idea that immune response 
in children might be less eﬃcient than adults. In each model we propose the threshold 
condition for eradicating both strains/species of malaria. We also verify our result 
numerically. 
Assume that the transmission rates of both strains are the same in both groups (α11 = 
α12 = α1 and α21 = α22 = α2). Now, we would like to compare critical rates of 
vaccination to eliminate strain 1 from the population (rate of vaccination for strain 2 
or both strains can be considered in the similar way) in both models, with and without 
age-classes. Because it takes longer for juveniles to recover, recovery rate of adults 
are always bigger, ν1 < ν2. By comparing these two recovery rates with one in the 
homogeneous population model (ν), ν1 < ν < ν2. The critical rate of vaccination to 
eliminate strain 1 from the host population in the non age-class model is 
uc = µ(R2 01 − 1). 
The critical rate of vaccination for strain 1 in the age-class model is � 
(µ + ν) (µ + ν) 
� 
uc−age = µR2 + − (µ + ω).01 (µ + ν1) (µ + ν2) 
Note that we write uc−age in terms of R01 which is the basic reproductive ratio of 
strain 1 in the absence of vaccination in the non age-class model. By our parameter 
range, individuals stay in the juvenile class until they are 15 year old (the maturation 
rate, ω, is 1/15) and they die at age 70 year old (µ = 1/70). We assume that the 
infectious periods of juveniles and adults are 20 and 14 days. Hence, we assume that 
ν1 = 365/20 < ν = 365/17 < ν2 = 365/14. In the non age-class model, we vaccinate a 
whole population while we vaccinate only juveniles in the age-class model. If R2 = 8 01 
and N = 200, 000, we have 
ucN = 20000 and uc−ageNj = uc−age 
µ
N = 5, 210
(µ + ω)
as the total number of individuals whom we need to vaccinate within 1 year to eradicate
 
strain 1 when there are no age classes and when there are age classes, respectively. We
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ﬁnd that public heath only needs to vaccinate at least 5,210 juveniles per year to control 
strain 1 while they need to vaccinate at least 20,000 of random individuals to be able 
to drive out strain 1. From this result, we suggest that vaccinating only juveniles is 
more eﬀective than random individuals. 
4.4 Controlling mosquitoes 
Another eﬀective way of controlling malaria is by controlling mosquitoes (Takken and 
Knols, 2005). Several means aﬀect mosquitoes diﬀerently. For example, destroying 
the mosquito’s habitat and breeding sites, the use of larvicide, and introducing sterile 
mosquitoes help to reduce the number of new coming mosquitoes (Fillinger and Lind­
say, 2006; Fillinger et al., 2009; Scott et al., 2002). The use of repellents and bed nets 
does not kill mosquitoes but helps to decrease the biting rate (Bradley et al., 1986). 
By spraying the walls and ceilings of the house with insecticide, the survival of adult 
mosquitoes resting indoors is reduced (Pates et al., 2005). Recent reports show im­
provement of the study that could lead to introducing genetically modiﬁed mosquitoes, 
that could kill 100 per cent of parasites in their guts, to replace wild mosquitoes (Ito 
et al., 2002; Povelones et al., 2009) so that the transmission of malaria to humans is 
reduced by reducing the probability of successful infection in a human who gets bitten 
by an infectious mosquito 
Referring to the basic reproductive ratio of strain i (for i = 1, 2) of the system (3.1.4), �
αiβiNM 
R0i = .(µ + ν)η 
Because the use of mosquito repellents and bed nets reduces the biting rate which is 
described in the model via the transmission rate of infection to humans and mosquitoes 
(βi, αi) such that βiN = bphi and αiM = bpmi respectively where; b is the biting rate of 
mosquitoes (bites/human/year); phi is the probability of successful infection with strain 
i in human, and pmi is the probability of successful infection with strain i in mosquito, 
the basic reproductive ratio of the strain in the system (3.1.4) is reduced by the eﬀect of 
reducing the biting rate. Furthermore, if the biting rate is eﬀectively reduced such that 
R0i becomes less than 1, the strain is eradicated from the host population. Although 
reducing biting rate of mosquitoes can reduce the basic reproductive ratios of both 
strains at the same time, here we only show the result of it in strain 1 when 
b2ph1 pm1R2 = 01 (µ + ν)η 
The study of it in strain 2 can be done in the similar way. The study of the eﬀect of
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Figure 4-25: (a) A relation between the ratio of the biting rate which is reduced by 
applying control via bed nets and repellents (bc) comparing with the biting rate at the 
beginning when a control is not applied yet (b) and the square of the basic reproductive 
ratio of strain 1 (b = 0.5 ∗ 365, ph1 = 0.1, pm1 = 0.85) (b) A relation between the 
recruitment rate which is reduced by control via destroying mosquito habitat (Bc) 
comparing with the recruitment rate at the beginning when a control is not yet used 
(B) and the square of the basic reproductive ratio of strain 1 (B = M ∗ η = 4.2e+6, 
b = 0.5 ∗ 365) 
reducing biting rate to both strains at the same time is consequently the result of those 
two studies. In Figure 4-25(a), we show that the basic reproductive ratio of strain 1 
is reduced by decreasing biting rate of mosquitoes at the beginning. At bc/b = 1, it is 
before the control is launched where R2 = 5.95, bc represents the new biting rate when 01 
the control is present, and bc = b = 0.5 ∗ 365 bites/human/year. After the biting rate 
b2 is reduced so that bc/b < 1, the basic reproductive ratio of strain 1 
�
R2 = c ph1 pm1 
� 
01c (µ+ν)η 
is decreased. If the biting rate bc is below 0.2 (or bc/b < 0.41), strain 1 dies out. 
By destroying the mosquito’s habitat,applying the larvicides, or introducing the sterile 
mosquitoes, we reduce the parameter B which is the recruitment rate of mosquitoes in 
the basic reproductive ratio. Again, here we only consider the eﬀect of it in strain 1. 
Figure 4-25(b) shows that reducing prevalence of strain 1 can be done by decreasing 
the recruitment rate of mosquitoes via destroying the mosquito’s habitat or breeding 
sites. At Bc/B = 1 where Bc is the new recruitment rate when the control is present, 
we begin with R2 = 5.95 and Bc = B = 4.2e+6 numbers of mosquitoes per year. 1 
After the recruitment rate is reduced by the control so that Bc/B < 1, the basic 
Bcbph1 bpm1 Mreproductive ratio of strain 1 
�
R2 = 
�
, where M is 231000 without any 1c η2(µ+ν) 
control, is decreased. In case the recruitment Bc is below 7e+5 mosquitoes/year (or 
Bc/B < 0.17), strain 1 is extinct. 
By considering the possibility of replacing the wild mosquitoes by genetically modiﬁed 
mosquitoes that could kill the malaria parasites in their guts, we might be able to 
reduce the prevalence of malaria by reducing the probability of infection in human 
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When ph1 is reduced, the basic reproductive ratio R
2 
01c becomes smaller (see 
Figure 4-26(a)). At phc/ph1 1, the control is absent. When the control is applied, 
the ratio becomes less than 1 and when ph1 is below 0.01 (or ph1c/ph1 < 1/R
2 
01 ≈ 0.13), 
malaria is eradicated. 
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Figure 4-26: (a) A relation between the ratio of the probability of successful infection in 
human when the control is applied (phc) and when it is not applied (ph) with R2 (b) A 01 
plot between rate of killing mosquitoes by the insecticide (ω) and the basic reproductive 
ratio (R01) 
Finally, by launching the insecticide programme to control the mosquitoes, some adult 
mosquitoes die in the sprayed areas. We can describe this strategy in the model (3.1.4) 
by removing both susceptible and infectious mosquitoes at rate ω. Hence, the terms 
−ωU , −ωV1, and −ωV2 are added to the right hand side of the diﬀerential equations 
for U , V1, and V2 in the system (3.1.4). The total size of mosquito population is now 
b2ph1 pm1 qtime-dependent. The basic reproductive ratio becomes R2 = . In Figure 4­01c (η+ω)(µ+ν) 
26(b), we show the relation between rate of decreasing mosquitoes by the insecticide 
and the basic reproductive ratio. In case, we start with R2 = 8 in the absence of 01 
the insecticide programme, the basic reproductive ratio is reduced when the insecticide 
programme is eﬀective. To eradicate malaria, we need ω = 129 or in other words 
we need to shorten mosquito’s lifetime to be approximately 3 days on average by the 
insecticide. 
In conclusion, we suggest that all the control measures should be launched together to 
eﬃciently ﬁnd the way to reduce the loss from malaria or hopefully eradicate it. The 
optimal strategy should be further studied. 
Conclusion and discussion 
We discuss the control measures in mosquitoes. This is done by considering the ba­
sic reproductive ratios, how the controls aﬀect parameters in the model and conse­
quently aﬀect the basic reproductive ratios, and how to eradicate the disease accord­
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ing to the threshold condition. Several ways of controlling mosquitoes are discussed. 
For example, destroying mosquito’s habitats, applying larvicides, and releasing ster­
ile mosquitoes reduce the number of new coming mosquitoes, which is described by 
the recruitment rate in the model. To eradicate the disease, the controls must be ap­
Bb2phpmplied until 
�
R0 = < 1
� 
where B is the recruitment rate and other parameters 
η2(µ+ν)N 
are ﬁxed. Other controls such as the use of bed nets, releasing genetically modiﬁed 
mosquitoes that could not transmit malaria, the use of insecticides, are also discussed 
in the similar way. 
4.5 Conclusions and discussion 
We ﬁrst study a status-based model based on Gog and Grenfell (2002) for two strains of 
inﬂuenza when isolation and vaccination are present. The goal of this study is to try to 
understand how isolation and vaccination help with controlling inﬂuenza. We propose 
critical isolation rate and vaccination coverage in terms of the parameters when there 
is no intervention. These sets of critical values help to predict what the result in long 
term should be when isolation and vaccination are applied. This may be useful in term 
of controlling inﬂuenza. Numerically, we assume a delay in isolation. We ﬁnd that 
the delay leads to serious outbreaks through the time space. Hence, we recommend 
public health to start isolation programme since the beginning to reduce loss as much 
as possible. We next consider the epidemic quantities: the basic reproductive ratio, 
the mean age at infection, the invasion rate of new strain, and the economic cost. By 
comparing the basic reproductive ratios, we ﬁnd that strains should be more virulent 
when isolation or vaccination are present to be able to invade the host population. 
We ﬁnd that the host mean age at infection is extended by isolation, vaccination, or 
coexistence with the other strain. Interestingly, isolation and vaccination lead to higher 
rate of invasion comparing with when there is no intervention. We suggest that a new 
strain needs to have a higher rate of invasion to be able to establish in the population 
not only to compete with the endemic strain but also in the situation that controls are 
applied. We ﬁnd that isolation and vaccination help to reduce the total cost of loss 
from hospitalization and individual income. 
Second, we study a vaccination model of inﬂuenza with waning of immunity and cross-
immunity with time. This model is used to study inﬂuenza strains in the same cluster. 
In this work, we ﬁrst introduce a constant rate vaccination and propose a critical 
rate of vaccination to eliminate inﬂuenza from the population. We next introduce a 
time-dependent rate of vaccination to minimize the treatment cost for inﬂuenza. We 
ﬁnd the optimal control that helps to eliminate inﬂuenza and minimize the treatment 
cost. From our optimal control shape, a high rate of vaccination is needed at the 
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beginning but it can be reduced after certain time later. Moreover, we also ﬁnd that 
cross-immunity help to strictness of control measure. 
Third, in this section, we introduce vaccination into the malaria model in Chapter 3. 
We consider two types of vaccination models: with no age classes and without age 
classes. We propose critical vaccination rates for eliminating both strains of malaria 
for both models. By comparing the minimum number of individuals whom we need 
to vaccinate within one year to eradicate malaria strain from the human population, 
we ﬁnd that vaccination only in juveniles is more eﬀective than vaccination in both 
juveniles and adults. 
We ﬁnally end this chapter by discussing about controlling mosquitoes. This is one 
of the most important way to control diseases such as malaria. We consider four 
diﬀerent means of controlling mosquitoes: 1) by using bed nets and repellents to reduce 
bitting rate of mosquitoes, 2) by using larvicides, destroying mosquito’s habitat, and 
introducing sterile mosquitoes, to reduce mosquito newcomers, 3) by replacing wild 
mosquitoes by genetically modiﬁed mosquitoes that do not transmit malaria to reduce 
the probability of infection, and 4) by applying insecticide to increase the death rate 
of adult mosquitoes. To eliminate malaria, we introduce a critical value of a controlled 
variable in each means. 
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Chapter 5 
Conclusion and further work 
For decades, the world has been challenged by the reemergence of multi-strain infectious 
diseases such as inﬂuenza, malaria, HIV, and hepatitis. In this work, we are particularly 
interested in inﬂuenza and malaria which are endemic in many areas of the world. We 
use mathematical models to study the dynamics of the diseases in order to try to 
understand and gain insights when various factors are taken into account. In some 
diseases, for instance inﬂuenza, cross-immunity plays an important role in reducing the 
prevalence and spread of the disease. Hence, we here concentrate on the presence of 
cross-immunity in the model. In chapter 2, we use a real line to represent antigenic 
space where each point on the real line represents each strain of inﬂuenza. The system 
of n ordinary diﬀerential equations based on the status-based framework by Gog and 
Grenfell (2002) becomes a system of two integro-diﬀerential equations. When mutation 
in the virus is introduced, we ﬁnd that a travelling wave occurs and represents an 
antigenic drift process with strains present in the population dying out and being 
replaced by new ones at new points in the antigenic space. We also ﬁnd that the 
presence of cross-immunity might not aﬀect a wave speed of travelling wave. In the 
case that cross-immunity is only conferred on two neighbouring strains, we show that 
a travelling wave always occurs whenever mutation is present and we furthermore 
calculate the minimum wave speed which is independent of the cross-immunity value. 
This model can be further investigated in a two-dimensional antigenic space. In the 
second section, we propose a metapopulation model to study spatial heterogeneity in 
two subpopulations. We introduce the basic reproductive ratio of the system and show 
numerically that the threshold conditions are satisﬁed. This metapopulation model 
should be further investigated when controls such as vaccination and vaccination are 
present or when stochastic eﬀects are included. 
We devote chapter 3 to study a multi-strain vector-borne disease like malaria. In the 
ﬁrst section, we introduce a status-based framework where an individual is categorized 
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by its immune status and cross-immunity is conferred by exposure to the disease via an 
infective mosquito, rather than developing the full infection itself, the model becomes 
tractable with only one immune variable to describe host immunity to each strain. The 
model is studied analytically and numerically for threshold conditions for a strain. In 
the second section, we introduce single-species models for P. falciparum and P. vivax 
with acquired immunity allowed to wane with time. We then introduce a coinfection 
model that captures interactions between both species by including suppression of 
both species to each other during coinfection. We further investigate whether P. vivax 
avoids encountering P. falciparum which is more harmful by introducing seasonality 
in transmission rate of P. falciparum as a sinusoidal function under the assumption 
that there is a season in each year that P. falciparum is highly transmitted. We 
ﬁnd that the prevalence of P. vivax is high between every two peaks of P. falciparum 
which suggests that during high transmission of P. falciparum, P. vivax may maintain 
lower transmission and it may become highly transmitted later when the prevalence of 
P. falciparum is low. By omitting coinfection between P. falciparum and P. vivax, we 
propose a cross-immunity model by assuming that cross-species immunity is present and 
acts in the similar way with suppression during subsequent infection in the coinfection 
model. We study the relation between cross-immunity values, cross-immunity of P. 
falciparum to reduce transmission of P. vivax and cross-immunity of P. vivax to reduce 
complication of P. falciparum. We ﬁnd that when the former is very high, P. vivax 
may die out while both coexist no matter how large the latter is unless the former is 
very high. Moreover, we further investigate the mean age of infection. We ﬁnd that 
the latter helps to increase the mean age at infection while the former reduces it. 
In addition, we study a single species or strain model with waning immunity based on 
the SIRS model for human population and the SI model for mosquito population. We 
individualy incoporate seasonality, incubation time in mosquitoes, and vector-bias to 
infectious humans. In case there are three seasons (hot, rainy, winter) in each year, 
by introducing seasonality in the recruitment and transmission rates, malaria might 
be highly transmitted between hot and rainy season. By incorporating incubation 
time in mosquitoes, the prevalence of malaria is reduced when malaria parasites take 
longer to incubate in mosquitoes. By including manipulation of malaria parasites that 
infectious humans might be more attractive to mosquitoes than susceptible or recovered 
humans, a diﬀusion term to represent mosquito movement, and a chemotactic term 
toward chemical such as breath or sweat, travelling waves from infected population to 
uninfected population occurs. We also ﬁnd that the more attractive infectious humans 
are, the faster the disease travels and spreads. The minimum wave speed is calculated 
analytically. We next study a vector-bias bias model in detail. However, the model for 
humans is based on the SIS model which is another type of model that has been used 
to study malaria and is in more simplistic form. We show that transcritical bifurcation 
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occurs at the basic reproductive ratio of the system equaling 1 by projecting the fold 
onto the extended centre manifold. We introduce incabation time in mosquitoes into 
the vector-bias model and ﬁnd that the longer incubation time reduces the prevalence 
of malaria. We then incorporate a random movement of mosquitoes and a chemotactic 
terms toward humans, both of which result in the occurence of travelling waves. Its 
speed is estimated numerically and the minimum wave speed is calculated analytically. 
In chapter 4, we study multi-strain models in the presence of controls. We introduce 
isolation and vaccination into the status-based model for inﬂuenza based on Gog and 
Grenfell (2002) in the ﬁrst section. In the isolation model, infectious individuals are 
removed to isolation. A fraction of newborns is vaccinated with two possibilities, ac­
quiring immunity to strain 1 only or acquiring complete immunity to both strains, in 
the vaccination model. We determine steady states and their stability conditions. We 
plot transcritical bifurcation diagrams with isolation rate and vaccination rate as bifur­
cation parameters. We then illustrate some of numerical results that satisfy with the 
diagrams. We compare epidemic quantities, the mean age at infection, the invasion rate 
of a new strain, and the economic cost. For example, we show that the host’s mean 
age at infection is increased by isolation, vaccination, and the presence of the other 
strain. By considering the invasion rate of strain 2, we ﬁnd that the new strain with 
higher transmission rate is preferred in the presence of isolation and vaccination. In the 
second section, we study controls in inﬂuenza based on the SIRC model with waning 
of immunity in recovered and cross-immune individuals (Casagrandi et al., 2006). We 
consider constant and time-dependent rate of vaccination in the model. We propose 
a critical rate of vaccination to eradicate the disease. In case the goal of vacccina­
tion campaign is to eradicate inﬂuenza with minimizing the treatment cost, we ﬁnd 
that cross-immunity is an important key for the shape of the optimal control. The 
weaker cross-immunity is, the stronger vaccination control needs and the more number 
of infectious individuals is. 
For malaria, controls can be applied in either humans or mosquitoes. Here, we as­
sume that vaccination is available and study two types of models, with and without 
age-classes. The model is based on a status-based framework in Section 3.1, Chap­
ter 3. The ﬁrst model considers the homogeneous population of humans while the 
second model takes into account the less immune response in children than adults. 
For both models, we propose the threshold conditions to eradicate malaria and verify 
them numerically. In controlling mosquitoes, there are various means such as destroy­
ing mosquito’s breeding sites, applying larvicide, using bed nets and repellents, using 
insecticide, and possibly introducing genetically modiﬁed mosquitoes. Several means 
aﬀect mosquitoes diﬀerently. Here, we consider how controls aﬀect parameters in the 
model via the basic reproductive ratio of the system, since eradication follows if con­
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trols are applied until the basic reproductive ratio becomes less than 1. This work 
can be further investigated by introducing multiple controls in a host-vector model for 
malaria for optimal control strategies. 
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